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In recent years there has been increasing interest in the role of the immune system in
reproductive physiology. The aim of this study was to quantify immune cell populations
within the cow corpus luteum (CL) throughout the oestrous cycle in order to investigate
whether these cells could be involved in controlling luteal function, particularly around
the time of luteolysis. Although prostaglandin F2a (PGF2a) released from the uterus is
known to be the luteolytic substance in the cow, events occurring at the level of the CL at
this time are less clearly defined. Immune cells and their cytokine products have
significant potential to influence the cells of the CL at luteolysis.
Six CL were collected from each of four stages of the oestrous cycle, identified on the
basis of their gross appearance, for preliminary immunohistochemical studies. Immune
cell populations and MHC II expression varied throughout the oestrous cycle. In
particular, the number of macrophages, T-lymphocytes (CD5+, CD4+) and MHC II
expression was significantly higher in late stage CL (after luteolysis) compared to all
other stages. To study in more detail the cellular events associated with luteolysis, the
oestrous cycles of 19 cows were synchronised. CL were collected between days 16 and
20 of the following oestrous cycle. A significant increase in the number of T-
lymphocytes (CD5+, CD8+) was detected in CL collected from day 16 onwards,
compared to days 13-14. This increase occurred prior to functional luteolysis.
Artificially-induced luteolysis was then assessed as a potential model for further studies
around luteolysis. CL collected 6, 12 and 24 hours after luteolysis, induced using a
single injection of 25mg PGF2a, had undergone dramatic structural regression which
bore little resemblance to events during normal luteolysis and so this model was
rejected. The role of endogenous PGF2a in inducing the influx of T-lymphocytes was
then investigated. Production of PGF2a was inhibited in 12 cows between days 15 and
18 of the oestrous cycle and artificially replaced in six cows for 24 hours before
collection of the C.L on day 18. The number of macrophages was significantly lower in
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all animals in which PGF2a was inhibited compared to control animals but T-
lymphocyte numbers were not significantly altered.
Cytokine production within the CL was also studied using the reverse trancriptase
polymerase chain reaction (RT-PCR). Tumour necrosis factor-a, (TNF-a), interleukin-
1 (3 (II-1 (3) and interferon-y (IFN-y) were detectable in similar amounts in CL at all stages
of the oestrous cycle and after induced luteolysis and PGF2a inhibition. Monocyte
chemoattractant protein-1 (MCP-1) was higher in CL from animals after functional
luteolysis compared to CL collected prior to luteolysis but the increase occurred before
macrophage numbers in the CL increased. MCP-1 may be involved in chemotaxis of
monocytes into the CL during luteal regression.
In conclusion, these results provide further evidence of a role for immune cells,
particularly T-lymphocytes, in controlling CL function, outwith their involvement in
structural luteolysis. Increasing concentrations of PGF2a may be one of the major factors
influencing the presence of macrophages, and possibly other immune cells, in luteal
tissue. The presence of mRNA for TNF-a, EL-1 (3, IFN-y and MCP-1 at all stages studied
indicates a potential role for these substances in the CL although more detailed
investigations are required. MCP-1 appears to have a specific involvement in the
chemotaxis of monocytes to the CL in preparation for structural regression.
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In the last thirty years there have been significant advances in our understanding of
the reproductive cycle in the cow and how it is controlled. This has led to the
development of improved methods of oestrous synchronisation and artificial
insemination as well as embryo transfer. All of these techniques are now used
successfully in a wide range of management systems. However there are still many
reproductive processes that are not fully understood and new areas of research
relating to reproduction are emerging. In particular, the role of the immune system,
which would previously have been regarded as being somewhat irrelevant to
reproduction, has recently come under investigation. This interest has been
stimulated as advances in the fields of immunology and reproductive endocrinology
have revealed an overlap in function between the two systems (Mori, 1990; Stern and
Coulam, 1992).
The cells of the immune system and their products have the capacity to influence
reproduction from the level of the hypothalamus to the uterus (Tabibzadeh, 1994). In
particular, immune cell populations in the ovary may affect the lifespan and function
of ovarian structures especially around key ovarian events such as ovulation and
luteolysis (Brannstrom and Norman, 1993; Pate, 1995; Terranova and Montgomery
Rice, 1997). However, the mechanisms by which these cells may exert their effects
have yet to be fully established, partly because of the vast number of potential cell
interactions involved.
In this review the basic physiology of the oestrous cycle in the cow will be discussed
followed by the structure and function of the bovine corpus luteum and luteolysis.
The immune system and its role in reproduction will then be discussed in some
detail. For the purposes of this review I will concentrate on the cow with reference to
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other species where relevant. The luteal phase of the oestrous cycle will be
emphasised, with limited reference to the control of follicular development except in
relation to the immune system.
1.2. Basic physiology of the bovine oestrous cycle
The hormonal events and ovarian dynamics associated with the oestrous cycle in the
cow are well known (Hansel and Convey, 1983; Greenwald and Roy, 1994) and may
be summarised briefly as follows; the normal oestrous cycle in the cow lasts around
21 days. During this time the CL is the dominant ovarian structure between days 2
and 17 (Hansel et al., 1973). The CL forms after ovulation from the granulosa and
theca interna cells of the collapsed ovulatory follicle and its primary function is to
produce progesterone which will prepare the reproductive tract for pregnancy (see
Smith et al., 1994 for a review). Luteal development is rapid and maximum size is
reached around days 6-9 of the oestrous cycle (Hafs and Armstrong, 1968; Ireland et
al., 1980). During luteal development progesterone production by the CL increases,
resulting in peak systemic concentrations around day 8. The high systemic
progesterone concentrations are then maintained until luteolysis begins around day
17-18 (Hafs and Armstrong, 1968; Wiltbank, 1994).
Regression of the CL at the end of its lifespan in the non-pregnant cycle occurs in
response to prostaglandin F2a (PGF2a) which is released from the uterus. (Luteolysis
is discussed in detail in this review in Section 1.4). There is a rapid decline in the
concentrations of follicle-stimulating hormone (FSH) and progesterone during
luteolysis. The decline in progesterone concentrations removes the negative feedback
effect on both gonadotrophin-releasing hormone (GnRH) from the hypothalamus and
luteinising hormone (LH) from the anterior pituitary. These hormones control the
growth of the ovulatory follicle and therefore progesterone inhibits maturation of a
dominant follicle until after luteolysis, although waves of follicular growth,
controlled by LH pulses, continue to occur throughout the lifespan of the CL
(Fortune, 1994; Greenwald and Roy, 1994). Factors affecting follicular development
and selection of the dominant follicle in the cow are reviewed by Webb et al. (1992)
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and follicular steroidogenesis is described by Gore-Langton and Armstrong (1994).
Ovulation in the cow is caused by the preovulatory LH surge which is itself induced
by the high concentrations of oestradiol produced by the pre-ovulatory follicle.
Ovulation takes place around 24 hours after the LH surge and then the next cycle of
luteal development begins.
1.3. The Corpus Luteum
1.3.1 Gross structure
The gross appearance of the CL changes markedly throughout the oestrous cycle and
these changes can be used to determine the approximate age of luteal tissue collected
from animals with unknown reproductive histories (Ireland et al., 1980; Fields and
Fields, 1996). The early CL developing after ovulation grows rapidly between days 1
and 4 to around 1-1.5cm in diameter. At this stage the point of follicular rupture is
still visible and the tissue is soft and creamy red in colour with a blood-filled centre.
Between days 5 and 12 the CL matures to its maximum size of 2-2.5cm and the
tissue becomes more firm in texture and orange in colour, although the apex is still
red. A fluid filled lacuna can sometimes be found. The presence or absence of a
lacuna during the CL lifespan does not appear to alter luteal function (Okuda et al.,
1988). After this stage the CL does not alter in size but becomes firmer in texture,
has a vivid homogenous orange colour and distinct blood vessels develop over the
capsule. After the onset of luteolysis, the CL decreases rapidly in size until it is
eventually absorbed into the ovarian stroma. The regressing CL is much more fibrous
and somewhere between bright yellow and white in colour.
During pregnancy the CL is maintained at its maximum size throughout gestation
(see Gibori, 1993 for a review article). The CL is required functionally until the last
70 days of pregnancy (see Niswender and Nett, 1994, for a review). The CL of
pregnancy is similar in structure to a mid-cycle CL (Sawyer, 1995) but regresses
much more slowly after parturition than the CL from a non-pregnant cycle and small,
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white areas of luteal tissue (corpus albicans) can often be seen in ovaries which are
remnants of CL from previous pregnancies (Ireland et al., 1980).
1.3.2. infrastructure
The CL of the cow, as in other ruminants, is made up of a variety of cell types (see
O'Shea, 1987 and Fields and Fields, 1996 for review articles). Luteal cells make up a
significant proportion of these cells but there are also large numbers of fibroblasts
and endothelial cells as well as cells of the immune system, particularly macrophages
(O'Shea et al., 1989; Lei et al., 1991). The bovine CL also contains a large amount of
collagen (Luck and Zhao, 1993; Luck et al., 1995). Many of the non-luteal cells
present are associated with the significant vascular network in luteal tissue as the CL
receives the highest blood flow, relative to its size, of any organ (Smith et al., 1994).
The luteal cells have been classified on the basis of cell diameter into two distinct
populations: small luteal cells and large luteal cells (Ursely and Leymarie, 1979;
Koos and Hansel, 1981). Small luteal cells are around 10-22p.m in diameter but there
is some variation in the size specified for large luteal cells: >25|im from
enzymatically dispersed luteal cell studies (Hansel et al., 1987) and >35(im from
morphometric studies (O'Shea et al., 1989). Although the two cell populations are
distinct there is likely to be some overlap in size and it is more difficult to clearly
differentiate the two luteal cell populations by light microscopy in the sheep than the
cow (O'Shea et al., 1990; Parkinson et al., 1994). In recent years there has been some
suggestion that subpopulations of large and small luteal cells may also exist (Fields
and Fields, 1996; Schmitt et al., 1996)
1.3.3. Luteal cells - ultrastructural andfunctional differences
In addition to difference in size, large and small cells also have different
ultrastructures and functions (Niswender et al., 1985; Fields and Fields, 1996).
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1.3.3.1. Ultrastructural differences
The ultrastructures of large and small luteal cells in the cow CL have been studied in
detail (Koos and Hansel, 1981; O'Shea et al., 1990). Both cell types contain
intracellular structures associated with steroidogenesis including numerous
mitochondria and abundant smooth endoplasmic reticulum. The small cells have a
relatively smooth surface with a cup-shaped nucleus which stains intensely for
chromatin. Large cells have a central round nucleus with less dense chromatin than
small cells and a more distinct nucleolus. The surface membrane of the large cell is
highly convoluted, with numerous microvilli which hold large and small cells tightly
together. This tight cell adhesion has to be overcome when attempting to disperse
luteal tissue to obtain populations of luteal cells for in vitro studies. The cytoplasm of
large cells also contains Golgi complexes and rough endoplasmic reticulum, both
structures being required for protein production.
One of the distinguishing features of large cells is the presence of small electron
dense granules within their cytoplasm which are released by exocytosis (Parry et al.,
1980; O'Shea et al., 1990). These granules were initially thought to contain
progesterone because of a correlation between progesterone concentrations and
granule release during the oestrous cycle of the sheep (Gemmell et al., 1974; Stacy et
al., 1976). However, immunocytochemical studies showed that these granules
contained oxytocin and its carrier protein neurophysin (Fields and Fields, 1986;
Sawyer et al., 1986) as well as vasopressin (Wathes et al., 1984) and relaxin in
pregnant cows (Fields et al., 1980). A later study showed that these secretory
granules were present in large luteal cells at all stages of the luteal lifespan and that
the number of cells containing them varied between 3% on day 3 of the oestrous
cycle and 85% on day 19 (Fields et al., 1992). The substances contained in these
secretory granules have a variety of functions (Smith, 1986; Schams, 1987). The role
of oxytocin is discussed in detail in Section 1.4.3.1.
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1.3.3.2. Functional differences
Although large and small cells both contain the cell organelles required for steroid
synthesis they differ greatly in basal progesterone production as well as in their
response to a variety of hormones including LH and PGF2a (see Hansel et al., 1991
for a review).
Basal production of progesterone by large luteal cells is around 20 times higher than
that of the small cells (Koos and Hansel, 1981) and these high basal levels account
for at least 80% of the progesterone produced by the CL in vivo (Niswender et al.,
1985). However small luteal cells are far more responsive to stimulation by LH in the
cow and the sheep (Ursely and Leymarie, 1979; Koos and Hansel, 1981; Fitz et al.,
1982). Initially this was thought to be due to the presence of greater numbers of LH
receptors on small cells compared to large cells (Fitz et al., 1982). However, more
recent studies have found equal numbers of LH receptors on large and small luteal
cells, or greater numbers of LH receptors on large luteal cells compared to small
luteal cells (Harrison et al., 1987; Chegini et al., 1991). The numbers of LH receptors
present on luteal cells is regulated by progesterone, particularly in early CL (Jones et
al., 1992).
Small and large luteal cells also differ in their responsiveness to PGF2a, the main
luteolytic hormone in the cow. Studies in vitro have demonstrated that PGF2a
stimulates progesterone production by small cells but inhibits progesterone
production by large cells (Alila et al., 1988; Davis et al., 1989). Specific PGF2ot
receptors are found on both types of luteal cells (Powell et al., 1975) but the majority
are present on large cells (Braun et al., 1988). It appears therefore that large cells are
the main target for the luteolytic effect of PGF2a in late stage CL. Binding affinity for
PGF2a is higher in late stage CL compared to early or mid-cycle (Rao et al., 1979).
Receptors for prostaglandin E2 (PGE2), which is a luteotrophic substance in the cow
(Fitz et al., 1993), are also more abundant on large cells than small cells (Fitz et al.,
1982).
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Two morphologically distinct cell types, identifiable as large and small luteal cells,
are also present in the CL of pregnancy (Sawyer, 1995). In the pregnant cow CL both
cell types produce similar amounts of progesterone when unstimulated and respond
in the same way to gonadotrophins (Chegini et al., 1984). Another study found that
bothsmall and large luteal cells from pregnant cows contained equal amounts of
progesterone but neither cell type responded to LH-stimulation in vitro (Weber et al.,
1987).
1.3.4. The Development ofthe CL
1.3.4.1. CL formation after ovulation
The CL develops rapidly from the remnants of the dominant follicle after ovulation
(see Smith et al., 1994, for a review). After follicular rupture there is folding of the
follicular wall and fibroblasts, endothelial cells and theca interna cells migrate into
the early CL (O'Shea et al., 1980). The theca interna and granulosa cells luteinise and
large and small luteal cells increase in size and develop their characteristic features.
Increasing amounts of progesterone are produced as the luteal cells, particularly large
luteal cells, enlarge (Farin et al., 1986). Increased production of progesterone is also
associated with the rapid development of the blood supply in the CL (see Section
1.3.4.3.). Blood vessels gradually invade the collapsed follicle to establish a major
network of capillaries which will ensure that the majority of luteal cells are in close
contact with a blood supply (Niswender et al., 1976). After the blood supply is
established and luteinisation has taken place the changes within the CL are associated
with rapid growth of the tissue due to hypertrophy of the luteal cells as well as
proliferation of both luteal and non-luteal cells (Jablonka-Shariff et al., 1993).
Development of the CL is under the control of a large number of local and systemic
factors (Smith, 1994). In recent years there has been particular interest in the role of
matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinase (TIMP)
in CL formation. Metalloproteinases, such as gelatinase and collagenase, are locally
produced proteins extensively involved in tissue remodelling and angiogenesis, both
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significant processes in the CL. MMP activity has been observed in day 4 CL when
angiogenesis and cell proliferation will be occurring rapidly (Tsang et al., 1995).
However, MMP-2, MMP-9 as well as TIMP-1 and TIMP-2 were also present in CL
collected between days 6 and 16 of the oestrous cycle (Goldberg et al., 1996). It
appears that metalloproteinases have a role within the CL, not only during the period
of maximum growth, but also throughout its functional lifespan.
1.3.4.2. The origin of luteal cells
The cellular origin of the individual luteal cell types has been a subject of great
debate. Donaldson and Hansel (1965) stated, from histological studies, that luteal
cells in the cow CL developed from both the theca and granulosa layers of the follicle
and a similar finding was described by Lobel and Levey (1968). Later studies in the
sheep indicated that the theca interna was the source of the small luteal cell and the
granulosa cell the source of the large luteal cell (O'Shea et al., 1980). Similar
findings were then described in the cow where bovine granulosa and thecal cells,
when luteinised in culture, differentiated into large luteal type cells and small luteal
like cells respectively (Meidan et al., 1990).
In the cow CL, the novel use of monoclonal antibodies to antigens expressed on
theca and granulosa cell surfaces allowed clearer identification of the origins of the
two luteal cell types (Alila and Hansel, 1984). Indirect immunofluorescence was used
to look at binding of these antibodies at different stages of the CL lifespan. Large
cells were seen to primarily express granulosa cell antigen although this expression
declined with age of CL. The majority of small cells expressed thecal cell antigen
throughout the lifespan of the CL. However, around days 10-12 of the oestrous cycle
up to 46% of the large cells also expressed thecal cell antigen compared to 10% at
days 4-6.
These results provided evidence of the cellular origin of luteal cells but also indicated
that some small luteal cells develop into large luteal cells during the lifespan of the
CL, a process first suggested by workers studying basic histology of the bovine CL
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(Donaldson and Hansel, 1965). There is however some suggestion that the use of
enzymatically-dispersed cells in the monoclonal antibody study might have
artificially altered the luteal cell populations and hence, skewed the results (O'Shea
et al., 1990).
An ultrastructural study in the cow CL revealed no evidence of a separate population
of large cells that might have been formed from small luteal cells (O'Shea et al.,
1990), although a later morphometric study did find evidence that a proportion of
small luteal cells differentiated into large luteal cells late in the oestrous cycle (Lei et
al., 1991). In the sheep no change in large luteal cell numbers, indicative of
differentiation of small luteal cells into large cells, was detectable by morphometric
analysis of luteal tissue from different stages of the oestrous cycle (O'Shea et al.,
1986; Farin et al., 1986). However, a later study in the sheep showed that
significantly more small luteal cells differentiated into large luteal cells in ewes
treated with human chorionic gonadotrophin (hCG) and LH in vivo compared to
sheep CL from ewes treated with saline prior to collection of the CL (Farin et al.,
1988). The evidence for the differentiation of small luteal cells into large luteal cells
as part of luteal development remains somewhat inconclusive.
1.3.4.3. Angiogenesis
During development of the CL there is formation of a vascular network under the
influence of a range of angiogenic factors (Smith et al., 1994; Redmer and Reynolds,
1996). In addition angiogenesis is an important process during luteal regression when
rapid vascular restructuring takes place (O'Shea et al., 1977; Redmer et al., 1988).
The vascular component of luteal tissue is extensive and the mature CL receives one
of the greatest rates of blood flow to any organ, reaching 10-15ml/min per gram of
tissue (Ford and Chenault, 1981). The greatest flow rates are found during the luteal
phase and a rapid decline in flow is associated with luteolysis (Ford and Chenault,
1981; Wise et al., 1982). Adequate blood flow is vital for the support of luteal cells,
as well as the transport of luteal cell products, and is important for regulation of CL
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function (Niswender et al., 1976). The mechanisms involved in controlling the blood
supply of the CL vary throughout the lifespan of the CL (Keyes and Wiltbank, 1988).
The multiple factors involved in controlling angiogenesis in the ovary have recently
been reviewed (Redmer and Reynolds, 1996). Heparin binding growth factor
proteins, in particular fibroblast growth factors and vascular endothelial growth
factors appear to have a specific role in affecting angiogenesis within the corpus
luteum throughout its lifespan. However other, as yet undefined, factors are also
likely to be involved.
The bovine CL produces fibroblast growth factors throughout the oestrous cycle
although there is some variation in the results of different studies, probably related to
the different methods of detection used. Messenger RNA for fibroblast growth factor
2 (FGF-2) was present in CL at all stages of the oestrous cycle but was highest late in
the luteal phase (Stirling et al., 1991). Using immunohistochemical staining, Zheng
et al. (1993) reported that FGF-2 was more abundant than FGF-1 and varied in
concentration with the greatest amount present in the middle stage (Zheng et al.,
1993). Vascular endothelial growth factor (VEGF) has been described in most detail
within the ovine CL. VEGF mRNA is present in ovine luteal tissue and the amount
of mRNA encoding VEGF in the ovine CL is 2-3 fold greater between days 2-4
compared to days 8-15 (Redmer and Reynolds, 1996).
The expression of different angiogenic factors is thought to be controlled by the
various luteotrophic and luteolytic factors present within the CL at different stages of
the cycle. Expression of mRNA for FGF-2 is increased by LH and inhibited by
PGF2a in bovine luteal cells in vitro (Redmer et al., 1988, Stirling et al., 1991). In
addition, angiogenesis, particularly during luteal regression, may be regulated by the
presence of FGF receptors. In particular the receptor for FGF-2 (FGFR-2) is only
present in the vasculature late in the oestrous cycle (Redmer and Reynolds, 1996). It
is unclear why angiogenic growth factors are present throughout the lifespan of the
CL as most rapid vascular development occurs early in luteal development. However,
it appears that angiogenic factors are also involved in maintenance of vascular
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supply in the mature CL. Angiogenic factors could also have other roles within the
CL, possibly affecting CL differentiation and function (Redmer and Reynolds, 1996).
1.3.5. The Cellular Composition of the CL
Various techniques have been used to count cells from the CL, particularly to
calculate the relative proportions of large:small luteal cells. Unit gravity
sedimentation of dispersed luteal tissue separates different cell types, but large cell
populations are contaminated with small cells using this technique (Ursely and
Leymarie, 1979). Fluorescence-activated cell sorting reduces this contamination and
is also less damaging to the luteal cells than unity gravity sedimentation (Alila et al.,
1988; Brannian et al., 1993). However, both techniques involve dispersion of luteal
tissue and the dispersion process, particularly treatment with collagenase, is thought
to result in selective loss of large luteal cells (Rodgers et al., 1984; O'Shea et al.,
1989).
This artificial reduction in large cell numbers may explain the variations in
large:small luteal cell ratios from different studies. It is generally accepted that there
are far more small cells than large cells present in the cow CL at all stages of the
oestrous cycle, but estimates of actual figures for small luteal cellsdarge luteal cells
from dispersed luteal cell studies have varied from 5:1 (Weber et al., 1987) to
between 20:1 and 40:1 (Hansel et al., 1987).
Morphometric analysis of intact slices of luteal tissue has been used to calculate the
numbers of different cell types present in luteal tissue. A detailed morphometric
study by O'Shea et al. (1989) showed that the ratio of large:small luteal cells was in
the region of 1:7.6 in mid-cycle cow CL. Luteal cells accounted for only 30% of the
total number of cells present and around 70% of the total cell volume. However this
study was based on CL collected after synchronisation of oestrus using two injections
different cell populations from CL formed naturally (Hansen et al., 1987). Another
study where oestrus was synchronised using a combination of progesterone treatment
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and a single injection of PGF2« found that 40% of the total cell population from mid-
cycle CL was made up of luteal cells with 44% large luteal cells and 56% small luteal
cells, a considerably lower ratio of large:small cells than in any other study (Lei et
al., 1991).
Despite differences in luteal cell numbers, both of these morphometric studies found
that non-luteal cells made up the majority of cells present in mid-cycle CL (60-70%).
Endothelial cells were the most abundant non-luteal cell type (O'Shea et al., 1989).
The presence of such large numbers of non-luteal cells is, as discussed earlier,
associated with the large capillary network in the CL but it is also possible that these
cells may play a role in altering CL function. In particular, endothelial cells have
been shown to interact with small and large luteal cells in luteotrophic and luteolytic
events in vitro (Girsch et al., 1995).
The cellular composition of the mid-cycle CL (around day 12 of the oestrous cycle)
has been studied in the most detail. However, the proportions of different cell types
within the CL are not static but vary at different stages of its lifespan in both the
sheep and the cow (Farin et al., 1989; Lei ct al., 1991). Once again the actual
numbers vary between studies. Parry et al. (1980) found that luteal cells made up
51% of the total number of cells in the cow CL on day 6 of the oestrous cycle, 72%
on day 15 and 60% on day 20 whereas Lei et al. (1991) found that luteal cells made
up only 25% of the total cell population in both early luteal phase CL (day 6) and late
luteal phase CL (day 18) and was highest (40%) on day 12.
1.3.6. Corpus luteum function and control
The CL is influenced by a wide range of factors of both local and systemic origin
which influence its functional activity in different ways at different stages of the
oestrous cycle (see Rothchild, 1981; Behrman et al., 1991; Niswender and Nett, 1994
and Milvae et al., 1996 for review articles). The cellular composition of the CL, both
luteal cells and non-luteal cells, influences CL responsiveness to different hormonal
stimuli as well as cellular events within luteal tissue itself (Stouffer and Brannian,
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1993). In particular, the relative numbers of large and small luteal cells will influence
the CL because of their different functional properties (Section 1.3.3.2.). Although
large and small cells differ functionally when examined in separate populations in
vitro, the two cell types do interact (Harrison et al., 1987; Del Vecchio et al., 1994;
1995) and this is likely to be significant in terms of overall luteal cell function in vivo
(Redmer et al., 1991).
Progesterone production is not only influenced by the cellular composition of the
luteal tissue. Release of progesterone during the luteal phase of the oestrous cycle
and its abrupt decline after luteolysis are under the control of a wide variety of
luteotrophic and luteolytic factors (Alila and Dowd, 1991; Niswender et al., 1994).
The factors associated with luteolysis are discussed in Section 1.4.
1.3.6.1. Luteotrophic support of the CL
The main luteotrophic hormone in the ruminant is LH which is released from the
anterior pituitary in response to GnRH from the hypothalamus (Hansel, 1966;
Niswender and Nett, 1994). The studies which provided evidence for the role of LH
are reviewed by Alila and Dowd (1991). There is some debate in the literature about
the exact role of LH at different stages of luteal lifespan. In the sheep LH is required
for normal luteal function throughout the CL lifespan but the early CL is most
resistant to withdrawal of LH (see Baird, 1992 for review). In the cow however, it
appears that LH is required for normal CL development in heifers between days 2-7
of the oestrous cycle and is not important in maintaining progesterone production
between days 12 and 17 (Peters et al., 1994).
Although LH is the most significant luteotropic hormone its effect is not acute as
progesterone production continues in the absence of LH. In the bovine this is most
likely related to high baseline production of progesterone by large luteal cells
(Wiltbank, 1994). However, development and overall function of the CL is reduced
when LH support is withdrawn. LH production and activity itself is under the control
of a variety of processes. Progesterone has a negative feedback effect on LH release
(Goodman and Karsch, 1980) which results in the less frequent release of LH pulses
during the luteal phase than during the follicular phase (Rahe et al., 1980; Walters et
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al., 1984), although the pulse height is higher. In addition, LH receptor numbers vary
according to the stage of cycle (Diekman et al., 1978; Chegini et al., 1991) and
increased production of progesterone as the CL develops is associated with an
increase in the numbers of LH receptors (Jones et al., 1992). The binding of LH to
these specific receptors results in activation of cyclic AMP and Ca2+-
polyphosphoinositol-protein kinase C second messenger systems. The products of
these pathways lead to stimulation of progesterone biosynthesis (Alila and Dowd,
1991; Niswender and Nett, 1994).
Prostaglandin E2 (PGE2) may also have a luteotrophic role in the CL, particularly
during the maintenance of pregnancy (Fitz et al., 1993; Shelton et al., 1990). Uterine
PGE2 concentrations in cows were higher during the luteal phase and decreased
during the follicular phase (Cerbito et al., 1994). Another product of the arachidonic
acid cascade; prostacyclin (PGI-2) also has a luteotrophic effect (Milvae et al., 1986;
Hansel and Dowd, 1986)
Whether or not oxytocin acts as a luteotrophic hormone is unclear as results of
studies by various groups are contradictory. Different studies have found that
oxytocin either stimulates (Tan et al., 1982), inhibits (Miyamoto and Schams, 1991)
or has no effect (Milvae and Hansel, 1983) on progesterone production by luteal cells
in vitro. The differences between studies are likely to result from variation in dose
rates of oxytocin used as well as the use of luteal tissue collected at different stages
of the oestrous cycle and pregnancy. In sheep, loss of luteal oxytocin did not alter
progesterone production and so it seems unlikely that oxytocin is of importance in
providing luteotrophic support (Sheldrick and Flint, 1983). Oxytocin has a more
significant role in the luteolytic events in the CL (Flint et al., 1986) and this is
discussed in detail in Section 1.4.3.1.
A number of local factors also affect CL function and they may have luteotrophic or
luteolytic effects. These can be substances produced by luteal cells, by endothelial
cells and fibroblasts or cells of the immune system, and may act on the cell that
produces them (autocrine effect) or affect surrounding cells (paracrine effect). There
are very many substances which can affect luteal function and the list is continually
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expanding but they include a range of growth factors and cytokines (see Behrman et
al., 1993; Tsafiri and Adashi, 1994 and Pate, 1996 for review articles). The effect of
cytokines in the CL will be discussed in detail in Section 1.6.
1.4. Luteolysis
Luteolysis takes place at the end of the functional lifespan of the CL of the non¬
pregnant cycle and also at the end of pregnancy. Two separate processes are involved
beginning with functional regression, which is characterised by a rapid decline in
progesterone release, followed by structural regression when the luteal tissue itself is
destroyed (Knickerbocker et al., 1988; Niswender et al., 1994). The actual
mechanisms involved in the process of luteolysis are complicated and there is some
variation between species. For this part of the review I will concentrate on cattle and
sheep with reference to other species where relevant.
1.4.1. The luteolytic signal; uterine prostaglandin F2a (PGF2a)
It is now accepted that PGF2a released from the uterus is the primary hormone which
causes luteolysis in the cow and the sheep (Hansel et al., 1973; McCracken et al.,
1981; Silvia et al., 1991). This conclusion is based on a large number of studies over
a period ofmany years.
A uterine source for the luteolytic substance was first suggested when it was
discovered that removal of the uterus lengthened the lifespan of the CL in both cattle
and sheep (Wiltbank and Casida, 1956; Moor et al., 1970). A role for PGF2a in the
initiation of luteolysis was indicated when later studies showed that luteal regression
was delayed by inhibitors of prostaglandin synthesis infused directly in to the uterus
(Lewis and Warren, 1977; Milvae et al., 1986) and that the oestrous cycle was
prolonged in animals immunised with PGF antibodies (Fairclough et al., 1981). Less
direct evidence of a role for uterine PGF2a in luteolysis is the increase in systemic
concentrations of the major metabolite of PGF2(X around this time (Nancarrow et al.,
28
1973) and the fact that luteolysis can be successfully induced using exogenous PGF2a
(Hansel and Convey, 1983).
After endometrial PGF2a had been established as the luteolysin, the transport route of
PGF2a to the CL was investigated. In the sheep metabolism of PGF2a by the lungs is
rapid, although in the cow it is somewhat slower, and this meant that delivery via the
systemic blood flow was not possible. A local veno-arterial countercurrent system,
allowing transfer of PGF2a from the uterine vein directly into the ovarian artery, was
discovered (Hixon and Hansel, 1974; Hansel and Blair 1996).
1.4.2. Secretion ofPGF2a
PGF2a is metabolised by the lungs to 15-keto-13,14-dihydro-PGF2a (PGFM), a more
stable metabolite of PGF2a, with a half-life of around eight minutes (Kindahl et al.,
1981). Concentrations of PGF2a metabolites in peripheral plasma have been
demonstrated to be a reliable indicator of uterine synthesis and release of PGF2ot
(Guilbault et al., 1984) and are widely used to determine patterns of secretion of
PGF2a release in vivo (Kindahl et al., 1989).
In the cow PGFM concentrations in peripheral plasma and uterus are minimal until
around day 14-15 of the oestrous cycle when increased amounts of PGF2a are
detectable in the endometrium and small pulses of PGFM can be detected in plasma
(Shemesh and Hansel, 1975; Parkinson and Lamming, 1990). This is followed by the
release of larger pulses of PGF2ot which will actually induce luteolysis. These pulses
last 1-5 hours (Nancarrow et al., 1973; Kindahl et al., 1976a, 1976b) and they are
completely inhibited by pregnancy (Basu and Kindahl, 1987). The initial high
amplitude pulses induce luteolysis and an associated rapid decline in progesterone
secretion. However, several pulses of PGF2a continue after the decrease in
progesterone concentration and it is thought that they are required for complete
structural regression.
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1.4.3. Control of the pulsatile pattern ofPGF2a release
Although uterine PGF2« is now established as the luteolytic hormone and the
pulsatile secretion pattern of prostaglandin release is well documented, exactly how
this pattern of release is controlled in vivo is still a matter of debate. There are
multiple systemic and local factors involved in this process (reviewed by Silvia et al.,
1991).
1.4.3.1. The role of oxytocin
Oxytocin stimulates release of PGF2« from the uterus (Newcomb et al., 1977;
Lafrance and Goff, 1990) and is released, primarily from the large cells of the CL, in
a similar pulsatile pattern to that of PGF2a from the uterus at the time of luteolysis
(Vighio and Liptrap, 1986; Walters et al., 1984). From these results it seems likely
that this substance is involved in some way in influencing hormonal events at this
time (Flint and Sheldrick, 1983; Flint et al., 1986; Schams, 1989). It has been
suggested that there is a significant degree of positive feedback between the two
hormones such that uterine PGF2a stimulates luteal oxytocin release and oxytocin
then stimulates PGF2a release from the uterus (Flint and Sheldrick, 1983).
However, other studies have been unable to show a direct link between the two
hormones. Luteal cells in vitro do not release oxytocin in response to PGF2a
stimulation although it has been suggested that this is due to an indirect action of
PGF2a on luteal cells which is blocked in some way when cells are cultured (McCann
and Flint, 1990). There is also evidence that PGF201 functions independently of
oxytocin in vivo. In the sheep recent work has shown that PGF20C pulses are released
at normal frequency, although reduced magnitude, in the absence of the luteal source
of oxytocin (Mann and Lamming 1995b) and depletion of stored oxytocin from the
CL prior to luteolysis in normally cycling cattle did not affect luteolysis or the
duration of the oestrous cycle (Kotwica and Skarzynski, 1993). However it is
possible that in these studies oxytocin derived from the posterior pituitary played a
more significant role in the absence of an ovarian source.
30
Oxytocin has been measured in CL at different stages of the oestrous cycle. Maximal
concentrations of oxytocin have been observed in cow luteal tissue at mid-luteal
phase and then gradually decline and maximum expression of the oxytocin gene is
associated with luteinisation (see Wathes and Denning-Kendall, 1992 for a review).
These temporal relationships are difficult to fit with the theory of positive feedback
between uterine PGF2a and luteal oxytocin at the time of luteal regression
(Abdelgadir et al., 1987; Wathes et al., 1984; Parkinson et al., 1992) as the oxytocin
concentration falls prior to a decrease in progesterone concentration and luteolysis.
The relationship between release of PGF201 and oxytocin during the oestrous cycle
remains somewhat unclear. The timing of the development of oxytocin receptors
within the uterus would seem to indicate that the two substances do interact at
luteolysis. Increased endometrial responsiveness due to an increase in the
concentration of oxytocin receptors occurs from around day 13 of the oestrous cycle
onwards but is most marked between days 16 and 19 (Meyer et al., 1988; Mirando et
al., 1993). The development of oxytocin receptors would appear therefore to be an
important process in the initiation of luteolysis (McCracken et al., 1981; Flint et al.,
1990) and is thought to be controlled by the concentrations of steroid hormones, in
particular progesterone and oestrogen (Sheldrick and Flint, 1985; Jenner et al., 1991).
It is also unclear what substance initiates the pulsatile release pattern of PGF201 and
oxytocin in the first place. In the sheep there is some evidence that PGF20C first
initiates the release of oxytocin (Moore et al., 1986) but other workers suggest that
oxytocin derived from the posterior pituitary is involved (McCracken et al., 1984).
Maintenance of the pulsatile release pattern of both substances is under the control of
various factors including the presence of oxytocin receptors in the uterus (Flint et al.,
1990) and changes in the steroid environment, in particular the concentrations of
progesterone and oestradiol (Silvia and Taylor, 1989).
The duration of each pulse of PGF2a and oxytocin was thought to be limited by
depletion in oxytocin concentrations which would also explain the 5-12 hour delay
31
between pulses as stores are replenished (Flint and Sheldrick, 1983). However, it
now appears more likely these effects are due to the uterus becoming refractory to
further stimulus for a limited period of time (Sheldrick and Flint, 1986), a theory
supported by studies that have shown that prolonged treatment with oxytocin extends
luteal lifespan in cattle (Howard et al., 1990; Lutz et al., 1991) and inhibits oxytocin-
induced PGF2ot secretion (Lutz et al., 1991).
In addition to oxytocin receptors in the uterus there are also oxytocin receptors on
luteal cells (Okuda et al., 1992) and treatment with PGF2ot increases the numbers of
these receptors on luteal cells in vitro (Okuda et al., 1995). It appears therefore that
PGF2a and oxytocin also act in some autocrine/paracrine manner at the level of the
CL as well as between the uterus and CL.
1.4.3.2. The role of oestradiol
Oestradiol concentrations, as mentioned above, do appear to be involved in affecting
the timing of events around luteolysis. Reduced concentrations of oestradiol have
been shown to affect the ability of the uterus to release PGF2a in response to
oxytocin, weakening the luteolytic signal (Mann and Lamming, 1995a). Oestradiol
also increases uterine responsiveness to oxytocin possibly through controlling the
development of oxytocin receptors and increasing endometrial production of PGF2ot
(Parkinson et al., 1990; Beard and Lamming, 1994). It may also be involved in
regulating synthesis and release of oxytocin from the posterior pituitary gland as well
as having a synergistic effect with progesterone in enhancing oxytocin-induced
release of PGF2a (Lafrance and Goff, 1988; Lamming and Mann, 1995b). In the
sheep the progesterone:oestradiol ratio has been shown to influence the release of
PGF2a in response to oxytocin (Beard et al., 1994).
1.4.3.3. The role of progesterone
Likewise progesterone may also have a role in controlling PGF2a release. The uterus
requires progesterone stimulation for around 10-14 days in order for natural PGF2a
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release to take place in the sheep (Louis et al., 1977). The spontaneously-formed cow
CL does not respond to artificially induced luteolysis until after day 5 of the oestrous
cycle (Hafs et al., 1974; Henricks et al., 1974) whereas luteolysis can be artificially
induced by day 2 after ovulation in a CL induced by treatment with hCG (Howard
and Britt, 1990). Elevated progesterone concentrations during the development of the
hCG-induced CL may result in this early response to PGF2(X. However, artificially
increasing progesterone concentrations during days 1-3 of the oestrous cycle did not
result in a more rapid response to PGF2tt by spontaneously formed CL (Battista et al.,
1984). Therefore it appears that other factors are involved in this process (Howard
and Britt, 1990).
The exact actions of progesterone are still being investigated but this hormone could
have a role in stimulating the accumulation of substances required for synthesis of
PGF20C (Silvia et al., 1991) or may affect the ability of oxytocin to stimulate release of
uterine PGF2a (Lafrance and Goff, 1988). Early withdrawal of progesterone also
causes premature release of PGF2a and so it may act as a prostaglandin inhibitor for
much of the oestrous cycle with loss of this inhibitory effect occurring after
prolonged exposure of the uterus to progesterone (Kindahl et al., 1981). It has also
been suggested that progesterone blocks formation of endometrial oxytocin receptors
in ruminants (Mirando et al., 1993; Lau et al., 1992, 1993). However, a more recent
study showed that ovariectomised cows, treated with progesterone, released PGF2a in
response to an oxytocin challenge, whereas untreated cows and those treated with
oestradiol did not, although oxytocin receptors were present in the uteri of all animals
(Lamming and Mann, 1995a). This suggests that progesterone is involved in
controlling oxytocin receptor function. In addition, progesterone is involved in
inhibiting the luteolytic signal in the cow (Mann and Lamming, 1995c).
1.4.4. PGF2a sites ofaction
Specific receptors for PGF2a are found on all luteal cells (Powell et al., 1975) but the
majority are located on large luteal cells which are presumably the main site of action
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in vivo (Braun et al., 1988). The PGF2a receptor is induced rapidly after luteinisation
(Tsai and Wiltbank, 1995; Wiltbank et al., 1995). The number and affinity of binding
sites for PGF2a, as well as mRNA encoding the PGF2a receptor, increases between
days 3 and 20 of the oestrous cycle in the cow CL before being reduced after luteal
regression (Rao et al., 1979; Sakamoto et al., 1995). mRNA encoding the PGF2a
receptor in sheep is also found primarily on large luteal cells (Niswender et al., 1995)
and is abundant between days 2 and 12 of the oestrous cycle but, like the cow, is
reduced after luteolysis (Eldering et al., 1995).
The direct effects of PGF2a on luteal cells in vitro have been studied in some detail
with varying results. In contrast to the known luteolytic role of PGF2a in vivo,
progesterone secretion by cow luteal cells treated with PGF2a is increased (Hixon and
Hansel 1979; Davis et al., 1988; Meidan et al., 1992). Pate and Condon (1984) found
that PGF2a had no effect on basal production of progesterone but did inhibit agonist-
stimulated progesterone production after luteal cells had been cultured for 24 hours.
Conversely, in the sheep PGF2a either had no effect on, or inhibited, progesterone
production in vitro (Fletcher and Niswender, 1982; Fitz et al., 1993). A detailed
study using microdialysed cow CL concluded that the variation in results and
apparent contradiction in effects of PGF2a in vitro compared to its luteolytic effects
in vivo may be due to lack of cell-cell contact in culture conditions (Miyamoto et al.,
1993).
1.4.5. PGF2amechanisms ofaction
Although the luteolytic substance was identified many years ago, it is still not clear
exactly how PGF2ot exerts its effects at the cellular level. A range of possible
mechanisms of PGF2a action on luteal cells has been described (see Knickerbocker et
al., 1988; Wiltbank and Niswender, 1992 and Michael et al., 1994 for review
articles).
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There are direct cytotoxic effects of PGF201 on luteal cells (Braden et al., 1988) as
well as changes in cell membrane structure related to the loss in cellular function
(Carlson et al., 1982). Decreased utilisation of cholesterol for steroidogenesis by
luteal cells treated with PGF201 has been noted in sheep and cattle (Pate and Condon,
1989; Wiltbank et al., 1990; Grusenmeyer and Pate, 1992) as well as reduced
steroidogenic enzyme activity and reduced numbers of LH receptors (Fletcher and
Niswender, 1982). There is also evidence of a disruption of LH- stimulation of
progesterone production (Thomas et al., 1978; Wakeling and Green, 1981; Fletcher
and Niswender, 1982).
Altered luteal blood flow may be involved but it is not clear if this is a cause or a
consequence of luteolysis although the reduction in blood flow is unlikely to be
significant enough to cause hypoxia (Pharriss et al., 1970; Niswender et al., 1976;
Nett et al., 1976). The induction of high levels of intracellular calcium have also been
suggested as a mechanism of action for PGF2a during luteolysis (Alila et al.,
1990a, 1990b; Duncan and Davis, 1991;Wegner et al., 1990).
1.4.6. Inhibition of luteolysis in the pregnant animal
In the event of pregnancy, the CL does not undergo luteolysis but remains functional.
This requires 'maternal recognition of pregnancy', a process influenced by many
different factors and leading to a variety of hormonal events which inhibit luteolysis
(Bazer et al., 1994; Niswender et al., 1994; Hansen, 1995). Luteolytic peaks of
PGF201 are completely inhibited by pregnancy (Basu and Kindahl, 1987) although
there is some evidence that the uterine and peripheral concentrations of PGF2K are
slightly higher in pregnant than in non-pregnant cattle and sheep around day 17 of the
cycle (Inskeep and Murdoch 1980; Williams et al., 1983; Parkinson et al., 1990).
This phenomenon may be due to prostaglandin synthesis by the embryo (Shemesh et
al., 1979). However the bovine blastocyst has also been shown to be capable of
synthesis of progesterone which could be significant in protecting the CL from
luteolysis (Shemesh et al., 1979).
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The CL of early pregnancy has been shown to be more resistant to the luteolytic
effects of PGF2a than CL from non-pregnant cycles in the sheep between days 10 and
13 after oestrus (Silvia and Niswender, 1984). However, this effect is lost between
days 16 and 26 after oestrus (Silvia and Niswender, 1986). One explanation for this
development of resistance to PGF2a is the production of a protein by the developing
embryo which is known as bovine trophoblast protein-1 (bTP-1). bTP-1 and ovine
TP-1 (o-TP-1) are members of the alpha-interferon family (Imakawa et al., 1987;
Chard, 1991). More recently they have been identified as a unique subclass of
interferons now named as interferon-tau (IFN-t) and associated specifically with
maintenance of pregnancy (Roberts et al., 1992). Expression of mRNA for both
ovine and bovine IFN-x occurs when the conceptus elongates and increased
expression takes place before the time of luteolysis (Roberts et al., 1992).
Various studies have investigated the effects of bTP-1 in vivo and in vitro, using
either the actual protein or recombinant interferons (see Thatcher et al., 1995 for a
review). bTP-1 extends the lifespan of the CL when infused into the uterus of
normally cycling cows (Knickerbocker et al., 1986; Helmer et al., 1989b).
Progesterone secretion by granulosa and luteal cells in culture is increased by low
concentrations of recombinant bovine interferon-a (Luck et al., 1992). Injection of
recombinant bovine interferon-ai 1 (rBoIFN-a) or recombinant IFN-x prolongs CL
lifespan and increases the inter-oestrous interval (Plante et al., 1989; Meyer et al.,
1995). In the sheep intrauterine recombinant IFN-x also prolongs CL lifespan
(L'Haridon et al., 1995). The results of these and many other studies demonstrate a
clear anti-luteolytic effect for IFN-x in vivo although the exact mechanisms through
which this happens are still being investigated.
IFN-x is thought to act through inhibition of prostaglandin synthesis at the level of
the endometrium (Helmer et al., 1989b; Thatcher et al., 1989). Treatment of cows
with IFN-x resulted in reduced secretion of uterine PGF2(X (Meyer et al., 1995). This
effect on prostaglandin synthesis appears to be restricted to PGF2a as synthesis of
PGE, which is luteotrophic in the cow, is increased (Helmer et al., 1989a). This may
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be due to a direct effect on epithelial cells which are the major source of PGF2a rather
than stromal cells which produce mainly PGE (Bazer et al., 1991). It has also been
suggested that IFN-t might act through the inhibition of development of endometrial
oxytocin receptors (Bazer et al., 1991). rBoIFN-a also reduces oxytocin-induced
release of PGF2a from the uterus in vivo (Plante et al., 1991). Recent studies have
demonstrated that, in the sheep, IFN-t may exert an anti-luteolytic effect by blocking
the action of PGF2(X on large luteal cells in vitro (Wiltbank et al., 1992a).
Although the anti-luteolytic and luteotrophic effects of IFN-t are well documented in
the sheep and the cow some workers suggest that there may also be another
substance(s) involved in luteal preservation during early pregnancy (Wiltbank et al.,
1992b). Granulocyte-macrophage colony-stimulating factor (GM-CSF), which is
present in the endometrium, has been shown to increase the expression and secretion
of IFN-t from ovine conceptus tissues (Imakawa et al., 1993). It is likely that various
growth factors, colony stimulating factors and other cytokines have a role in the
complicated process of CL maintenance for pregnancy.
1.4.7. Local PGF2aproduction within the CL
The CL itself is also a potent source of prostaglandins, including PGF2(X, which could
be involved in cell-cell communication within luteal tissue (Rodgers et al., 1988,
Rodgers, 1990). Luteal PGF2a does not appear to play a significant role around
luteolysis in the cow as secretion is greater in cells from CL collected early in the
oestrous cycle compared to mid- and late-stage CL (Milvae and Hansel, 1983;
Rodgers et al., 1988). However, some studies have shown that the cytokine products
of immune cells can stimulate production of PGF2a by luteal cells in culture
(Nothnick and Pate, 1990; Fairchild Benyo and Pate, 1992) and it is possible that this
may be significant in events occurring at the cellular level around luteolysis. This
topic is discussed in detail in Section 1.6. There is evidence of a luteotrophic role for
luteal-derived PGI2 (Milvae, 1986).
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1.4.8. Structural luteolysis
Following functional luteolysis and the decline in progesterone production, the luteal
tissue itself is destroyed. Within a few days of functional luteolysis the CL has
reduced in size considerably, being present as a corpus albicans on the ovary. Before
the end of the next oestrous cycle, the regressing CL will have become almost
invisible. Such rapid regression of a relatively large structure involves dramatic
ultrastructural and morphological changes (Lobel and Levey, 1968; Gemmell et al.,
1976).
One of the earliest ultrastructural changes to occur is alteration to the cell membranes
which leads to increased membrane permeability and loss of cellular function
(Carlson et al., 1982). There is some evidence that superoxide radicals which are by¬
products of metabolic activity and have various roles in reproduction (see Riley and
Behrman, 1991, for a review), may be associated with the membrane changes that
take place at luteolysis (Sawada and Carlson, 1991). At the structural level, changes
in blood vessels are the first visible alteration, with loss of endothelial cell wall
structure and degenerating cellular fragments in blood vessels (Lobel and Levey,
1968; O'Shea et al., 1977; Archbald et al., 1981). Luteal cell changes then become
obvious, lipid accumulates in the cytoplasm and the cells become vacuolated and
shrunken, gradually losing their distinctive appearance. At this stage macrophages,
involved in the destruction and phagocytosis of dead and dying luteal cells, become
the predominant cell type (Lobel and Levey, 1968; Gemmell et al., 1976). Increased
numbers of lipid droplets in the cytoplasm of the macrophages indicates active
phagocytic activity (Katabuchi et al., 1989).
The vascular changes associated with the destruction of the CL of pregnancy are
similar to those seen in the CL from a non-pregnant cycle. However, the whole
process is slower and in the CL of pregnancy, large luteal cells appeared intact within
24 hours of parturition whilst there were signs of cellular damage associated with the
small luteal cells (Archbald et al., 1981; O'Shea and Wright, 1985).
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1.4.9. The Role ofApoptosis in luteal destruction
Apoptosis is a form of physiological cell death which appears to be genetically
controlled and occurs as part of the cycle of cell growth and cell death throughout the
body tissues including the ovary. The role of apoptosis in ovarian function has
recently been reviewed (Tilly, 1996). Apoptosis occurs in the CL and, unlike the
cellular events associated with structural regression which initiate an influx of
macrophages and destruction of the luteal cell wall, apoptosis is a more subtle
process of cell death. It involves shrinkage of the whole cell and fragmentation of
DNA in the nucleus as well as formation of characteristic apoptotic bodies (pieces of
membrane containing DNA fragments which then bud off from the cell: see Cohen,
1993, for a review). Macrophages are then involved in phagocytosis of the dead cells
but without involvement of other leukocytes as would be expected in an
inflammatory response.
The enzyme involved in cleaving of the DNA during apoptosis, a Ca2+/Mg2+ -
dependent endogenous endonuclease has been located in both granulosa and luteal
cells in the rat (Zeleznik et al., 1989). Apoptosis has been associated with follicular
atresia of small follicles in the chicken (Tilly et al., 1991), rat (Hughes and Gorospe,
1991) and sheep (Murdoch, 1995a) whilst luteal cell apoptosis in the mouse CL has
recently been connected with expression of mRNA for the PGFia receptor
(Hasumoto et al., 1997). Changes to vascular endothelial cells during luteal
regression were suggestive of apoptosis (O'Shea et al., 1977), but later studies in the
sheep have shown that apoptosis occurs not only in endothelial cells but also in the
luteal cells and fibroblasts of the CL (Sawyer et al., 1990).
DNA fragmentation has been described in CL collected after functional luteolysis
from the rat (Matsuyama and Takahashi, 1993), rabbit (Dharmarajan et al., 1994),
and sheep (Rueda et al., 1995; Murdoch, 1995b). Similarly, DNA fragmentation is
seen in cells from the bovine CL after induced and natural luteolysis (Juengel et al.,
1993) but not before the onset of luteolysis (Zheng et al., 1994). There is some
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evidence that tissue metalloproteinase inhibitors produced within the CL may also be
involved in the cellular changes associated with apoptosis at the time of luteal
regression (Juengel et al., 1994). Concentrations of TIMP-1 and TIMP-2 mRNA
increased in luteal tissue after induced luteolysis (Juengel et al., 1994) prior to
oligonucleosome formation which is associated with apoptosis (Juengel et al., 1993).
Apoptosis is controlled by a variety of factors which can either suppress or induce
cell death. Some of these factors have been detected within ovarian tissue from a
range of species (see Tilly, 1996 for a review article). A proto-oncogene bcl-2 is
involved in suppression of apoptosis along with antioxidants such as glutathione
peroxidase and superoxide dismutase. PGF2« acts within the ovary to increase
generation of reactive oxygen species (Sawada and Carlson, 1991). This process has
been linked with the induction of apoptosis therefore these substances may have a
role within luteal tissue in protecting cells from cell death.
Another member of the BCL-2 gene family, bax, induces cell death and there is some
evidence that this bax gene may have a role in follicular degeneration. In recent years
there has also been increasing interest in another group of proteases that may be
involved in regulation, particularly induction, of apoptosis (Tilly, 1996). This
includes interleukin-l(3-converting enzyme (ICE), cysteine protease P32 (CPP32) and
ICE-and-ce<i-3-homologue 1 (ICH-1).
Expression of ICE, CPP32 and ICH-1 has been reported in the rat ovary. In addition
there is some evidence that expression of CPP32 and ICH-1 is gonadotrophin
dependent although this is not the case with ICE (Flaws et al., 1995). There are no
reports of these substances within the cow ovary and further studies will be required,
both in vitro and in vivo, to assess their role in normal reproductive physiology.
Results from all species studied indicate that at any specific time point the number of
cells demonstrating signs of apoptosis within the CL is limited. This does not mean
39b
that apoptosis can be assumed to be unimportant in luteal regression as the process
takes place extremely rapidly. However more detailed studies will be necessary to
look at the significance of apoptosis in vivo as well as which cell types are involved
and the timing of events (Hansel and Blair, 1996). Studies using luteal cell cultures in
vitro may be of limited use because the techniques involved, such as collagenase
dissociation, can themselves induce apoptosis (Juengel et al., 1993).
1.5. The Immune System and the Ovary
The CL is made up of a large number of non-luteal cells (section 1.3.5.). These
include cells associated with the immune system such as lymphocytes, macrophages
and lymphocytes. An overlap in function between ovarian function and the immune
system has been recognised for some time (Bukovsky and Presl, 1979). In particular,
there has been increasing interest in the role of specific immune cell types in
affecting luteal function as well as other reproductive processes (see Adashi, 1990;
Pate, 1995, for review articles).
In this review the established roles of immune cells will be summarised to give some
background to this project and the main processes in which these cells are involved
(namely inflammation and the immune response, concentrating on cell-mediated
immunity) will also be summarised. Immune cell populations and their cytokine
products in the ovary will be discussed.
1.5.1. A briefoverview of the cells of the immune system.
Immune cells (white blood cells or leukocytes) are vital in the body for the
recognition and destruction of potentially harmful foreign antigens. These cells act
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both non-specifically in the process of inflammation, and specifically in the processes
of humoral and cell-mediated immunity (Kuby, 1994). A variety of immune cell
types, and the surface protein molecules they bear (known as major
histocompatibility complexes: MHC), are involved in all these processes. They have
distinct roles, although there is a significant degree of interaction and overlap in
function between them.
1.5.1.1. Lymphocytes
The lymphocyte is central to both the cell-mediated and humoral immune response.
Lymphocytes make up 20-40% of white blood cells in the body and possess the
attributes of diversity, specificity, memory and self/ non-self recognition required for
the operation of successful immuno-defense mechanisms (Kuby, 1994). All other
cells involved, although vital, play a more accessory role in terms of the immune
N
response. Lymphocytes can be divided into 3 groups; (1) B-lymphocytes which are
derived from the bone marrow and are involved in the antibody response to antigen
within the body (humoral response), (2) T-lymphocytes which are involved in the
cell-mediated response to antigen and which can be divided into several sub-groups,
and (3) null cells which do not express the membrane molecules distinguishing T-
and B- lymphocytes and which include the cell population known as natural killer
cells which are thought to be involved in host defence against tumour cells.
T-lymphocytes are the type of lymphocyte with the greatest functional potential in the
ovary. This is mainly due to their capacity to release a variety of cytokine products
which can have effects on cells outwith the immune system. There are two
subpopulations of T-lymphocytes: T-helper (Th) cells and T-cytotoxic (Tc) cells
which can be distinguished by their membrane glycoproteins. Both have different
roles in the cell-mediated immune response, as discussed in Section 1.5.3. However
this division of T-cells into two subsets with different functions is not absolute and
there is a degree of overlap between them.
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1.5.1.2. Monocytes and Macrophages - the mononuclear phagocytic system.
Monocytes, derived from the bone marrow, circulate within the blood stream and
migrate into body tissues where they differentiate into macrophages. These have a
phagocytic role in the body tissues. Some macrophages are fixed in specific areas,
whereas others (known as 'wandering' macrophages) migrate within the body.
Macrophages are involved in phagocytosis of exogenous antigens and there is a
significant degree of interaction between macrophages and other leukocytes,
particularly T-lymphocytes. The phagocytic response is greatly enhanced by
stimulation of the cells with interferon-y (IFN-y), a T-helper cell-derived cytokine.
Macrophages can themselves be a potent source of cytokines, in particular tumour
necrosis factor-a (TNF-a).
1.5.1.3. Neutrophils
Neutrophils (polymorphonuclear leukocytes) are involved in the process of
inflammation and make up 50-70% of circulating white blood cells. They are
attracted to sites of infection and tissue damage by various chemotactic factors,
including the cytokine products of activated T-cells. Increased numbers of
neutrophils are released from the bone marrow in response to infection. Neutrophils,
like macrophages, are phagocytic cells which contain lytic enzymes and bactericidal
substances in granules within the cytoplasm.
1.5.1.4. Eosinophils/basophils
Eosinophils and basophils are included with neutrophils in the family of granulocytes
because of the granular appearance of the cytoplasm, although they are much fewer
in number. Eosinophils, although phagocytic, are not associated with inflammation
but with defence against parasite infestations in the body. Degranulation of
eosinophils is seen in response to histamine and so eosinophils also have a role in
allergic responses. Basophils are non-phagocytic and, in conjunction with mast cells
within body tissues, are also involved in the development of allergic responses. They
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release histamine and other vasoactive substances from intracytoplasmic granules
during allergic responses.
1.5.1.5. Major histocompatability complexes (MHC)
The MHC is a surface glycoprotein molecule which is important in enabling the
immune system to recognise self from non-self. Class I MHC molecules are found on
all nucleated cells whereas class II molecules are generally associated with cells that
function as antigen presenting cells such as macrophages. In the immune response T-
helper cells respond to antigen in combination with MHC class II molecules (MHC
II) by releasing cytokines, whereas T-cytotoxic cells are activated and exhibit
cytotoxic activity only on recognition of antigen in combination with MHC class I
molecules (MHC I). MHC II expression is classically found only on cells of the
immune system. However, recently it has been hypothesised that non-immune cells
may also express MHC n, allowing these cells also to present antigen and enhance
the immune response (Bottazzo et al., 1986). Expression of MHC II by non-immune
cells in the CL during luteolysis could be significant (Fairchild Benyo et al., 1991).
1.5.1.6. Clusters of differentiation
Different sub-groups of T-cells and other immune cells express different membrane
molecules which can be recognised by specific monoclonal antibodies. The
monoclonal antibodies that reacted with a particular membrane molecule were first
named by the individual researcher concerned. However, this led to much confusion
and multiple monoclonal antibodies directed against the same membrane molecules.
In order to clarify the situation, the antibodies which recognise a particular membrane
molecule are grouped together as a cluster of differentiation (CD) for ease of
identification. Different subsets of lymphocytes therefore are recognised by different
CD numbers For example T helper cells are CD4 positive (CD4+) and T cytotoxic
cells are CD8 positive (CD8+).
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1.5.2. The Inflammatory Response
The inflammatory response comprises three main events; vasodilation, increased
capillary permeability and influx of phagocytic cells (Roitt, 1991). These events are
initiated by infection or tissue injury but the exact processes occurring at the cellular
level have not been fully established. Complex interactions between chemical
mediators released from either invading micro-organisms, damaged cells, various
enzyme systems and also leukocytes are involved. Chemical mediators, particularly
histamine released by mast cells and basophils in response to tissue injury, lead to
vasoconstriction. This causes the tissue capillaries to become engorged and, in
combination with increased vascular permeability, forces fluid and cells into the
tissues. In particular, cells of the immune system, including neutrophils,
macrophages, eosinophils, basophils and mast cells, move out of the capillaries and
migrate by a process of chemotaxis to the site of inflammation. Once present in the
site of inflammation activated macrophages and lymphocytes then produce cytokines
such as TNF-a, II-1 and interleukin-6 (11-6) which are also involved in controlling the
inflammatory response.
1.5.3. The Immune Response - Cell-mediated immunity
Cell-mediated immunity is a form of specific or acquired immunity where the
immune system can recognise and eliminate foreign molecules. Unlike the
inflammatory response, cell-mediated immunity, along with humoral (antibody-
based) immunity, is specific, has memory and the ability to diversify and differentiate
self from non-self (Roitt, 1991, Kuby, 1994). Although humoral immunity is
involved mainly in elimination of bacteria, it sometimes plays a role in cell-mediated
immunity. However, its role is secondary as B-cells do not appear to be localised in
significant numbers in the ovary. This review will concentrate on cell-mediated
immunity.
The cell-mediated immune response is dependent on recognition of antigen by T-
cells which initiates a chain of responses involving various effector immune cells.
Briefly, Th cells are activated in response to antigen presented in combination with
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MHC II molecules on specific antigen-presenting cells (APCs) such as macrophages.
However in addition to this, activation of Th cells is also dependent on a second
signal which induces RNA and protein synthesis by the Th cells. This is thought to be
interleukin-1 (II-1) released from the antigen-presenting cell.
After activation the Th cells secrete cytokines, particularly interleukin 2 (11-2) which
stimulates proliferation of Th cells as well as activation of Tc cells. Release of 11-2
results in expression of 11-2 receptors on Tc cells. These receptors are not present on
resting cells. The induction of 11-2 receptors occurs in response to activation of Th
cells by antigen and IL-1 as described above. For this reason the 11-2 receptor may be
used as an indicator of activation of T-lymphocytes.
The Tc cells, activated by 11-2, are involved in the cytotoxic response through
membrane damage and cell lysis of cells which are presented in combination with
MHC I molecules. In addition to activating the antigen-specific Tc cells, various
cytokines activate non-specific cytotoxic cells such as macrophages (enhancing their
phagocytic activity) as well as natural killer cells. Activated Tc cells produce
cytokines which may be involved in activation of other cell types, but to a lesser
degree than Th cells.
This is obviously an oversimplification of a complicated process which is not yet
fully understood. New information is continually being produced as investigative
techniques advance. However, even a basic understanding of the cellular events
which occur during inflammation and cell-mediated immunity have led workers to
consider a role for these processes in reproduction.
1.5.4. Immune cells and the ovary
The huge range of functions and interactions of immune cells within the
inflammatory and immune responses has become increasingly evident as research has
advanced. In particular, increasing information about the dramatic effects of various
cytokine products of the immune cells on surrounding cells has prompted researchers
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to consider a role for these cells outwith the immune system. The ovary, undergoing
a continual cycle of hormonal and structural changes throughout reproductive life, is
a potential site of action for these cells (Norman and Brannstrom, 1994).
1.5.5. Immune cells and the follicle
A specific role for the immune system within the follicle has been indicated for some
time. The cellular events seen during ovulation are very similar to those seen during
the inflammatory process (Section 1.5.2.). Therefore ovulation in the rat has been
considered to be a form of inflammatory reaction (Parr, 1974; Espey, 1980; Espey,
1994). Morphological studies in the sheep ovary have also revealed that vasodilation,
increased vascular permeability, tissue oedema as well as accumulation of
neutrophils and eosinophils are all features of the ovulatory process (Cavender and
Murdoch, 1988).
A number of earlier studies provided indirect evidence of a role for immune cells in
the follicle, particularly around ovulation. High dose anti-inflammatory drugs, such
as aspirin, suppressed ovulation in the rat (Parr, 1974). Ovulation was also delayed in
mature rats treated with anti-thymocyte serum to suppress maturation of T-
lymphocytes (Bukovsky et al., 1977) whereas leukocyte supplementation of perfused
rat ovaries in vitro caused an increase in the ovulation rate (Hellberg et al., 1991).
However, a later study failed to show any effect on ovulation in rats whose leukocyte
populations had been severely depleted (Chun et al., 1993). In the sheep another anti¬
inflammatory drug, indomethacin, delayed ovulation. This did not appear to be
caused by inhibition of prostaglandin synthesis in the follicle but was related to
suppression of a specific leukocyte chemoattractant agent involved in attraction of
various types of immune cell to the follicle around ovulation (Murdoch and
McCormick, 1989, 1991, 1993).
Other studies have shown direct effects of immune cells on granulosa or thecal cells
in vitro. Peritoneal macrophages increased progesterone secretion by murine
granulosa cells in vitro (Kirsch et al., 1981). Conversely, gonadotrophin-induced
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progesterone production was markedly inhibited by macrophages, particularly
activated macrophages, in cultures of rat granulosa cells, although macrophages did
appear to increase the number of viable granulosa cells present in culture (Shakil and
Whitehead, 1994). T- and B- lymphocytes stimulated progesterone production by
granulosa cells from the rat (Hughes et al., 1991) and human (Emi et al., 1991)
whereas in the pig, granulosa cell progesterone production was stimulated by
lymphocytes only in the presence ofmonocytes (Maier et al., 1990).
A variety of immune cell types, particularly macrophages, have been recorded in the
follicle from a range of species. In the human, macrophages were found associated
with the perifollicular capillaries and increased in number in the follicle after
ovulation (Katabuchi et al., 1989). In the mouse there was a rapid entry of
macrophages into the follicle at ovulation (Simon et al., 1994) and macrophages have
also been associated with the transformation of preantral to antral follicles in the
human ovary (Bukovsky et al., 1995b). After ovulation the number of macrophages
in the collapsed pig follicle increased almost fourfold (Standaert et al., 1991).
Lymphocyte numbers were insignificant in follicles from women and mice. However,
they were present in significant numbers in pig follicles and increased dramatically in
number after ovulation (Standaert et al., 1991). Detailed studies in the rat
(Brannstrom et al., 1993a) and women (Brannstrom et al., 1994c) showed that
neutrophils, as well as macrophages, were the most significant cell types present in
the medullary and thecal areas of the preovulatory follicle and increased in number at
ovulation. The increase in numbers of neutrophils after ovulation may be related to
hormonal events at this time because inducing ovulation with hCG in the rat results
in increased numbers of neutrophils in the rat ovary (Chun et al., 1993).
Eosinophils are present in the sheep ovulatory follicle (Cavender and Murdoch,
1988). However, these cells appear to be of limited importance, as artificially
reducing the number of eosinophils using prednisilone did not affect ovulation
(Murdoch and Steadman, 1991). Eosinophils were also the most prominent blood cell
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type present in the preovulatory follicle within the pig ovary (Standaert et al., 1991).
In the cow an increased number of mast cells was observed in the growing dominant
follicle from day 19 onwards (Nakamura et al., 1987) and increased numbers of mast
cells were seen in the rat ovarian bursa at pro-oestrus (Gaytan et al., 1991). The exact
significance of these cell types is not clear but mast cell products, including
histamine and heparin, are associated with inflammation and so they may be involved
in events around ovulation (see Krishna et al., 1989 for a review). In the hamster,
degranulation of mast cells in the ovary was associated with the LH surge prior to
ovulation (Krishna and Terranova, 1985): however, antihistamine treatment did not
inhibit ovulation in the sheep (Halterman and Murdoch, 1986).
1.5.6. Immune cells and the corpus luteum
The role, if any, of immune cells in the CL, apart from their involvement in structural
luteolysis, is not clear. Suppression of lymphocyte production in the cow using anti-
lymphocyte serum resulted in a reduction in both the concentration of circulating
progesterone and LH in treated cows (Alila and Hansel, 1984). Suppression of
macrophages and T-lymphocytes in the rabbit using high dose prednisilone during
the luteal phase did not alter progesterone profiles and luteolysis proceeded as normal
(Seiner et al., 1992) whereas in the rat immunosuppression with dexamethasone
prevented luteal regression (Wang et al., 1993). Macrophages increased progesterone
secretion by mouse luteal cells in vitro (Kirsch et al., 1981) and activated neutrophils
inhibited LH-stimulated progesterone production in cultured rat luteal cells
(Pepperell et al., 1992). These results demonstrate that a specific, non-phagocytic
role for the immune cell in the CL is possible but that this varies between species.
One type of immune cell has an established role in the CL. The macrophage is
involved in the destruction of luteal tissue after luteolysis (Lobel and Levey, 1968;
Paavola 1979; Bagavandoss et al., 1991). Macrophages are relatively easy to identify
in tissue on the basis of their cell morphology and were recorded in CL prior to the
development of specific monoclonal antibodies which could be used for
immunohistochemistry. Macrophages were described in guinea pig CL and their
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presence in large numbers in regressing luteal tissue suggested that they might be
involved in luteal destruction (Paavola 1979). In the cow, macrophages were also
described in regressing luteal tissue (Lobel and Levey, 1968) and increased numbers
of macrophages were found in regressing rabbit CL in comparison to young CL
(Bagavandoss et al., 1988; 1990).
Roby and Terranova (1989) used immunohistochemistry to look at bovine and rat
ovaries and found macrophages to be present in the CL of both species. In the cow,
they were found in thecal cords which extend from the capsule into the centre of the
CL whereas in the rat, macrophages were localised in the centre of the CL. In the pig,
macrophages were the most prominent leukocyte in the CL and greatest numbers of
macrophages were recorded in the early developing CL and during luteal regression
(Standaert et al., 1991; Hehnke-Vagnoni et al., 1995). Macrophages infiltrated the
pig CL in response to implantation of luteal tissue with a PGF2«-impregnated implant
(Hehnke et al., 1994).
Macrophages are also present in CL after ovulation. Kirsch et al. (1981) identified
macrophages in mouse CL after induction of ovulation using gonadotrophins. In the
human CL, the presence of macrophages in the early CL suggested a role for these
cells in the proliferation and luteinisation of granulosa cells as well as in influencing
progesterone production (Katabuchi et al., 1989). A more recent study in the human
CL found macrophages to be the most significant immune cell type at all stages of
the luteal lifespan (Nouza et al., 1995).
Although macrophages have been described in the greatest detail in the CL, there are
other immune cell types present which, in addition to any other effect, are likely to be
involved in attraction and activation of macrophages after luteolysis. Lymphocytes
were first described in CL from day 14 of the oestrous cycle in the cow (Lobel and
Levey, 1968). Bagavandoss et al. (1990) found T-lymphocytes to be present in
similar numbers at different stages of pseudopregnancy and pregnancy in the rabbit
including after luteal regression. In the rat, T-lymphocytes were consistently sparse in
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the CL throughout pregnancy and pseudopregnancy (Brannstrom et al., 1994a)
whereas in the pig the highest numbers of T-lymphocytes were found in the corpus
haemorrhagicum, immediately after ovulation (Standaert et al., 1991).
The situation in the human CL is not clear as different studies have yielded
conflicting results. Using an image analysing system, few T-lymphocytes (CD3+,
CD4+ or CD8+) were recorded at any stage of CL lifespan (Petrovska et al., 1992),
whereas Wang et al. (1992c) recorded CD4+ and CD8+ T-lymphocytes in the human
CL close to blood vessels. Bukovsky et al. (1992) did not find any T-lymphocytes in
developing and mature human CL initially but in a later study they did observe T-
lymphocytes (CD3+, CD4+ or CD8+) between degenerating granulosa luteal cells in
regressing CL. There was also some evidence of invasion of CD4+ cells into older
CL after degenerative changes were already present (Bukovsky et al., 1995a).
Brannstrom et al. (1994c) found no variation in populations of CD8+ or CD3+ T-
lymphocytes in the human CL throughout the menstrual cycle. However, the ratio of
CD8+:CD4+ T-lymphocytes was higher than that seen in the blood, suggesting that
there might be a preferential attraction of the CD8+ cells into the CL.
B-lymphocytes do not appear to be an important component of the CL leukocyte
population in any species studied. Wang et al. (1992c) found no B-cells in human CL
at any stage of the menstrual cycle. Many other studies have not investigated B
lymphocytes at all, presumably because these cells are involved in antibody
production and are considered unlikely to affect luteal cell function.
Neutrophils have been described in luteal tissue. In the pig CL, neutrophils were
present in similar numbers throughout the oestrous cycle (Standaert et al., 1991). One
study in women did not find any neutrophils in CL at any stage (Bukovsky et al.,
1992), although a later study did describe significant numbers of neutrophils in
human CL. Highest numbers of neutrophils were present after ovulation, but were
present in constant numbers for the rest of the CL lifespan, with no increase in
regressing CL (Brannstrom et al., 1994c). In the rat, neutrophils were present in large
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numbers in CL of pregnancy and pseudopregnancy although their numbers declined
as the CL aged (Brannstrom et al., 1994a). Neutrophils are phagocytic cells and may
be involved in structural luteolysis. However, luteal regression does not appear to be
associated with an increase in neutrophil numbers, and macrophages seem to play a
far more important role in destroying luteal tissue after luteolysis.
Eosinophils have been described in greatest detail in the CL of the sheep and the pig.
As their distinctive granular cytoplasm makes identification of these cell types
relatively easy, the limited detail in the literature suggests that these cells are not
present in large numbers in mature and regressing CL from other species.
Eosinophils were observed in regressing sheep CL after luteolysis was induced with
PGF2a, with highest numbers present between 2-4 hours after PGF2a injection (Nett
et al., 1976; Murdoch, 1987). In the pig, eosinophils were the most prominent cell
type in the naturally regressing CL and were also present in high numbers in the
corpus haemorrhagicum (Standaert et al., 1991). Eosinophils were found in very low
numbers in rat CL at all stages (Brannstrom et al., 1994a).
It can be seen from these studies that immune cell populations in CL from different
species vary considerably. There are also variations between studies in the same
species which are difficult to explain but are likely to reflect different techniques of
tissue collection, preparation and cell counting. It is likely that the most recent
studies using specific monoclonal antibodies and morphometric analysis systems are
most representative of the situation in vivo, but a considerable volume of work is still
required, particularly to investigate cell populations at different stages of the CL
lifespan.
1.5.7. MHC expression in the CL
MHC class I is expressed by all cell types and therefore is found on cells of the CL.
However, MHC II is expressed by a more limited number of cell types and increased
expression of MHC II enhances the immune response (Section 1.5.1.5.). It is possible
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therefore that altered MHC II expression in the CL could be involved in the immune
processes which occur around the time of luteal regression.
MHC II molecules were present on human and rhesus monkey granulosa-lutein cells,
but not on theca-lutein cells or large antral follicles (Khoury and Marshall, 1990).
The same study showed no MHC II expression in any cell type in the rat CL. Another
study, which looked in detail at MHC II expression in the human CL at different
stages of the oestrous cycle (Petrovska et al., 1992), found that MHC II expression
was associated with both granulosa-lutein and thecal-lutein cells and was highest
during the time of peak endocrine activity (days 7-9) and fell during luteal regression.
However, Bukovsky et al. (1995a) found that both MHC I and MHC II expression in
human granulosa-lutein cells was enhanced in late-luteal and regressing CL. It is not
clear why the results from these two studies conflict, but may be due to the different
techniques employed.
In the rabbit, MHC II expression associated with activated T-lymphocytes did not
vary throughout the CL lifespan or after luteal regression. MHC II expression on
other cell types was not investigated (Bagavandoss et al., 1990). However, MHC II
expression increased in the rat CL during the later stages of both pseudopregnancy
and pregnancy (Brannstrom et al., 1994a). The cells expressing MHC II appeared to
be macrophages but this was not confirmed.
Some of the most detailed studies on MHC II expression have been performed using
the cow CL. Expression of both MHC I and MHC II on bovine luteal cells was first
recorded in a study looking at the effects of the cytokine interferon-gamma (IFN-y)
on MHC expression (Section 1.6.3; Fairchild and Pate, 1989). A later study by the
same group looked at MHC expression in the CL during the oestrous cycle and after
induced luteolysis. MHC I expression did not vary significantly between any of the
groups studied, whereas MHC II expression increased with age of CL and after
induced luteolysis (Fairchild Benyo et al., 1991). In mid-cycle CL (days 10-12)
greatest MHC II expression was associated with a subgroup of large cells described
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as "large less-dense cells" and expression in this cell population increased by day 18,
along with increased expression in the small cell population. In the sheep, MHC II
expression was present on both large and small cell populations on days 10 and 14 of
the oestrous cycle and day 14 of pregnancy, although there was reduced MHC II
expression on large cells from CL collected during pregnancy (Kenny et al., 1991).
Results from both the cow and the sheep demonstrate that MHC II expression occurs
on luteal cells in vivo. This in turn suggests that altered MHC II expression may be
involved in the immune mechanisms which occur around luteolysis. However, these
ruminant studies are based on collagenase dispersion of luteal tissue followed by
analysis of MHC II expression on dispersed cells by flow cytometry. It is possible
that the process of tissue preparation could alter MHC II expression and identifying
the specific cell types that are expressing MHC II by flow cytometry presents some
difficulties. For these reasons, further analysis of intact luteal tissue is needed to
confirm the results from flow cytometric analysis and to identify more accurately the
cell types involved.
1.6. Cytokines and the ovary
One of the main reasons for the increased interest in immune cells within the CL is
the volume of information which is becoming available about the cytokine products
of these cells. Cytokines were originally associated with regulation of the amplitude
and duration of immune-inflammatory responses and were named according to the
presumed cell source (for example, lymphokines from lymphocytes and monokines
from monocytes). However, in recent years it has become apparent that other cell
types, including epithelial and endothelial cells as well as cells of the reproductive
tract, also have the potential to produce cytokines and that the term cytokine now
includes a much wider range of cell products than originally described (Blackwill and
Burke, 1989).
The wide range of effects and increasing overlap between the function of some
cytokines and the role of hormones makes the definition of a cytokine somewhat
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difficult (Rothwell, 1991). However the majority of cytokines are low molecular
weight proteins which act as intercellular messengers between the same or different
cell systems, although a few may have more widespread effects within the body.
They act locally in an autocrine or paracrine fashion, exerting their effects by
combining with high affinity cell surface receptors to alter RNA and protein
synthesis. They are highly potent, acting at minute concentrations and are released
from cells for very short periods of time. The transient nature of their release and the
huge number of possible interactions that may occur between different cytokines and
cytokine-secreting cells makes it difficult to define specific roles for individual
cytokines. In any case, it is likely that the effects of individual cytokines are of
limited significance in vivo, and that any response seen will be the result of a vast
network of cytokines acting in combination (Tabibzadeh, 1994). However, in order to
limit this complexity, the majority of investigations have involved detailed studies of
individual cytokines, or at most two or three cytokines in combination.
The cytokine family is large and constantly increasing in number. It includes the
interleukins, tumour-necrosis factors, colony-stimulating factors, interferons, growth
factors, activin, inhibin and chemotactic factors. Recently there has been particular
interest in the role of various growth factors on CL function (Lobb and Dorrington,
1993; Liebermann et al., 1996) and the insulin-like growth factors have been studied
in some detail (Adashi, 1992b; Amselgruber et al., 1994; Spicer and Echternkamp,
1995). Such a wide range of factors obviously has an enormous potential range of
effects which is outwith the scope of this review. However, in summary, these cell
products act as a communication system within a cell network, acting to connect and
influence various body systems, including the reproductive system (Kennedy and
Jones, 1991).
1.6.1. Cytokines and their effects within the reproductive system.
There is now a large amount of literature available describing the effects of cytokines
at all levels of the female reproductive tract, including the hypothalamus and pituitary
gland (Tabibzadeh, 1994; Spangelo and Gorospe, 1995), uterus (Tabibzadeh and
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Sun, 1992; Philippeaux and Piguet, 1993) and ovary (Adashi, 1992a; Vinatier et al.,
1995).
Within the ovary a range of cytokines has been studied. In particular, there has been
much interest in the potential roles of tumour necrosis factor-a (TNF-a), interleukin-
ip (II-1 (3) and interferon-y (IFN-y) on ovarian follicular and luteal development
(Kokia and Adashi, 1993; Terranova et al., 1993; Pate, 1996). These three cytokines
are of particular interest for a variety of reasons and, because they have already been
studied in detail in the field of immunology, assessment of their roles in the ovary is
somewhat easier.
1.6.2. The effect ofcytokines on follicularfunction and ovulation.
As discussed earlier, there are populations of immune cells within ovarian structures
and tissues throughout the oestrous cycle, all with the potential to affect surrounding
cells (Section 1.5.). Within developing and ovulatory follicles, lymphocytes,
eosinophils, mast cells and particularly macrophages have been recorded, although
there is some inter-species variation. More recent research has focused on the
cytokine products of these cells and their specific effects on follicular cells in vitro
and in vivo using a variety of approaches. Several possible mechanisms of action for
these cytokines have been recorded.
1.6.2.1. Effects of cytokines on follicular cells in vitro
Effects on steroid synthesis have been observed in some species. Gorospe and
Kasson (1988) observed an increase in basal and FSH-induced progesterone
production by rat granulosa cells cultured with lymphocyte supernates. Production of
oestrogen and progesterone by pig granulosa cells in culture was altered by
stimulated and unstimulated splenocytes, potent sources of various cytokines,
although the effect varied between cells from follicles of different sizes (Hughes et
al., 1990). Other workers described more specific effects of individual cytokines.
TNF-a increased production of progesterone and PGF201 by human granulosa cells in
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vitro (Zolti et al., 1990). However in the pig, TNF-a inhibited insulin- and FSH-
stimulated (but not basal) progesterone biosynthesis by granulosa cells and
stimulated production of PGE2 and PGF201 (Veldhuis et al., 1991).
In the preovulatory rat follicle both TNF-a and 11-1(3 stimulated progesterone
secretion and production of PGF2a and PGE in vitro (Brannstrom et al., 1993c). This
effect was seen in cultures of thecal cells alone: granulosa cells were unaffected, a
finding that confirms a previous study showing that 11-1(3 was expressed only in the
rat theca-interstitial cell in vivo (Hurwitz et al., 1991b). However another study found
that IL-1 (3 stimulated release of various prostaglandins only from mixed cultures of
rat thecal and granulosa cells, with no effect on the individual cell populations
(Kokia et al., 1992). Pig granulosa cells also responded to 11-1(3 with inhibition of
basal and LH-stimulated progesterone production by porcine granulosa cells in vitro,
an effect that was dependent on the dose of 11-1(3. LH-induced luteinisation was
inhibited (Fukuoka et al., 1988, 1989). hCG-stimulated androgen production by rat
thecal cells in culture was inhibited by both II-la and 11-1(3, although 11-1(3 had a
more dramatic effect (Hurwitz et al., 1991a)
FSH-stimulated oestradiol production in the rat was inhibited by TNF-a (Adashi et
al., 1989). Similar findings were described when bovine granulosa cells were treated
with a range of cytokines in vitro. All cytokines tested, including TNF-a, IL-1(3 and
IFN-y, had a potent inhibitory effect on FSH-induced oestradiol production from cells
collected from small follicles, but had no effect on cells collected from large follicles
(Spicer and Alpizar, 1994).
There is less information on the effects of interferons on follicular function. IFN-y
inhibited FSH-stimulated oestradiol and progestin secretion and LH-receptor
formation in immature rat granulosa cells, whilst IFN-a had no effect (Gorospe et al.,
1988). Similar findings were described in the rat, where both recombinant IFN-y and
a mixture of rat IFN-a / IFN-y inhibited FSH-induced inhibin and progesterone
secretion from cultured granulosa cells (Xiao and Findlay, 1992).
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Cytokines are not only capable of affecting steroid biosynthesis by cells, they can
also directly affect the replication and development of follicular cells. In the pig, Il¬
ia has been shown to stimulate proliferation of granulosa cells in culture in addition
to inhibiting progesterone secretion (Fukuoka et al., 1989). 11-1(3 inhibited LH/hCG
receptor induction by FSH in rat granulosa cells (Kasson and Gorospe, 1989), and Il¬
ia inhibited luteinisation of porcine granulosa cells in culture (Fukuoka et al., 1988).
11-1(3 increased LH-induced ovulation in the rat ovary 3-fold (Brannstrom et al.,
1993d) and TNF-a induced ovulation in unstimulated, or more effectively in LH-
stimulated ovaries (Brannstrom et al., 1995). In the absence of gonadotrophin, 11-1(3
induced ovulation in the rabbit ovary (Takehara et al., 1994). Further evidence of a
specific role for 11-1(3 in ovulation was provided by a study which demonstrated that
an II-1 receptor antagonist inhibited ovulation in the perfused rat ovary (Peterson et
al., 1993).
Although leukocytes are relatively scarce within ovarian follicular structures (Section
1.5.5.), it appears that cytokines may well have a role within the developing follicles.
It is difficult to generalise because of differences between studies as a result of
different techniques and cell culture conditions as well as inter-species variation.
However, it appears that their main role may be to inhibit differentiation of the
developing theca and granulosa cells in vivo so allowing follicular growth
(Fukumatsu et al., 1992).
1.6.2.2. Cytokines in the follicle in vivo.
The above studies give some indication of the huge potential range of effects of
cytokines in vitro. However, these do not necessarily indicate a role for these
substances in vivo. As in the case of the immune cells themselves, if cytokines do
play a significant role within the ovary, their expression may vary at different stages
of follicular development. The minute concentrations involved and the transient
nature of their production makes detection of cytokines difficult in tissue. However,
some workers have demonstrated the presence of these substances within follicular
structures. In general, the focus of interest has been IL-1 (3 and TNF-a because of
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their role in inflammation, a process which has many similarities to ovulation (Espey,
1980).
Roby and Terranova (1989) used immunohistochemistry to study TNF-a in the rat
ovary and found that the most intense staining was associated with the granulosa
layer of atretic follicles and with granulosa cells surrounding the antral cavity in pre¬
ovulatory follicles. Cell blot analysis confirmed that granulosa cells contained and
produced TNF-a. A later study found TNF-a mRNA in the rat ovary. The results of
this study indicated that this mRNA did not come from white blood cells but that
ovarian cells and/or macrophages were the source (Sancho-Tello et al., 1992). In the
human follicle, granulosa cells were also found to secrete TNF-a, and TNF-a
immunoactivity has been found in human follicular fluid (Roby et al., 1990; Wang et
al., 1992b). In the mouse, TNF-a mRNA and protein were observed only in oocytes
of follicles after the formation of the second layer of germ cells and the most intense
expression was associated with atresia (Chen et al., 1993). A detailed study in the
cow demonstrated that production of TNF-a varied between follicular structures.
TNF-a bioactivity was significantly higher in the preovulatory follicle (Zolti et al.,
1990). TNF-a was present in detectable amounts in human follicular fluid collected
from normal and polycystic ovaries (Jasper and Norman, 1995).
A recent study in the sheep showed that TNF-a was present in the thecal endothelial
cells of the preovulatory follicle (Murdoch et al., 1997). A role for TNF-a was
suggested in follicular rupture as ovulation was inhibited by intrafollicular injection
with TNF-a antiserum. In addition, TNF-a was shown to induce ovarian cell
apoptosis in vitro (Murdoch et al., 1997).
In the rat, EL-1 [3 is expressed only by theca-interstitial cells. Expression appears to be
gonadotrophin-dependent, with a 4-5 fold increase in II-1 [3 expression after exposure
to hCG. This might suggest a role for this substance around the time of ovulation
(Hurwitz et al., 1991b). TNF-a, II-1 and 11-6 bioactivity have been detected in the
ovulating rat ovary (Brannstrom et al., 1994b). In the mouse Il-la and 11-1(3 were
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found in the thecal layer at ovulation and were also present in granulosa cells after
ovulation (Simon et al., 1994). Human follicular fluid cells also contained a small
amount of mRNA encoding 11-1(3 (Polan et al., 1991).
1.6.3. Cytokines and the Corpus Luteum
The presence of immune cells within luteal tissue, as well as in follicular structures,
has led workers to consider a possible role for cytokine products within the CL.
Although the main luteotrophic and luteolytic factors have been established in most
species, there is still little information concerning events occurring at the cellular
level within the corpus luteum. Immune cell populations acting through their
cytokine products have the potential to affect luteal function profoundly. As with
follicular tissue, there is an increasing volume of published work relating to
cytokines in the CL. In particular there is considerable interest in the role of TNF-a
within the CL (Terranova, 1997).
1.6.3.1. The effect of cytokines on luteal cells in vitro
Various cytokines, alone or in combination, have been shown to have a range of
effects on luteal cells in culture. Results vary, even within species, and this is likely
to reflect the different techniques used.
In the rat, TNF-a inhibited hCG-supported progesterone production by luteinised
granulosa cells (Adashi et al., 1990). In contrast, progesterone production by human
granulosa-lutein cells in culture was unaffected by TNF-a, although PGE2 and PGF2a
accumulation increased (Wang et al., 1992b). TNF-a has been shown to stimulate
proliferation of human granulosa-lutein cells in culture (Wang et al., 1992b).
In human luteal cell cultures, IFN-y alone (but not IFN-a) inhibited basal and hCG-
induced progesterone formation. This effect was increased when TNF-a and IFN-y
were added together to cell cultures (Wang et al., 1992a). Slightly different results
were described by Fukuoka et al. (1992) who observed inhibition of progesterone
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production only by IFN-y and not TNF-a. This study also demonstrated that IFN-y, as
well as TNF-a and II-la, inhibited FSH-stimulated oestradiol production by human
luteinised granulosa cells in culture. Another study also found that 11-1(3 inhibited
hCG-stimulated production of oestradiol but that II-1(3 did not affect unstimulated
production of progesterone or oestradiol (Barak et al., 1992). No alteration in
progesterone production was observed when primate luteal cells from mid- and late-
stage CL were treated with IFN-y, TNF-a or IL-1(3. However, a significant increase
in production of PGF2a by luteal cells treated with IL-1(3 was observed (Young et al.,
1994).
There are several, sometimes contradictory, studies looking at cytokines and pig
luteal cells. Pitzel et al. (1993) found that TNF-a inhibited basal and hCG-stimulated
production of progesterone and oestradiol (which is luteotrophic in the pig), whereas
Tekpetey et al. (1993) failed to show any effect of TNF-a on progesterone
production in porcine large or small luteal cells in culture. In a study looking more
specifically at the effects of TNF-a within the ovary around the time of luteolysis in
the pig, Wuttke et al. (1995) showed that TNF-a inhibited progesterone production
by inhibiting both luteal oestradiol production and preventing the stimulatory effect
of PGF2a on steroid secretion.
There has been a considerable amount of research in recent years looking at the
effects of cytokines on bovine luteal cells in culture. II-1 (3 had no significant effect on
progesterone production by mid-cycle luteal cells (days 9-12) in vitro but did cause a
dose-dependent increase in prostaglandin (PGF2a, PGE2 and 6-keto-PGFia) release
(Nothnick and Pate, 1990). A later study described a decrease in progesterone
production when luteal cells were chronically exposed to IL-1 (3, an effect that did not
appear to be mediated by prostaglandins (Townson and Pate, 1994).
IFN-y caused an initial 50% decrease followed by a dramatic increase (400%) in
production of PGF2a and 6-keto PGFia by luteal cells (days 9-12) in vitro. LH-
stimulated progesterone synthesis was also inhibited by treatment with IFN-y, but
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this did not appear to be related to the increase in prostaglandin production as the
effect was not reversed by indomethacin, an inhibitor of prostaglandin synthesis
(Fairchild and Pate, 1991).
Another study looking at the effects of TNF-a alone, or in combination with other
cytokines, found that TNF-a caused a dose-dependent increase in both PGF2a and 6-
keto-PGFia production by cultured bovine luteal cells but had no effect on basal
progesterone production (Fairchild Benyo and Pate, 1992). In combination with
either IL-lp or IFN-y, both of which have been shown to stimulate luteal
prostaglandin production, TNF-a had synergistic effects on PGF2a production. This
study also showed that IFN-y significantly reduced luteal cell numbers in culture
although TNF-a alone did not. However, these two cytokines in combination were
extremely cytotoxic, with only 20% of cells maintained compared to controls
(Fairchild Benyo and Pate, 1992). A more recent study looked at the effects of
cytokines on luteal cells collected at different stages of the oestrous cycle. PGF2a
production was stimulated and progesterone production inhibited by TNF-a, IL-1 (3
and EFN-y alone or in combination, but there was no cytotoxic effect of TNF-a and
IL-ip on early (day 6) luteal cells unlike other stages (Greene and Pate, 1995).
Cytokines may also exert their effects by inducing apoptosis in luteal cells. In
cultured mouse luteal cells IFN-y and TNF-a, alone and in combination, decreased
the number of viable cells in culture (depending on dose and age of culture) and also
increased the amount of fragmented DNA, associated with apoptosis, in luteal cells
(Jo et al., 1995).
1.6.3.2. Cytokine production in the CL
The ability of luteal cells to produce cytokines in vitro has been investigated as well
as the presence of various cytokines in luteal tissue in vivo. In the CL there has been
particular interest in the presence of TNF-a as this cytokine is produced by
macrophages which are present in CL from most species, particularly after luteolysis.
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Cells from regressing rabbit CL produced TNF-a in vitro in response to
lipopolysaccharide whereas this effect was significantly reduced in young CL
(Bagavandoss et al., 1988). However no detectable TNF-a bioactivity was present in
unstimulated luteal cells, suggesting a limited role for this substance in vivo.
Although no attempt was made to localise the cell origin of TNF-a production, the
presence of large numbers of macrophages in regressing CL led the authors to
suggest that these cells were the most likely source (Bagavandoss et al., 1988). A
later study found similar results in CL from pregnancy and pseudopregnancy in
rabbits where TNF-a was detected in low amounts by bioassay at all stages but was
significantly increased in regressing CL (Bagavandoss et al., 1990).
TNF-a was detected by immunohistochemistry in regressing luteal tissue from rat
ovaries collected at pro-oestrus. TNF-a was localised in the centre of the CL, and
was associated with cells that also stained positively with antibodies to macrophage
markers (Roby and Terranova, 1989). Immunohistochemistry was also used to detect
TNF-a in unstaged human CL. Activity was observed in both large granulosa-lutein
cells and small paraluteal cells (Roby et al., 1990).
There is also evidence of TNF-a production in ruminant CL. A study using
immunohistochemistry found immunoreactive TNF-a in bovine CL although no
attempt was made to stage the tissue or compare CL of different ages. The staining
was most intense in the thecal cords which extend into the CL from the capsule, and
smaller numbers of TNF-a-positive cells were seen between luteal cells. As in the rat
and the rabbit, these positively stained cells had the morphological appearance of
macrophages (Roby and Terranova, 1989). In sheep CL, collected following PGF2a-
induced luteolysis, TNF-a bioactivity increased only after the decrease in
progesterone had occurred but before there was evidence of luteal destruction (Ji et
al., 1991). Northern blots and in situ hybridisation were also used to look for changes
in mRNA for TNF-a within luteal tissue, but none were seen during induced
luteolysis, leading the authors to conclude that TNF-a arose from an extraovarian
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source, such as leukocytes (Ji et al., 1991). However, limited conclusions can be
drawn from this study because artificial induction of luteolysis may not reflect events
occurring during natural luteolysis.
Another study in the cow attempted to overcome this problem by using a
microdialysis system placed within the ovary to collect samples during both natural
and induced luteolysis (Shaw and Britt, 1995). They also found that any increase in
TNF-a detected by radioimmunoassay (sensitivity 35pg/ml) occurred after a decline
in progesterone in all animals that underwent luteolysis (natural or induced). Cows
that did not undergo luteolysis by day 22 and 24 of the oestrous cycle showed no
change in TNF-a concentrations. This study is the most detailed so far in regard to
investigating events during natural luteolysis, and the collection of samples direct
from the ovary is a major breakthrough, allowing more accurate assessment of
intraovarian and particularly intraluteal events. However, as discussed by the authors,
cytokines can have dramatic effects at such small concentrations that it is possible
that this technique, using radioimmunoassay, is not sensitive enough to detect
changes in TNF-a concentrations that could have significant effects in the CL.
TNF-a protein was detected by Western blot in all CL collected from pigs during the
oestrous cycle (days 8 and 12-15) and during pregnancy (days 12-112). There was no
obvious variation in immuno-intensity between groups (Hehnke-Vagnoni et al.,
1995). In the same study, immunohistochemistry showed that TNF-a was associated
with blood vessels, connective tissue and the capsule of the CL. Further analysis
revealed that many of the cells that stained positively for TNF-a also stained
positively for an endothelial cell marker. This finding corresponds with the
identification of TNF-a receptors on the small cell population (i.e. small luteal cells
or endothelial cells) of the pig CL (Richards and Almond, 1994). In the pig, unlike
other species described above, TNF-a was only found in functional CL and there was
no positive staining for TNF-a in CL where progesterone concentrations had fallen
after functional luteolysis. The authors indicate that this is probably related to the
decrease in endothelial cells which occurs at the time of luteolysis (Hehnke-Vagnoni
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et al., 1995). TNF-a has previously been shown to inhibit proliferation of endothelial
cells in the rabbit CL (Bagavandoss and Wilkes, 1991). Significantly, in the pig CL,
macrophages were not associated with TNF-a immunostaining at any stage (Hehnke-
Vagnoni et al., 1995).
1.6.4. Monocyte Chemoattractant Protein-1 (MCP-1) and the CL.
In recent years there has been interest in the role of MCP-1 in the CL. MCP-1 is a
member of the intercrine (3 family of cytokines which are involved in inflammation
and tissue repair (Oppenheim et al., 1991; Leonard and Yoshimura, 1990). MCP-1
acts as a specific chemoattractant for monocytes when injected into the ears of rats
(Zachariae et al., 1990) and also acts as a chemoattractant for monocytes in vitro
(Yoshimura et al., 1989).
These specific chemoattractant effects of this cytokine led workers to consider a role
for MCP-1 in the CL, particularly around the time of macrophage infiltration during
structural regression. MCP-1 has been found in pig luteal cells (Hosang et al., 1994a)
and a recent study showed increased MCP-1 expression in late stage rat CL
(Townson et al., 1996). An increase in MCP-1 was also observed in rat CL after
luteolysis induced using prolactin (Bowen et al., 1996). It appears that MCP-1 may
be the substance which induces the influx of macrophages into the CL (Pate, 1996).
MCP-1 is a member of the chemokine superfamily which includes a large number of
cytokines involved in adhesion and chemotaxis of a variety of leukocytes (Taub,
1996). At present the majority of studies focus on the potential role of MCP-1 within
the CL but other chemokines may also be significant. Macrophage inflammatory
protein-1 (MlP-la and MIP-1(3), T-cell activation gene 3 (TCA-3) and regulated-
upon-activation, normally T-cell expressed and secreted (RANTES) are all involved
in monocyte chemoattraction and some of these substances are also involved in T-
cell migration. The chemokine superfamily is still expanding and the specific role of
many of these substances in inflammation in vivo has yet to be clearly defined. It is
likely however that in future some of these chemokines will be found to have a role
in the changing leukocyte populations within the CL.
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1.7. Conclusion
In recent years there have been considerable advances in our understanding of how
the immune system functions and, in particular, the potential actions of their cytokine
products are being revealed. The exact role of the immune system in reproduction is
unclear at present because of the vast number of potential interactions that may be
involved. However, it is rapidly becoming clear that the reproductive system and
immune system are not independent entities, as was once thought, but interact in the
control of all reproductive processes. Future studies will involve establishing the
exact roles of individual immune cell types and cytokines within ovarian structures,
where possible. This is likely to be complicated by the number of cell and cytokine
interactions involved. Only after establishing the roles of key cells and substances
will it be possible to establish the order of events involved in the immunological
control of reproductive function.
The basic physiological processes which occur during the reproductive cycle of the
cow have been understood for many years. This has allowed the development of
various hormone treatments which may be used to improve fertility rates and treat
reproductive conditions in commercial herds. However, the success of such fertility
programmes and treatments is limited. It appears that other factors, which have yet to
be clearly defined, must be involved in controlling the oestrous cycle in the cow.
There is a limited amount of published research investigating the potential role of the
immune system in affecting reproduction in the cow. In particular, the role of the
immune system in controlling luteal function in vivo has not been studied.
The aim of the research described in the following chapters was to investigate firstly,
the populations of immune cells within the cow CL throughout the oestrous cycle and
particularly around the time of luteolysis, in order to assess the potential role of these
cells in CL function. Secondly, to investigate the immune cell populations within CL
where luteolysis was artificially induced and artificially inhibited and finally, to look
for further evidence of a role for the immune system within luteal tissue by studying




The techniques which have been used repeatedly in the course of this work are
described in this chapter. Any other techniques which were used in single
experiments are described in the appropriate chapter. Detailed protocols for the
molecular biology techniques can be found in Appendix 1.
2.1. Materials
The sources of the individual chemicals are detailed within the protocols. Frequently-
used materials and chemicals including solvents, chemicals for buffers and plastic or
glass ware were obtained from the Sigma Chemical Co., Poole, Dorset, UK or BDH
Chemicals Ltd., Poole, Dorset, UK.
2.2. Methods
2.2.1. Blood sampling
Blood samples (7-10ml) were collected from either the coccygeal or jugular veins.
Blood samples collected at slaughter were taken from the heart within 15 min of
slaughter. All blood samples were collected into lithium heparin using either glass
Vacutainer tubes (143U heparin/tube, Becton Dickinson, U.K.) or glass tubes (10ml)
containing 200U heparin/tube (Sigma Chemical Co., Poole, Dorset, U.K.).
After collection, blood samples were mixed gently and then centrifuged (30 min,
1000 g, 4°C or room temperature). Plasma was then stored at -20°C prior to
progesterone and/or PGFM assay.
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2.2.2. Classification ofCL
Where ovaries were collected from animals of unknown reproductive history, the CL
were classified using the method described by Ireland et al. (1980). Luteal tissue was
classified as Stage I (days 1-4 of the oestrous cycle), Stage II (days 5-10), Stage HI
(days 11-17) and Stage IV (days 18-20) according to a variety of characteristics
which are summarised in Table 2.1. Any CL which did not fit clearly into any of the
four stages were disregarded.
Table 2.1
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present
1 Taken from Ireland et al. (1980)
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2.3. Hormone Assay techniques
2.3.1. LH Binding assay
2.3.1.1. Reagents
125I-hLH (lOOCi/g) was purchased from Keith Ferguson, Dept. of Chemical
Pathology, Hammersmith Hospital, London, UK. Human chorionic gonadotrophin
(hCG, Chorulon:1500 IU hCG/ampoule) was purchased from Intervet Laboratories,
Cambridge, UK.
1) SET (homogenizing) buffer
0.3M sucrose, ImM EDTA, lOmM Tris-HCl, pH 7.4.
2) Assay buffer
40mM Tris-HCl, pH 6.5
3) BSA
5% BSA in 40mM Tris-HCl, pH 7.4
4) ,25I-hLH tracer
Diluted in assay buffer to give 100,000cpm/100|il.
5) hCG for non-specific binding tubes
Dilute 1 vial Chorulon (1500U/vial) in 3ml assay buffer to give a stock solution of
500IU hCG/ml.
6) Polyethylene glycol (PEG) [MW, 8,000]
25% PEG in 40mM Tris-HCl, pH 7.4.
7) IgG
0.5% IgG in 40mM Tris-HCl, pH 7.4
2.3.1.2. Preparation of luteal homogenate
Luteal cell pellets were homogenised on full power in a Polytron homogeniser
(Kinematica, Lucerne, Switzerland) for 10 sec in ice-cold SET buffer (approx
lOml/g) and filtered through four layers of cheese cloth. Homogenates were then
stored on ice if used immediately, or at -20°C for longer term storage. Portions of
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frozen luteal tissue were weighed and homogenised in ice-cold SET buffer (lOml/g).
The average weight of luteal tissue used was 250mg.
2.3.1.3. Measurement of specific binding of 125I-LH
The samples were assayed using the method described by Bramley et al. (1987). All
samples were set up in triplicate. Non-specific binding (NSB) was set up in duplicate
and assessed by inclusion of 50 IU Chorulon in the incubation. A preparation of
sheep CL homogenate with a binding capacity of 5.1fmol I-hLH/pg DNA was
included as an internal standard in each assay (interassay coefficient of variation 6%).
A set volume (50pl) of each luteal homogenate was used initially but this volume
was adjusted (between 20-100|Lil) where initial binding was outwith the assay range.
Each tube contained 1ml total volume;
50[il of luteal homogenate
750|ll of 0.5% BSA in assay buffer
100)xl of125I-hLH tracer
NSB lOOpl of Chorulon (50IU)
Bo lOOpl of assay buffer
The tubes were vortexed and incubated at 20°C for 16-20 hours.
After incubation, the tubes were chilled on ice and bound and free hormone were
separated by polyethylene glycol precipitation (PEG) as follows;
0.5ml of 0.5% IgG was added to all tubes except total counts followed immediately
by 1ml of ice-cold 25% PEG. The samples were then vortexed and centrifuged at
2000 g for 30 min. The supernatants were carefully aspirated and the 125I associated
with the pellet was counted in a multiwell Packard "Crystal" gamma counter at an
efficiency of 75%.
69
Specific binding was calculated as the difference between total binding and binding
in the presence of excess unlabelled hormone. The results for each sample were
expressed per microgram of DNA.
2.3.2. Progesterone Assay
Plasma progesterone concentrations were analysed by radioimmunoassay as





3g gelatin (swine skin)
200mg Thimerosal
200ml 0.5M P04 (pH 7.4)
Made up to 2000mls using double distilled water and stored at 4°C.
2.3.2.2. Preparation of standards
Standard solutions were prepared from P-0130 (Sigma Chemical Co., Poole, Dorset)
diluted in assay buffer to give 8 standards ranging from 7.8-1000pg/tube. Two
standard curves were prepared where more than 100 samples were being assayed.
2.3.2.3. Assay protocol
All samples and standards were assayed in glass tubes (12 x 75mm). Two quality
controls (1 high progesterone, 1 low progesterone) were assayed with the plasma
samples.
1. 50|il of ovariectomised bovine plasma was added to each standard (100|il) which
was assayed in triplicate. The standards were made up to 500pl using assay buffer.
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2. Plasma samples (lOOpl) were dispensed in duplicate and made up to 500|al with
assay buffer.
3. 100|il l25I-labelled progesterone (1-140, [Amersham International pic, Amersham,
UK], made up in assay buffer and lmg/ml 8-anilino-l-naphthalene sulfonic acid
(ANS) to give between 13,000-15,000 counts per minute in lOOjxl) was added to
each tube.
4. 200(il antiserum R31/8 (1:16,000) was added to all tubes except totals and blanks
(NSB). Blanks received 200|nl of assay buffer.
5. All tubes were vortexed and then left to incubate for 3 hours at room temperature.
6. In order to separate free and bound antibody 100pl each of donkey-anti-rabbit
serum 1:35 (10% 0.1M EDTA) and normal rabbit serum 1:300 were added to all
tubes except totals.
7. The tubes were vortexed and left to incubate at 4°C overnight.
8. All tubes except totals were prewashed by adding 1ml of cold assay buffer and
centrifugation at 2000 g for 30 min at 4°C.
9. The supernatant was then carefully decanted and the tubes allowed to dry briefly.
10. The activity in the precipitates was then counted.
2.3.2.4. Assay calculations
Progesterone assays were analysed using Assayzap (Zaristow software, Haddington,
East Lothian, Scotland). Assay sensitivities and coefficients of variation are detailed
in each chapter.
2.3.3. 13,14-Dihydro-15-keto-prostaglandin F2a (PGFM) Assay
Plasma samples were assayed for the stable metabolite of PGF2a, 13,14-dihydro-15-
keto-prostaglandin F2« (PGFM), using the assay developed by Dr R. Kelly, MRC




1.81 PBS (0.05M) 1:10
18g sodium chloride
2g sodium azide
2g gelatin (dissolve first in 200ml ddH20)
MOX;




pH 5.6 and make up to 21 with dH20.
2.3.3.2. Preparation of standards
A standard curve was prepared by diluting a top standard of PGFM (5120pg/ml) by
50% in assay buffer and continuing this serial dilution to give 10 standard dilutions
ranging from lpg/lOOfil -512pg/100(il. 20% MOX was added to each standard used
in the assay.
2.3.3.3. Extraction method for prostaglandins from plasma
1. 0.5ml 20% ethanol and 10pl acetic acid were added to 0.5ml of each plasma
sample in a 1,5ml polypropylene tube.
2. The samples were mixed gently, left at room temperature for 5 minutes and
centrifuged at maximum speed in a microfuge.
3. The supernatants were applied to Bond-Elut C18 columns that had first been
primed with 2 column volumes (0.85ml) of 100% ethanol and then 1 column
volume of 10% ethanol.
4. The columns were washed with 1 column volume of distilled water and then 1
column volume of hexane.
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5. The samples were eluted into 20ml glass tubes with 2 volumes (0.75ml) of ethyl
acetate and then evaporated to dryness under nitrogen at 60°C (30-45 min).
6. 1 OOjj.1 of phosphate-buffered gelatin-saline pH 7.8 and lOOpl of MOX B solution
was used to reconstitute the precipitate.
7. Finally the tubes were incubated at 60°C for 1 hour to allow methyloximation to
take place and then diluted to a final volume of 500pl with PBS.
2.3.3.4. Assay protocol
All standards (IOOjj.1) were assayed in triplicate. Two standard curves were prepared
for the assay. Samples (25p,l and lOOpl) were analysed in duplicate and made up to
100|ll with assay buffer. Two different volumes of samples were used because it was
likely that the concentrations of PGFM would vary considerably between the
different dose rates.
Method
1. lOOjxl of samples and standards were dispensed into polypropylene tubes.
2. 100|il of tracer (radiolabelled 13, 14 dihydro-15-keto PGF2a coupled to proline-
tyrosine, supplied by Dr R. Kelly), 20,000cpm/100|ll, was added to all tubes.
3. 1 OOptl of R-144 (1:40,000) was added to all tubes except blanks (NSB) which
received 100pl of assay buffer.
4. The tubes were vortexed and then covered and incubated for 3 hours at room
temperature.
5. IOOjllI of normal rabbit serum (NRS,SAPU, 1:200) and 100|ll of donkey-anti-rabbit
serum (DARS, SAPU, 1:20,) and 10% 0.1M EDTA were added to all tubes except
total counts, vortexed and incubated overnight at 4°C.
6. 1ml of cold assay buffer was added to each tube except totals and the tubes were
then centrifuged at 2000 g for 30 min (4°C).
7. The supernatants were carefully decanted, tubes allowed to drain and then the
precipitates were counted in a gamma counter.
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2.4. DNA Assay
DNA in each sample was assayed fluorometrically using the method described by
West et al. (1985).
2.4.1. Reagents
1) EDTA




lOOmM NaCl in lOmM Tris, pH 7.
4) Bisbenzimide
Stock 200mg/ml stored at 4°C in dark. Diluted 1/1000 in NaCl-Tris buffer
immediately prior to use.
2.4.2. Preparation ofstandard curve
Calf thymus DNA (Sigma, Poole, Dorset) was used as the DNA standard. A stock
solution was prepared (2mg/ml) and stored at 4°C.
To prepare a standard curve the stock solution was diluted with ddH20 to give a
range of 9 dilutions from lpg/ml-200pg/ml, aliquoted and stored at -20°C prior to
use. A quality control containing 50pg DNA/ml was also prepared and stored at
-20°C.
2.4.3. Assay method
All standards and samples were prepared in triplicate. Samples of luteal homogenates
were first diluted 1/5 in NaCl-Tris buffer to bring the DNA concentrations within the
range of the standard curve. Duplicate quality controls and tubes containing no DNA
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were included in each assay. Two sets of standards were prepared and put through the
fluorimeter before and after the samples.
Protocol;
Glass test tubes were used throughout.
1) 1.4ml cold EDTA (lOmM, pH 12.3) was added to lOpl of each sample or
standard.
2) All tubes were incubated at 37°C for 20 min and then cooled on ice for 5 min.
3) 2M KH2P04 was added to each tube in sufficient volume to adjust pH to 7.0
(calculate volume by adding 2M KH2PO4 in small volumes to 14ml EDTA and
divide amount by 10 to calculate amount required per tube.)
5) 1.5ml bisbenzimide (200ng/ml diluted in NaCl Tris buffer) was added and the
tubes were vortexed briefly.
6) Fluorescence was then measured using a fluorimeter [Excitation =350nm (340nm
nearest filter) Emission=455nm].
7) The standard curves were then plotted on graph paper and concentrations of DNA
calculated from the relative position of the samples on the curve.
2.5. Basic Immunohistochemistry protocol
The technique was based on an avidin-biotin complex (ABC) method described by
Hsu et al. (1981).
1. Sections of tissue (6pm) were cut on a cryostat (Shandon AS650M, Shandon, UK),
then mounted on to gelatin-coated slides and air-dried for 2 hours.
2. The sections were then fixed in cold acetone for 5 min and washed in PBS (pH
7.3).
3. Endogenous peroxidase staining was blocked by treating the sections with 5 units
of glucose oxidase/mP1 in lOmM [3-D glucose, ImM sodium azide and 0.1M
phosphate buffered saline (pH 7.3) for 50 min at 37°C. The slides were washed for
10 min in PBS.
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4. Sections were then treated with 1.5% normal horse serum for 15 min at room
temperature, primary antibody was added and the sections were incubated
overnight at 4°C.
5. The following day, slides were again washed for 10 min with PBS and then
incubated for 30 min at room temperature with biotinylated second antibody.
6. After washing, the slides were incubated with the avidin-biotin reagent for 30 min
at room temperature and washed again.
7. The reaction product was visualised by incubating with 3-amino-9-ethyl carbazole
(AEC) for 10-15 min.
8. The slides were then washed in tap water, counterstained in Meyer's haematoxylin
(2 min) and mounted using Immu-mount (Shandon, Pittsburgh PA 15275), an
aqueous mountant.
For each batch of slides, one slide was included in which normal horse serum was
substituted for primary antibody (negative control) and sections of bovine lymph
node were also included as positive controls.
2.6. Carbol chromotrope stain for eosinophils
Eosinophils were detected on sections from frozen tissue using the carbol
chromotrope method described by Lendrum (1944). Sections of gut were used as
positive controls.
Method;
1. 6|am sections were cut, fixed in cold acetone for 10 min and air dried before
staining in haematoxylin for 1 min (stains nuclei blue).
2. The sections were washed in water, differentiated in acid alcohol and then the blue
stain was developed briefly in Scott's tap water substitute.
3. The sections were then stained for 10 min at room temperature in carbol
chromotrope solution (5g phenol, 2.5g carbol chromotrope, 500ml distilled water).
4. All slides were rinsed briefly in alcohol and then held in xylene before mounting
in DePeX mounting medium (BDH, UK).
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2.7. Non-specific esterase staining of macrophages.
Macrophages were stained using the method described by Hudson and Hay (1989) as
follows;
1. 6pm sections of tissue were fixed for 30 sec at 4°C in 30ml of 0.1M phosphate
buffer, pH 6.6 mixed with 45ml acetone and 25ml formaldehyde solution.
2. The slides were then washed 3 times in distilled water and allowed to air dry.
3. The pararosaniline dye was prepared immediately before use; 6ml pararosaniline
stock solution (lg pararosaniline, 5ml 10M HC1, 20ml distilled water, heated to
70°C, cooled to room temperature and filtered.) was added to 6ml 4% sodium
nitrite and diluted to 200ml with 0.067M phosphate buffer pH 5.
4. The pH of the activated dye solution was adjusted to pH 5.8 with 0.1M sodium
hydroxide.
5. 50mg oc-napthyl acetate was dissolved in 2ml acetone and added to the dye
solution.
6. The sections were incubated at 37°C for 45 min and then rinsed in distilled water.
7. 0.4% methyl green was used as a counterstain (l-2min) and the sections were
finally washed in distilled water, air dried and mounted in DPX.
2.8. Haematoxylin and eosin (H&E) stain
H&E was used to stain sections of CL for morphological studies.
1. Sections of luteal tissue (4pm) were cut onto glass slides.
2. The slides were placed in an automatic processor (Linnistain).
3. The sections were stained in Harris haematoxylin (Surgipath, U.K.) for 1 min and
then washed in water for 30 sec.
4. The sections were stained in Scott's tap water substitute for 30 sec and then
counterstained in Putt's eosin for 30 sec.




DISSOCIATION OF THE BOVINE CORPUS LUTEUM
3.1. INTRODUCTION
A variety of techniques may be used to study the corpus luteum in vitro. It is possible
to study cell populations within the CL using individual sections of tissue by
techniques such as immunohistochemistry or electron microscopy. In addition luteal
tissue can be dispersed to produce mixed populations of luteal and non-luteal cells
that may be used in techniques such as cell culture and also flow cytometry.
However, successful dissociation of luteal tissue for use in these techniques is not an
easy process. Dispersion of luteal cells from the CL requires breakdown of the
significant collagen component of the CL (Luck and Zhao, 1993) and the separation
of closely-interlocking large and small cells (Chegini et al., 1984), whilst minimising
damage to the luteal cells themselves. In particular, large cells, with their extensive
cytoplasm, are very susceptible to damage during dissociation. Large and small luteal
cells differ in many ways, including their responsiveness to LH and basal
progesterone production (see review by Hansel et al., 1991) and therefore a high
proportion of damaged large cells within a dispersed population of mixed luteal cells
may alter significantly the response and properties of mixed luteal cells during in
vitro studies.
It is not clear at present how large and small luteal cells interact (Del Vecchio et al.,
1994), although it is likely that the proportion of luteal cells present at each stage of
the oestrous cycle will influence the function of the CL in vivo. In addition to
minimising damage to luteal cells during dispersion, it is also important to produce
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cell populations which are representative of the proportions of cells present in the
intact CL, so that the conclusions reached reflect the physiology of the CL in vivo.
Collagenase preparations have been widely used to dissociate luteal tissue for
experiments in vitro. However, morphometric studies of CL in both the cow and the
sheep have suggested that collagenase dissociation does not always produce cell
populations representative of intact luteal tissue. In particular, there is a selective loss
of large luteal cells (Rodgers et al., 1984; O'Shea et al., 1989). We have observed
differences in cell populations following dissociation of equine luteal tissue with
collagenase (Broadley et al., 1994) compared to cell populations produced by
mechanical dissociation without the use of any collagenase enzymes.
The first aim of this study was to compare dispersed bovine luteal cell populations,
prepared using a range of commonly used collagenase enzymes, with those prepared
by mechanical dissociation. The second aim was to determine whether the type of
collagenase used had an effect on the cell membrane of dissociated cells, using LH
receptor populations to indicate cell membrane integrity. The data obtained from this
study would allow us to select the conditions which were most appropriate for the
preparation of dispersed luteal cell populations for cell culture and, in particular, for
flow cytometry studies which would be used to investigate immune cell populations
within the bovine CL.
3.2. MATERIALS AND METHODS
3.2.1. Materials
Seven collagenase preparations were used in this study: Collagenase IA, Collagenase
V and Collagenase XI (Sigma Chemical Co., Poole, Dorset, UK.), Worthington I and
Worthington IV (Cambridge Bioscience, Cambridge, UK.) and Collagenase D and
Collagenase/dispase (Boehringer-Mannheim, East Sussex, UK.). The collagenase
enzymes selected are commonly used in studies involving dissociation of bovine CL
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and have a range of enzymatic activity (Table 3.1). Variations in collagenase
activities are known to occur between different batches of the same collagenase.
Therefore sufficient enzyme was obtained to enable one batch to be used throughout
the study. Hepes buffer was purchased from Flow Laboratories, Irvine, U.K.













2.7 1.7 >0.1 1.2
COLLAGENASE
(collagen digestion)
2030 510 196 425
NEUTRAL PROTEASE
(caseinase)
110 65 331 43 33.2
CLOSTRIPAIN 0.9 0.7 2.6 0.4 0.7
TRYPSIN 0.29 0.1
DISPASE >0.8
*Enzymatic activity in units/mg dry weight.
3.2.2. Dissociation of luteal tissue and analysis.
3.2.2.1. Collection and preparation of luteal tissue
Ovaries from non-pregnant cows were collected at the abattoir within 15 minutes of
slaughter and transported on ice to the laboratory. Stage in CL (days 11-17 of the
oestrous cycle) were selected according to the criteria described by Ireland et al.
(1980) and dissected from the surrounding ovarian tissue. The selection criteria are
described in Chapter 2 (Section 2.2.2).
Three or four Stage IE CL were combined, and the tissue was minced finely using a
scalpel blade before being washed by gentle repeated inversion in buffered HBSS
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(Hanks balanced salt solution without divalent cations, containing 20mM Hepes,
100U penicillin/ml, lOOpg streptomycin/ml) and filtered through a 100 pm stainless
steel mesh. The filtrate from this wash represented the cell population produced by
mechanical dissociation (MD) of luteal tissue. In order to assess the effect, if any, of
washing the tissue prior to collagenase treatment, samples of minced luteal tissue
were collected on two occasions before and after washing and fixed in 4% buffered
formalin. Sections from paraffin blocks prepared from these samples were stained
with haematoxylin and eosin and the cell morphology examined by light microscopy.
In particular the proportion of large cells within the tissue was assessed as these cells
are more susceptible to damage because of their extensive cytoplasm. Washing of the
tissue prior to collagenase treatment did not alter tissue morphology although it did
result in less red blood cell contamination after dispersion.
3.2.2.2. Collagenase dissociation of luteal tissue
The washed tissue was then divided into 5g portions and placed in 50ml plastic
centrifuge tubes. The collagenase treatment of luteal tissue was based on the method
described by Simmons et al. (1976) as follows;
A collagenase enzyme made up in dissociation media (buffered HBSS containing
divalent cations, 10% foetal calf serum, 0.02% DNase, 100U penicillin/ml and
100)lg/ml streptomycin) was added to each tube (3ml/g) and mixed gently. The
centrifuge tubes were then placed in a shaking water bath at 37°C for 50 minutes.
Following collagenase digestion or mechanical dissociation the cells were filtered
through a 100pm stainless steel mesh to remove undigested tissue, washed twice in
buffered HBSS" and collected by gentle centrifugation (10 min 200 g). Any
undigested luteal tissue remaining was frozen at -20°C for LH binding assay.
3.2.2.3. Cell counts
The dissociated cells were resuspended in buffer and the total cell yields for 5g of
luteal tissue calculated using a haemocytometer. Cytospin cell preparations were
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produced using a cytocentrifuge (10 min, 100 g) and stained with Diff-Quik (Baxter,
Thetford, Norfolk, UK). The number of large cells present in the cytospin preparations
was expressed as a percentage of the total cells present rather than as a ratio of
large:small cells because of the difficulty in clearly differentiating small luteal cells
from the other cell types present such as endothelial cells. In particular, there were
many cells which appeared to have distinct nuclei and small portions of uneven
cytoplasm attached. It was difficult to assess whether these cells were small luteal cells
or large luteal cells that had lost their cytoplasm. The number of intact large cells
(identified on the basis of their size, central nucleus, distinct nucleolus and intact
cytoplasm) in a total of 200 cells was calculated. The remaining cells were frozen at -
20°C for LH binding assay. There was a minimum of 10 replicates for each of the four
collagenase treatments and mechanical dissociation.
3.2.3. Analysis ofcell populations by flow cytometry.
3.2.3.1. Principles of flow cytometry
Flow cytometry is a technique which allows simultaneous measurement of a variety of
physical characteristics of a single cell within a large population of cells. Between 500
and 4000 cells in a fluid stream may be measured per second. A flow cytometer can
measure the relative size and granularity (or surface complexity) of a cell by recording
how it interacts with a focused laser beam. The degree of light diffraction caused by an
individual cell is proportional to the cell surface area and the degree of light refraction
plus reflection is proportional to cell granularity. The cells are then presented as a series
of dots on a graph (dot-plot) as shown in Fig. 3.1. The X-axis represents light
diffraction (forward light scatter, FSC), related to cell size, and the Y-axis represents
light refraction and reflection (90° light side scatter, SSC), related to cell granularity.
Therefore the smallest, least granular cells, such as lymphocytes will be present in
Region 1 of the dot plot (Fig 3.1) and large, granular cells, such as macrophages will be
found in Region 2 (Fig 3.1).
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Fig. 3.1. Regions of dot plot associated with cells of a specific size and complexity.
The X-axis represents forward light scatter (FSC) and the Y-axis represents
light refraction and reflection, side scatter (SSC).
In addition to measuring cell size and granularity the flow cytometer can also
measure the fluorescence intensity of a cell. For this function cells are first stained
with a monoclonal antibody and then linked to a fluorescein-conjugated second
antibody. The fluorimeter detects fluorescent cells within a large population which
allows different cell types to be identified (for example, CD4+ T-lymphocytes in a
mixed population of white blood cells). Fluorescent cells can be expressed as a
percentage of the total population or, where the properties of the cell types involved
are known, the fluorimeter can be programmed to count cells only within a range of
size and complexity by setting specific 'gates'.
The use of the flow cytometer to detect cells that have been stained with specific
antibodies and fluorescent markers is decribed in Chapter 6, Section 6.2.8. However,
in this study flow cytometry was used to compare the proportions of different luteal
cells, based on their size and granularity, within dispersed cell populations produced




3.2.3.2. Flow cytometry of luteal cell populations
Aliquots of luteal cells in buffer from the dissociation procedure described above
were washed in cold PBS (containing 0.1% azide and 1% BSA). The resulting cell
pellet was resuspended in PBS to give a concentration of cells in the region of 2xl06
cells/ml and kept on ice. PBS was used at this stage because HBSS fluoresces, and
this would affect the results. The flow cytometer (FACScan flow cytometer, Becton
Dickinson, Mountain View, USA) was then used to analyse lxlO4 cells from each
sample using settings of FSC 2.0 and SSC 1.5.
3.2.4. LH Binding Assay
The samples were assayed using the method described by Bramley et al. (1987)
which can be found in Chapter 2 (Section 2.3.1.).
3.2.5. DNA Assay
DNA in each sample was assayed fluorometrically using the method described by
West et al. (1985) which can be found in Chapter 2 (Section 2.4.).
3.2.6. StatisticalAnalysis
Differences between cell populations produced using the various collagenase
enzymes and mechanical dissociation were analysed using the Kruskal-Wallis test for
one way non-parametric analysis of variance. Where statistically significant
differences were apparent, a Mann Whitney U test was used to compare the data
between groups. Groups were considered to be significantly different where /?<0.05.
3.3. Results
3.3.1. Preliminary results- comparison of 6 collagenase enzymes
Initially six collagenase enzymes were compared by visual assessment of dissociated
cell populations and measurement of LH binding.
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3.3.1.1. Visual assessment
Dispersed cell populations were examined under a microscope to investigate whether
there were obvious differences between cells prepared using different enzymes. In
particular the appearance of the large cells was studied as these cells are most
susceptible to damage;
1. Worthington 1 (Wl)
There initially appeared to have been good dispersion but on closer examination
the cell types present were all of similar size. It was difficult to distinguish small
cells from damaged large cells or non-luteal cells. The large cells were ragged in
appearance with portions of cytoplasm missing.
2. Worthington 4 (W4)
Few intact large cells were present, most large cells appeared ragged or had a
vacuolated cytoplasm. There were few clumps but, as in cell dispersions from
Worthington I, the various cell types were difficult to differentiate.
3. Collagenase IA (CIA)
The different cell populations within the cell dispersions were easier to identify,
with a higher percentage of intact large cells present (although there were more
clumps of cells present than either of the Worthington collagenases).
4. Collagenase V (CV)
There was good dispersion with distinct populations of large and small luteal
cells. The small cells tended to appear in clumps but not to the extent seen with
Collagenase IA.
5. Collagenase XI (CXI)
Similar in appearance to Collagenase V with good dispersion of distinct cell
populations.
6. Collagenase D (CD)
Intact large cells and good dispersion with little clumping. Similar appearance to
Coll V and XI.
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3.3.1.2. LH Binding /Preliminary Study
Results of the LH binding assay can be seen in Fig 3.2. LH binding varied quite
considerably between dispersed cell populations produced using different collagenase
enzymes (0.33-1.87/per pg DNA).
FIGURE 3.2 Preliminary Study- LH binding (pg/pg DNA) to luteal cells dispersed
using 6 collagenase enzymes; Worthington 1 (Wl), Worthington 4 (W4),
Collagenase IA (CIA), Collagenase V (CV), Collagenase XI (CXI)
and Collagenase D (CD)1
2.5 T
2 -
From the LH binding results and visual assessment of dispersed populations of cells
3 enzymes were chosen (Worthington 1, Collagenase XI and Collagenase V) for
further study. An additional enzyme, Collagenase/dispase (Boehringer Mannheim),
was also selected, although it was not included in preliminary work.
Collagenase/dispase is a relatively "gentle" enzyme, containing a highly purified
collagenase and is recommended by the manufacturers for studies where preservation
of functionality and surface protein integrity are important.
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3.3.2. Comparison offour collagenase enzymes and mechanical dissociation
Following on from the preliminary study, cells prepared by four collagenase
preparations were compared with each other and mechanical dissociation. Cell
populations produced by these treatments were compared by recording the total cell
yield from 5g of mid-cycle luteal tissue, the number of large luteal cells in
dissociated cell populations, the number of intact LH receptors (and analysis of
dispersed cell populations by flow cytometry).
Abbreviations used in the Results and Discussion sections are as follows;
1. Mechanical dissociation (MD),
2. Collagenase V (CV),
3. Collagenase XI (CXI),
4. Collagenase dispase (CDp),
5. Worthington 1 (Wl).
3.3.2.1. Total Cell Yield
The cell yields produced by the different dispersion treatments are shown in Figure
3.3. There were no significant differences between CXI, CV, Wl and MD. However
CDp had a significantly smaller (/?<0.005) yield of cells from 5g luteal tissue. This
result was not surprising as the cell pellets produced after treatment with CDp were
visibly smaller than any of the others throughout the study.
3.3.2.2. Large luteal cell numbers
The MD cell preparations contained a significantly higher number of large cells
(p<0.05) than the other groups with levels around 35-40% (Fig. 3.3) although there
were obvious clumps of mixed cell types in these cytospin preparations (Fig. 3.4a).
Direct smears ofMD cell preparations on glass slides confirmed that these clumps
were not a result of cytocentrifugation. There were no statistically significant
differences between CXI, CV and Wl, although the number of large cells present in
W1 preparations was always lower than CXI and CV. Cell populations produced by
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CXI and CV appeared to be similar on examination of cytospin preparations, there
was good dissociation of cells with limited clumping and large cells remained intact
(Fig. 3.4b/3.4c). The cells produced using Wl, particularly the large cells, tended to
have a ragged appearance and there were often portions of detached cytoplasm within
the cell populations (Fig. 3.4d). CDp produced significantly lower numbers of large
cells (p<0.05) compared to the other collagenase enzymes and MD, although the
large cells seen in cytospin preparations from CDp were usually intact with very little
cell debris.
FIGURE 3.3 Total cell yield and number of large luteal cells from 5g of luteal
tissue after mechanical dissociation (MD) or collagenase
dissociation using Worthington 1(W1), Collagenase XI (CXI),
Collagenase V (CV) or Collagenase Dispase (CDp).
12 x
* There were significantly fewer cells in total (p<0.005) and significantly fewer large
luteal cells (/?<0.05) in cell populations produced using CDp compared to all other
treatments.
** There were significantly more large luteal cells (p<0.05) in luteal cell populations
produced by MD compared to all other treatments.
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FIGURE 3.4a. Cytospin appearance of luteal cell populations prepared by
mechanical dissociation (MD x218).
LLC =■ Large. Luutea_l Ge.ll
FIGURE 3.4b. Cytospin appearance of luteal cell populations prepared by
collagenase dissociation using Collagenase V (CV x218).
FIGURE 3.4c. Cytospin appearance of luteal cell populations prepared by
collagenase dissociation using Collagenase XI (CXI x218).
FIGURE 3.4d. Cytospin appearance of luteal cell populations prepared by































Initial dot plots showed some distinct differences in appearance in particular between
mechanically dissociated cell populations and those produced by the various
collagenase enzymes (Fig. 3.5 a-d).
Successful use of the flow cytometer is dependent on a good cell dispersion and the
presence of distinct cell types if specific cells are to be identified. Unfortunately,
because of the nature of the cell populations involved in this study, neither of these
requirements were fulfilled. Dispersed luteal cell preparations were not made up
completely of distinct cells and there was a high incidence of clumps of mixed cell
types, as well as damaged cells and other cell debris within the cell populations. A
clump of small cells would appear to be larger and more complex than a single small
cell and would therefore be recorded as a single complex large cell, whereas large
cells with portions of cytoplasm missing may be identified as similar in size to small
cells. Moreover, since there is some evidence of small luteal cells differentiating into
large luteal cells during the oestrous cycle (Alila and Hansel, 1984; Niswender et al.,
1985), small and large luteal cells may not be distinct enough to be separated by size
alone.
It was therefore decided that flow cytometry would be of little use in accurately
defining luteal cell types and proportions within dispersed cell preparations and the
technique was not used further in this study.
3.3.2.4. LH Binding Studies
LH binding to luteal cells
There were no significant differences in LH binding per pg of DNA between MD,
CXI, CV or CDp, although CDp exhibited the highest levels of binding (Fig. 3.6).
LH binding levels were significantly lower (/?<0.005) in cell populations produced
using W1.
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Figure 3.5. Flow cytometry: Dot plot appearance of cell populations produced after
mechanical and collagenase dissociation of luteal tissue.
a) Mechanical dissociation. b) Collagenase XI.
rsc
FIGURE 3.6 LH binding (pg/pg DNA) to luteal cells after mechanical
dissociation (MD) or collagenase dissociation using
Worthington 1(W1), Collagenase XI (CXI), Collagenase V (CV)




MD W1 CXI CV CDp
'Each figure represents the mean (+/-s.e.m.) for a minimum of 8 treatments.
*LH binding was significantly lower (p<0.005) in cell populations produced using
W1 compared to all other treatments.
LH binding to luteal tissue
LH binding to luteal tissue after mincing and washing of the various batches of
corpora lutea (prior to mechanical or collagenase dissociation) from different days
varied between 1.31-2.1 per jj.g DNA (Table 3.2) and there were no significant
differences in LH binding in tissue remaining after any of the collagenase treatments
and mechanical dissociation (Fig. 3.7).
Table 3.2 LH binding to different batches of luteal tissue, prior to mechanical or
collagenase dissociation.
Run No. 1 2 3 4 5 6

















LH binding (pg/(ig DNA) to luteal tissue remaining after
collagenase dissociation using Worthington 1 (Wl),
Collagenase V (CV), Collagenase XI (CXI), Collagenase
Dispase (CDp) or mechanical dissociation (MD)1.
Wl CV CXI CDp MD
1
Each figure represents mean (+/- s.e.m.) from 4-8 experiments.
3.4. Discussion
A variety of collagenase preparations have been used to prepare dispersed luteal cells
in a range of studies investigating their properties. Differences in the large:small cell
ratios produced by collagenase dissociation (Hansel et al., 1987) compared to
morphometric analysis of luteal tissue (O'Shea et al., 1989) led us to investigate the
possibility that the type of collagenase used may affect the cell population produced
by dissociation and hence influence the conclusions of some in vitro studies. In this
study, we were interested in damage that might also occur during luteal cell
dispersion at the level of the luteal cell membrane. We used numbers of LH receptors
per cell as an indicator of such damage.
It is not possible to draw conclusions about specific collagenase enzymes, nor to
describe conclusively the properties of individual collagenase preparations because of
the variation in enzymatic activity between different batches of the same enzyme.
Moreover, the degree to which each enzyme affects cells will also depend on the
dissociation conditions including temperature, time, concentration of enzyme and the
use of repeated incubations. However, we minimised the effects of these variables in
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this study by using the same batches of collagenases throughout and a single
incubation in a shaking water bath at 37°C. The results confirmed that different
collagenase enzymes produced luteal cell populations that differed in cell yield,
proportion of large cells and cell membrane characteristics.
Cell yields from MD, CV, CXI and W1 were similar, but CDp produced a
significantly smaller number of cells. This was probably due to the low collagenase
activity of this enzyme which reduced the rate of collagen breakdown and, therefore,
increased the time necessary to release cells from intact tissue. Longer and/or
repeated incubations of luteal tissue with this collagenase may improve the cell yield
from this particular enzyme preparation.
There was marked variation in the percentage of large cells produced using the
different treatments. Mechanical dissociation produced a high yield of large cells;
however they tended to be found in mixed clumps of large and small cells, making
the technique unsuitable for most luteal cell studies. The collagenase enzymes, CV
and CXI, produced cell populations with around 22% large cells. The large cells
obtained were easy to identify, had intact cytoplasm and appeared to have suffered
little cell damage. This was in contrast to the cell populations produced using W1
which were much more disrupted in appearance with portions of detached cytoplasm
making identification of individual cells more difficult.
The selective loss of large cells during collagenase dissociation has been recognised
by several workers (O'Shea et al., 1989; Hansel et al., 1991). The extensive
cytoplasm of the large cells may render them more susceptible to structural damage
during dissociation than the more compact cytoplasm of the small cell (Koos and
Hansel, 1981). Hansel et al.. (1987) used collagenase to disperse luteal tissue from
CL at various stages of the oestrous cycle. Their preparations had ratios of small
cellsdarge cells between 20:1 and 40:1. The low numbers of large cells seen in their
study, [using the dissociation technique described by Gospodarowicz and
Gospodarowicz (1972)], compared to the present study may be due to their repeated
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incubations with collagenase during dissociation compared to our use of a single
incubation. Repeated exposure to collagenase may increase damage to large cells,
particularly where crude collagenase enzymes with high tryptic activity are
employed. Compared to results from dissociated cell populations, morphometric
studies of intact luteal tissue have reported much lower smalhlarge cell ratios in the
region of 7.6:1 to 10.2:1 (Weber et al., 1987; O'Shea et al., 1989). Since the cell
ratios obtained in this study using either of the Sigma collagenase enzymes, CXI or
CV, were reasonably representative of luteal cells proportions in vivo, it would
appear that either of these enzymes would yield luteal cell populations in
physiological proportion for techniques such as cell culture.
Luteal cell LH binding was used in this study as an indicator of damage occurring to
the cell membrane. Luteinising hormone is the main luteotropic hormone in the cow,
although large and small luteal cells differ in their responsiveness to LH (see Hansel
et al., 1991 for a review). Small cells show a dramatic increase in progesterone
production in response to LH (Koos and Hansel, 1981; Weber et al., 1987). In
contrast, LH responsiveness is much reduced in large cells. There is some debate in
the literature as to the reason for this difference in responsiveness. Some studies have
described the presence of more LH receptors on small cells in comparison to large
cells (Fitz et al., 1982) whereas others have found equal numbers of LH receptors or
more to be present on large cells (Chegini et al., 1991; Harrison et al., 1987; Smith et
al., 1996). LH receptor numbers vary according to the stage of cycle (Diekman et al.,
1978; Chegini et al., 1991). However, since the LH receptor is found at all stages of
luteal lifespan until luteolysis, it is a good candidate to be used as an indicator of
membrane damage to the luteal cell.
Differences in LH binding were not only the result of use of collagenase, as two
collagenase dispersions (CDp and CXI) gave cell preparations which demonstrated
higher levels of binding than mechanically dispersed cells. Differences may also have
been affected by variation in the total numbers of large and small luteal cells present
after dispersion. Mechanically dispersed populations of cells contained large clumps
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of mixed cell types, as well as fibrous strands possibly originating from the capsule
or trabeculae, which may have contributed less to the total LH binding, although
there is some evidence that binding sites may be present on cells other than luteal
cells in the CL including blood vessels (Chegini et al., 1991).
The high LH binding demonstrated by cell populations produced by CDp compared
to other treatments may result from the low enzymatic activity of this enzyme, so
causing less damage to receptors than other higher activity collagenase preparations.
Conversely, the relatively crude collagenase Wl, which has high proteinase activity,
produced luteal cell populations with significantly lower numbers of intact LH
binding sites compared to MD. This collagenase has been widely used in luteal cell
studies though we have shown here that not only are the large cells visibly damaged
during dissociation with Wl, but that cell membrane LH receptors are also affected.
It is likely therefore that receptor sites for other hormones and/or proteins (Chegini et
al., 1991) may also be affected by treatment with Wl collagenase and this should be
taken into consideration when studies involving receptor sites or hormonal
responsiveness are undertaken, and when comparing results from studies using
different collagenase treatments.
In conclusion, we have demonstrated firstly that mechanical dissociation produces a
high yield of intact large cells but mixed clumps of large and small cells probably
make this approach unsuitable for most luteal cell studies. Secondly, dispersion of
bovine corpora lutea using different collagenase enzymes produces luteal cell
populations which vary in cell yield, proportion of large cells and LH binding. These
results led us to select Collagenase XI to be used in our own studies where dispersed
luteal cell populations were required. Finally, since the type of collagenase used to
dissociate luteal tissue is an important variable, it is imperative to take this into
account when studying luteal cell properties and interactions in vitro, as this could
markedly influence the results.
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Chapter 4
Immune cell populations in the bovine corpus luteum
throughout the oestrous cycle.
4.1. Introduction
The cow corpus luteum, in common with other species, is made up of a variety of cell
types. These include large and small luteal cells as well as significant numbers of
non-luteal cells including fibroblasts and endothelial cells and immune cells such as
lymphocytes and macrophages (see review by Fields and Fields, 1996). Although the
proportions of cell types present within luteal tissue vary during the oestrous cycle
and pregnancy, non-luteal cell populations make up a significant number of the total
cell types in the CL at all stages (O'Shea et al., 1989; Lei et al., 1991).
Many of the non-luteal cells, such as endothelial cells and fibroblasts, are associated
with the large number of blood vessels which are present within luteal tissue. The
mature CL receives one of the highest rates of blood flow of any organ, relative to its
size, within the body (Ford and Chenault, 1981; Smith et al., 1994). This blood
supply, in combination with the extensive network of capillaries, allows efficient
transport of luteal cell products including progesterone, oxytocin and prostaglandin
as well as delivery of lipoprotein substrates and oxygen to the CL. It may be therefore
that immune cell populations are present within the ovary for most of the cycle purely
as a result of the volume of blood circulating through the tissue. However there is
some evidence that the migration of immune cells, particularly lymphocytes, into the
ovary is an active process as numbers of lymphocytes in utero-venous lymph are
higher than those in jugular blood (Alders and Shelton, 1990).
Immune cells, in particular macrophages, have a specific role during luteolysis when
they are involved in the dramatic destruction of luteal tissue which occurs at this time
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(Paavola, 1979; Bagavandoss et al., 1988). Their role in this situation is similar to the
function of immune cells within the body where they are involved in recognition and
destruction of 'foreign' or damaged tissue. However, in recent years increasing
information about the potential effects and actions of immune cells and their
products, outwith their accepted function, has led some workers to consider a more
active role for these cells within the ovary. (Adashi, 1990; Brannstrom and Norman,
1993; Pate and Townson, 1994).
It would seem likely that, if immune cells do play a significant role within the CL,
then there will be some variation in their number and/or cell type at different stages
of the oestrous cycle which are not associated with actual destruction of luteal tissue.
However there is limited information on immune cells types and numbers present
within the cow CL. As early as 1968, Lobel and Levey recorded the presence of
immune cells within the bovine CL. Since then others have studied cell populations
within the cow CL but immune cells have often been included under a general
description of 'non-luteal cells' (Parry et al., 1980; O'Shea et al., 1985; Lei et al.,
1991). There are no details on the proportions of specific immune cell types in the
cow CL throughout the oestrous cycle. Populations of immune cells have been
identified, and in some cases quantified, within CL from other species including the
rat (Brannstrom et al., 1994a), rabbit (Bagavandoss et al., 1988), pig (Standaert et al.,
1991) and human (Wang et al., 1992c). These studies have shown variations in
immune cell types present within luteal tissue which appear to be species-specific.
The aim of this study was to identify and quantify immune cell populations within
the bovine CL throughout the oestrous cycle.
There are obviously very many different groups and sub-groups of immune cell
populations that can be identified by immunohistochemistry. We selected a range of
cell types, partly based on work in other species but in particular using information
from studies which have looked at the effects of a range of cytokines, produced
mainly by T-lymphocytes and macrophages, on bovine luteal cell populations in vitro
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(see Pate, 1995 for review). These were of interest to us because it was our intention
in the longer term to investigate production of these cytokines in the ovary in vivo.
We chose to investigate CD8+ (cytotoxic/suppressor cells) and CD4+ (helper/inducer
cells) T-lymphocytes as well as CD5+ T-lymphocytes (includes the majority of T-
lymphocyte sub-populations) to give a more general indication of changes within the
total T-lymphocyte population. We were also interested in macrophage numbers in
the CL because these cells are not only a potent source of cytokines themselves, but
are also attracted and activated by the cytokine products of T-lymphocytes. In
addition, they play a vital role in the destruction of luteal tissue during luteolysis. B-
lymphocytes were selected out of general interest although, as they are primarily
involved with the antibody response to antigen in the body, they would be less likely
to have an active role in the CL.
Major histocompatability complexes (MHC) are glycoprotein molecules found on the
surface of cells. They are required for recognition of antigen by T-lymphocytes. Class
I MHC is expressed on virtually all cells and is associated with the response of
cytotoxic T-cells to cell surface antigens on foreign or infected cells. MHC class II
molecules are also associated with the T-cell immune response but their expression is
more limited. Recently cells outwith the immune system have been shown to express
MHC II, including cells from the human and sheep CL (Khoury and Marshall, 1990;
Kenny et al., 1991) and altered MHC II expression could be important if the immune
system does have significant effects on CL function.
MHC II expression on cultured bovine luteal cells from day 10-14 CL was first
described by Fairchild and Pate (1989). They used flow cytometry to assess MHC II
expression throughout the oestrous cycle and during early pregnancy (Fairchild
Benyo et al., 1991). However, this method yields limited information as to which
cells are the actual source of the MHC II expression because of the difficulty in
identifying individual cell types accurately. In addition, the collagenase dissociation
of CL and repeated incubations required to prepare luteal cells for flow cytometry
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may not only result in cell populations that are not representative of the intact CL
(O'Shea et al., 1989; Hansel et al., 1991) but may also alter MHC II expression. We
therefore decided to study MHC II expression using immunohistochemistry as well
as flow cytometry.
Eosinophils have a variety of functions in both immune and inflammatory responses.
They are highly phagocytic for cells bearing antigen/antibody complexes. Increased
systemic populations of eosinophils are particularly associated with parasitic
infestations and allergic reactions but high numbers of eosinophils have also been
observed in the sheep CL. Increased numbers of eosinophils have been seen
particularly after induced luteolysis (Nett et al., 1976) and the existence of a luteal
chemoattractant for eosinophils as well as the role of eosinophils in luteal function in
the sheep has been investigated (Murdoch et al., 1987; Murdoch and Steadman,
1991). Since there were no descriptions of eosinophils in the cow CL, we looked for
these cells using a carbol chromotrope stain which stains the granular cytoplasm of
the eosinophil.
4.2. Materials and methods
4.2.1. Collection and preparation of tissue
All CL were collected, staged and snap-frozen in dry ice/isopentane at a local
abattoir. The majority of CL were from Holstein-Friesian cross or continental cross
heifers. In order to assess more accurately the stage of the oestrous cycle, both
ovaries were collected and the uterus was examined for signs of oestrus, such as
increased mucus and hyperaemia, and to confirm that there was no pregnancy. The
stage of the oestrous cycle was then assessed by examination of the CL and other
ovarian structures using the criteria described by Ireland et al. (1980), summarised in
Chapter 2, (Section 2.2.2.). This method allocates CL into 4 groups based on luteal
age: Stage I (days 1-4), Stage II (days 5-10), Stage in (days 11-17) and Stage IV
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(days 18-20). Any CL which did not clearly fall into any of the described categories
were discarded.
After staging and within 30 minutes of slaughter, the CL were blunt-dissected from
the ovary and cut into 3-6 pieces, depending on size. One or two pieces from each CL
were then placed onto OCT on individual cork discs and snap frozen in a mixture of
dry ice/isopentane. All samples were stored at -70°C prior to sectioning for
immunohistochemistry.
4.2.2. Tissue collected
1. Four stage 13 or HI CL were collected to optimise the techniques that would be
used.
2. CL were selected from stages I-IV of the oestrous cycle for the primary
experiment. Six CL were collected for each stage of the cycle.
4.2.3. Selection ofmonoclonal antibodies.
A wide range of ruminant-specific antibodies are available. However, there is some
variability in the staining properties of these antibodies on frozen tissue. Moreover
the high fat content of the CL can cause problems with background staining, and it
was therefore necessary to test several different antibodies to select a panel which
would give specific staining. Table 4.1 lists the monoclonal antibodies that were
tested. Sections of bovine gut and/or lymph node were used as positive controls
throughout. The distribution of staining on positive control sections allowed us to to
determine that the monoclonal antibody was staining the correct cell types.
Finding a monoclonal antibody that would consistently and clearly detect
macrophages proved to be difficult. Prior to finding a suitable monoclonal antibody,
a non-specific esterase stain for macrophages was tested (Chapter 2, Section 2.7) but
this was also unsuccessful because of excessive background staining in luteal tissue.
This was also a problem with many of the monoclonal antibodies that we tried. In
particular sheep macrophage markers did not produce good staining despite the fact
99
that some of these monoclonals are known to cross-react with cattle tissue. These
monoclonals may have worked more successfully on paraffin sections. Eventually,
clear identification of macrophages was achieved using the VMRD monoclonal,
DH59B.
The panel of monoclonal antibodies selected is shown in Table 4.2.
Table 4.1
Monoclonal antibodies which were tested during the course of the study.
Monoclonal Specificity Source Isotype Form1
CC17 CD5 IAH, Compton,UK IgG, S
CACT80-C CD8 VMRD, Pullman,
USA
IgGi A/F
GC50A1 CD4 VMRD, Pullman,
USA
IgM A/F
IL-A12 CD4 ILRAD IgG2a S
CC8 CD4 IAH, Compton, UK IgG2a S
CC21 B-cell (WC30) IAH, Compton, UK IgG, s
DU2104 B-cell Basel Institute
Switzerland
IgM s
VPM36 MHC II (DQ) Dept. Vet. Path.
Edinburgh University
IgG, s
VPM54 MHC II (DR) Dept. Vet. Path.
Edinburgh University
IgG, s
































Supernatant (S) or Ascites Fluid (A/F)
100
Table 4.2
Monoclonal Antibodies (MoAb)-Final panel
MoAb Specificity Isotype Source Form3 Dilution













DU2104 B-cell IgM Basel Institute,
Switzerland
S 1/5
DH59B GM1 IgG, VMRD,
Pullman, USA
A/F 1/2000
TH14B MHC II (DR) IgG2a VMRD,
Pullman, USA
A/F 1/1500
VPM36 MHC II (DQ) IgG, University of
Edinburgh
S 1/20
1 Howard et al. (1988).
2 Howard and Morrison (1991).
3
Supernatant (S) or Ascites Fluid (A/F)
4.2.4. Immunohistochemistryprotocol
The basic protocol for immunohistochemical staining of luteal tissue is described in
Chapter 2 (Section 2.5). The technique was based on an avidin-biotin complex
(ABC) method described by Hsu et a/.(1981) and optimised as described below.
4.2.5. Optimisation of immunohistochemical technique.
4.2.5.1. Blocking of endogenous peroxidase
Since endogenous peroxidase staining was very intense in luteal tissue, the blocking
of endogenous activity had to be optimised for successful immunohistochemistry.
Incubation with glucose oxidase (5U/mr') was compared with hydrogen peroxide
(0.3% H2O2 in methanol) for 30 minutes prior to addition of primary antibody.
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Hydrogen peroxide was extremely effective at blocking endogenous peroxidase
activity but caused a significant loss of luteal cell structure. Although some
endogenous staining remained after glucose oxidase treatment, the luteal tissue
appeared intact, making quantification of positively stained cells, particularly cells
expressing MHC n, much easier. For this reason, glucose oxidase was used
throughout.
4.2.5.2. Dilution of primary antibody and incubation time
The panel of monoclonal antibodies was used at a range of dilutions to select optimal
dilutions for experimental work. Phosphate-buffered saline (pH 7.3) containing 0.1%
sodium azide was used as diluent. In general, ascites fluid was used at dilutions of
1/200-1/2000 and supernatant was used at dilutions of 1/5 to 1/20. Various
incubation times and temperatures for primary antibody binding were compared.
Incubation overnight at 4°C was found to give clearer staining than 1 hour at 37°C for
all monoclonal antibodies tested.
4.2.5.3. Visualisation of product
We compared two peroxidase substrates from Vector Laboratories (Burlingame,
USA) that are widely used to visualise the product. Diaminobenzidine (DAB)
produced a brown reaction product which was long lasting and did not fade on
exposure to light. A red reaction product was obtained by incubating with 3-amino-9-
ethyl carbazole (AEC) which resulted in a more distinct stain than DAB against the
background of luteal cells. AEC had the disadvantage of the colour on the section
fading within one month of preparation however. To overcome this, AEC was used
and positive cells on sections were counted as soon as each batch of sections was
processed. Incubation with AEC for 10-15 minutes at room temperature was found to
be optimal. However, there was some variation depending on which monoclonal
antibody was being used. Slides were therefore examined during the incubation and
the reaction stopped before 10 minutes if necessary.
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4.2.6. Assessment of immune cell distribution in luteal tissue
Prior to counting of positively stained cells, the general distribution of different cell
types and MHC II expression was assessed in luteal tissue. Individual lymphocytes
and macrophages were found scattered amongst the luteal cells (Fig. 4.1a) and there
were also occasional clumps of lymphocytes which tended to be associated with
larger blood vessels (Fig. 4.1b). T-lymphocytes and macrophages were found in
greater numbers in the capsule of the CL (Fig 4.1c) and in trabeculae extending from
the capsule. MHC II expression (DQ and DR) was the most difficult to evaluate
because staining was less clearly associated with individual cells.
The primary aim of this study was to investigate the populations of immune cells
within luteal tissue at different stages of the oestrous cycle as a first step towards
assessing the potential effects of immune cells and their cytokine products within the
CL. If the cytokine products of immune cells have a significant role within the CL it
is most likely that they will act directly on the surrounding cells. Therefore, after this
preliminary investigation, it was decided that positively stained cells would be
counted in regions of the CL that were primarily made up of luteal cells. The capsule
and associated fibrous areas were therefore avoided, as were fields dominated by
large blood vessels. For statistical analysis the mean of counts (40x objective of a
binocular microscope) from 6 fields were calculated for each luteal section. Results
from each CL were then combined to give a mean figure for each stage of the
oestrous cycle ( n=6 CL per group) which were then analysed. When assessing MHC
II expression only cells with a clear positive stain were included.
4.2.7. Carbol chromotrope stain for eosinophils
Eosinophils were detected on sections from frozen tissue using the carbol
chromotrope method described in Chapter 2 (Section 2.6). Sections of gut were used
as positive controls.
4.2.8. Non-specific esterase staining ofmacrophages.
Non-specific esterase staining of macrophages was attempted using the method
described by Hudson and Hay (1989) which is described in Chapter 2 (Section 2.7).
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FIGURE 4.1a. Individual T-lymphocytes (CD5+) within luteal tissue (x 70).
FIGURE 4.1b. T-lymphocytes (CD5+) present around large blood vessels (x 70)
FIGURE 4.1c. T-lymphocytes (CD5+) in large numbers in the CL capsule (x 70)
4.2.9. Statistical analysis ofdata.
Results were analysed using the Kruskal-Wallis test for non-parametric data and the
Mann-Whitney test was then used to analyse differences between samples where
present. A p value of less than 0.05 was considered statistically significant. All




T-lymphocytes were found in the CL at all stages of the oestrous cycle but there were
some variations in the different sub-groups investigated (Fig. 4.2). There were
significantly higher numbers of CD5+ and CD8+ T-lymphocytes O<0.01) at Stage
IV of the oestrous cycle compared to stage II. Populations of CD4+ lymphocytes did
not vary significantly throughout the oestrous cycle (Fig. 4.2).
4.3.2. B-lymphocytes
There were few B-lymphocytes in CL at any stages of the oestrous cycle, with most
fields containing no positively-stained cells with a maximum of 1-3 cells per 6 areas
counted.
4.3.3. Macrophages
Macrophages showed the most variation in numbers compared to the other cell types
investigated. There were significantly more macrophages in stage I, III, and IV CL
(p<0.01) compared to stage II with the highest numbers of cells at stages I and IV
(Fig. 4.3).
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FIGURE 4.2. T-lymphocytes (CD5+, CD8+, CD4+) at Stage I (dl-4), Stage H (d5-
10), Stage III (dl 1-17) and Stage IV (dl8-20) of the oestrous cycle.
I II III IV
'Each figure represents mean figures from 6 CL.
*There were significantly (p<0.01) more CD5+ and CD8+ T-lymphocytes in
CL from Stage IV of the oestrous cycle compared to Stage II.
FIGURE 4.3. Number of macrophages in luteal tissue at Stages I (dl-4), II (d5-10),
III (dl 1-17) and IV (d 18-20) of the oestrous cycle1
'Each figure represents mean for 6 CL.
*There were significantly more (p<0.01) macrophages at Stages I, II and IV
compared to Stage II.
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4.3.4. MHCII Expression
Expression of both MHC n/DR (TH14B) and MHC II/DQ (VPM36) was recorded
(Fig. 4.4). MHC D/DR was significantly higher (p<0.01) in Stage IV CL compared to
stages I-m. MHC n/DQ was significantly higher in both Stage I (p<0.05) and Stage
IV CL (p<0.01) compared to Stages II and III.
FIGURE 4.4. Expression of MHC n/DQ (VPM 36) and MHC II/DR (TH14B) at
Stages I (dl-4), H (d5-10), III (dl 1-17) and IV (dl8-20) of the oestrous
cycle1
'Each figure represents mean for 6 CL.
*MHC n/DR expression was significantly higher (p<0.01) at Stage IV
compared to Stages I-III.
**MHC II/DQ expression was significantly higher at Stages I (p<0.05) and
IV (p<0.01) compared to Stages II and III.
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4.3.5. Eosinophils
Eosinophil numbers were significantly higher in stage I CL (p<0.01) compared to any
other stage (Fig 4.5). The highest numbers of eosinophils were found around the
central cavity of the early developing CL and they could easily be seen in sections
stained with haematoxylin and eosin (Fig. 4.6a).The presence of these cells could be
very dramatic with between 10-75 cells recorded per field in Stage I CL (Fig. 4.6b)
compared to 0-3 cells per field in Stages II-IV (Fig 4.6c).
FIGURE 4.5. Number of eosinophils in luteal tissue at Stages I (dl-4), II (d5-10), m






'Each figure represents the mean for 6 CL.
There were significantly more (p<0.01) eosinophils in Stage I CL compared
to all other stages.
107
FIGURE 4.6a. Eosinophils within Stage I luteal tissue (H&E, x 70).
FIGURE 4.6b. Stage I (days 1-4) luteal tissue (carbol chromotrope, x 218).
FIGURE 4.6c. Stage II (days 5-10) luteal tissue (carbol chromotrope, x 218).
4.4. Discussion
We have shown that populations of immune cells and MHC II expression vary during
the oestrous cycle of the cow, with the most dramatic alterations observed in stage IV
CL. At this stage there were significant increases in CD5+and CD8+ lymphocytes,
macrophages and expression of both MHC n/DQ and MHC n/DR. These results
appear to support the theory that immune cells have a significant role only in the
rapid structural dissolution of the CL (structural luteolysis) after release of PGF201
from the uterus has induced functional luteolysis.
This theory was put forward for the cow as early as 1968 when Lobel and Levey
reported that macrophages were most abundant in degenerating CL. Our results,
which also show an increase in T-lymphocytes and MHC II expression in the cow
CL, may give a more complete picture of events occurring at this time compared to
the findings of Lobel and Levey, due to advances in immunohistochemical
techniques and knowledge of immunological processes. T-lymphocytes, (in particular
CD8+, so-called cytotoxic T-cells) also increase during destruction of luteal tissue
and are associated with recruitment and activation of macrophages. In comparison B-
lymphocytes appear to be insignificant within the cow CL. The lack of B-
lymphocytes in cow CL was similar to data from the human CL which reported no B-
cells at any stage of the cycle (Wang et al., 1992c).
MHC II expression is now known to be required as part of the recognition processes
involved in response of T-lymphocytes to antigen (Roitt, 1991). Therefore, it could
be hypothesised that a cycle of attraction of T-lymphocytes and increased MHC II
expression, leading to increased attraction and activation of macrophages takes place
in the CL after functional luteolysis. Bagavandoss et al., (1988) also suggested that
this might be the possible order of cellular events within the rabbit CL at luteolysis
although the distinct rise in numbers of T-lymphocytes after luteolysis was not
observed in the rabbit.
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It would appear from the results described above that we have failed to find any clear
evidence of a role for immune cells, apart from the events occurring after luteolysis.
However, our results are based on the assumption that gross morphological
assessment is sufficiently accurate to allocate CL to different stages of the luteal
phase. This is particularly important when investigating events occurring within the
CL around key times such as luteolysis, when immune cells are most likely to have
some influence.
Some stages of the CL lifespan can be recognised visually with confidence using the
criteria described in Chapter 2, Section 2.2.2. (Ireland et al., 1980). Following
ovulation, the early CL is easily recognised because of its small size, soft texture and
haemorrhagic appearance. Likewise, Stage II CL are relatively easy to identify
because of the creamy pink colour and soft pleated appearance of the body of the CL
and lack of blood vessels over the surface. After this stage however it becomes
progressively more difficult to accurately assess the stage of the luteal phase without
the use of individual progesterone profiles which were not used in the present study.
Events within the CL around luteolysis occur very rapidly and there is no way of
visually differentiating CL that are in the process of undergoing structural luteolysis
from those that are approaching this stage, although events at the cellular level would
be expected to be dramatically different. It is likely that any CL that appear to be
Stage IV by the criteria of Ireland et al. (1980) will have undergone functional
luteolysis at least 24 hours previously. Although structural luteolysis also occurs
rapidly, there is a time lapse before the gross appearance of the CL changes. Thus,
although this method of CL categorisation is widely used and is extremely useful for
many studies, we conclude that, for studies of the critical events around luteolysis, it
is necessary to collect tissue from animals whose stage of cycle is known accurately
from sequential serum progesterone profiles.
There is other evidence which opposes the conclusion that immune cells within the
CL play no role around the time of luteolysis until after PGF2K is released from the
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uterus, in particular the effects of the cytokine products of immune cells on luteal
cells in culture. The cytokine products of T-lymphocytes and macrophages have been
shown to have a variety of effects on bovine luteal cells in vitro. Interferon-y (IFN-y),
interleukin-1 (3 (11-1(3) and tumour necrosis-a (TNF-a) all stimulate luteal PGF20C
production (Nothnick and Pate, 1990; Fairchild and Pate, 1991; Fairchild Benyo and
Pate, 1992). The same studies demonstrated that IFN-y inhibits basal progesterone
production by luteal cells and IFN-y and TNF-a inhibit LH-stimulated progesterone
production by luteal cells in culture. Both of these processes, namely decreased
progesterone production and increased PGF2a production, could be associated with
events occurring in the time leading up to functional luteolysis implying a role for
these immune cell products at this stage.
In addition to the changes in populations of T-lymphocytes, macrophages and MHC
II expression in regressing luteal tissue we also observed some significant changes in
cell populations at Stage I, i.e. during luteinisation and CL formation. Significantly
more eosinophils were observed in Stage I CL than at any other stage. This apparent
eosinophilia is an interesting finding which has not been described in other species.
An increase in eosinophils within the sheep CL was associated with PGF2a-induced
luteolysis (Murdoch, 1987) and it has been suggested that a chemoattractant may be
involved in this process. In the cow this increase in eosinophil numbers occurred
during CL formation rather than luteolysis, and it is difficult to suggest a role for
these cells at this time. However, it is interesting to note that large numbers of mast
cells have been recorded in the pre-ovulatory follicle of the cow which are not
present in such numbers in the early CL (Nakamura et al., 1987). This decrease in
mast cell numbers may be due to degranulation of the mast cells by the LH surge
prior to ovulation, a process which has been described in the hamster by Krishna and
Terranova (1985), and could explain the presence of large numbers of eosinophils in
early CL, as these cells are attracted by substances released from mast cells as part of
the inflammatory response. This process might also explain the high numbers of
macrophages found in the CL at this stage.
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Finally, in addition to the problems caused by lack of accuracy in visual staging of
luteal tissue, the methods of counting for immunohistochemical studies in the CL
should also be considered. As discussed in Section 4.2.6. we spent some time
considering the distribution of immune cell populations within luteal tissue. T-
lymphocytes and macrophages were found in greater numbers in the CL capsule and
trabeculae and around large blood vessels, in comparison to areas of CL
predominated by luteal cells. In addition, T-lymphocytes were found both
individually and in clumps. This lack of homogeneity in cell distribution makes
accurate cell counting very difficult. However it is noticeable that few authors appear
to take this irregular distribution in to account, making no mention of the problems it
presents. We overcame the difficulty by avoiding areas of luteal tissue where the
capsule or large blood vessels predominated. The approach to cell counts should be
considered when comparing results from different studies.
In conclusion, we have shown that the numbers of some immune cells and MHC II
expression vary throughout the oestrous cycle. This appears to be most significant in
Stage IV CL, suggesting that the main role of the immune system is in luteal
destruction at this stage. However gross luteal morphology is not sufficiently accurate
to assess the exact stage of the luteal phase around the time of luteolysis. We
conclude that it will be necessary to study immune cell populations in accurately
staged luteal tissues before a possible role for immune cells prior to functional
luteolysis can be definitely ruled out.
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Chapter 5
Immune cell populations in the bovine corpus luteum
around the time of luteolysis.
5.1. Introduction
The results from the previous chapter demonstrate that, as in many other species,
there are variations in the numbers of immune cells and MHC II expression in the
cow CL throughout the oestrous cycle. In particular, we demonstrated an increase in
T-lymphocytes, macrophages and MHC II expression in CL described as stage IV
(days 18-20). However, in order to assess when exactly these changes in cell
populations took place, we concluded that it would be necessary to look in detail at
CL collected around luteolysis because the methods used to stage CL visually are not
accurate enough to differentiate between CL immediately before or immediately after
luteolysis.
The potential role of immune cells around luteolysis is of particular interest because
so little is known about what is happening at the cellular level at this time. PGF2«
from the uterus has been shown to be the primary luteolytic substance in the cow
(Knickerbocker et al., 1988, for review) and luteolysis can be artificially induced
using synthetic prostaglandin from around day 5 of the oestrous cycle (Hafs et al.,
1974). In the light of this knowledge the potential role of any other cells might seem
somewhat irrelevant. However, although uterine PGF2« causes luteolysis, it is not
clearly understood how this prostaglandin causes luteolysis of the CL, nor how the
release of PGF2« from the uterus is controlled.
Immune cells and their cytokine products have recently been the centre of much
debate as to their function in modulation of ovarian activity (Adashi, 1989, 1990;
Brannstrom and Norman 1993; Pate, 1995). Rapidly advancing knowledge about the
immune cells and their products suggests that these cells are not only involved in
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destruction of the CL after luteolysis, but may also play an active role within luteal
tissue at other stages, particularly around the key events of ovulation and luteolysis.
However, because of the potential number of events and cell interactions involved it
will be difficult to clarify events occurring in vivo.
Lobel and Levey (1968) recorded an increase in lymphocytes from day 14 of the
oestrous cycle in the cow, a finding that has not been investigated further. Studies in
the pig, human and rat (Standaert et al., 1991; Brannstrom et al., 1994c; Brannstrom
et al., 1994a) have not shown a similar increase in T-lymphocytes but there appears
to be a large inter-species variation in immune cell populations within the CL. In
order to investigate immune cell populations in bovine luteal tissue further we looked
more specifically at CL around the time of luteolysis in the non-pregnant cycle,
between days 16 and 20 of the oestrous cycle. The various immune cell types and
MHC II expression present were detected by immunohistochemistry and the results
were compared with tissue from CL collected on days 13 and 14 of the oestrous
cycle.
5.2. Materials and methods
5.2.1 Oestrous Synchronisation
Twenty seven mature Friesian-cross heifers were selected from the Roslin Institute
herd and were examined per rectum to ensure that they had normal reproductive
tracts. Oestrus was synchronised in groups of 6-7 animals by insertion of
progesterone-impregnated intravaginal devices (PRID, Sanofi Animal Health,
Watford, U.K.) for 12 days. Cloprostenol (50ptg), a synthetic PGF2K analogue
(Estrumate, Pitman-Moore LTD, Crewe, U.K.) was given by intramuscular injection
on day 10. Following PRID removal, the animals were observed for signs of oestrus
3 times daily and the date and time of standing oestrus recorded. Blood samples were
collected for progesterone assay to confirm oestrus at this time.
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Throughout oestrous synchronisation and prior to slaughter the animals were housed
in slatted courts and fed a maintenance ration of silage and mineral supplement with
free access to water. One animal was excluded during the trial as she developed
mastitis. Animals were then sent for slaughter in four groups, varying the time from
oestrus to slaughter in order to collect CL at different stages around luteolysis. Blood
samples (7ml) for progesterone analysis were collected daily by coccygeal
venepuncture for 1 or 2 days prior to slaughter. Plasma was harvested after
centrifugation (30 min, 1000 g) and stored at -20°C. The cows were again observed
2-3 times daily for signs of oestrous behaviour in the days leading up to slaughter.
5.2.2 Tissue collection andpreparation.
Both ovaries were collected within 20-30 minutes of slaughter along with a 10ml
blood sample (Chapter 2, Section 2.2.1.). The ovaries were examined and any
structures (CL or follicles >10mm) present were recorded and measured. The CL was
removed from the body of the ovary as quickly as possible, the stage of cycle visually
assessed as previously (Ireland et al., 1980, Chapter 2, Section 2.2.2.) and then cut
into four pieces using a scalpel blade. The tissue was then either snap frozen in OCT
on a cork disc for immunohistochemistry (1 piece), snap frozen in foil for molecular
studies (2 pieces) or placed in 10% buffered neutral formalin for preparation of
paraffin blocks (1 piece). Blood samples were transported to the laboratory on ice,
centrifuged (30 min, 1000 g), plasma collected and stored at -20°C until progesterone
assay. The snap frozen tissues were transported to the laboratory on dry ice and
stored at-70°C. Samples in buffered formalin were removed from the formalin after
24 hours and then processed through to paraffin wax on a Tissue-Tek VIP 2000.
5.2.3 Haematoxylin and eosin stain for general morphology
Sections (8p.m) were cut from each block of paraffin-embedded tissue and processed
automatically using a Linistain GLX 22 for staining with haematoxylin and eosin as
described in Chapter 2 (Section 2.8). All sections were examined using high power
microscopy (magnification 40x) to assess general morphology of the tissue.
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The tissue sections from animals around the time of luteolysis (days 16-20) were
assessed in more detail in an attempt to decide if it was possible to tell by
morphology alone whether functional luteolysis had occurred. Four criteria were used
to compare sections; 1) loss of cell structure, 2) vacuolation of large cells, 3) intensity
of cellular appearance (i.e. numbers of cells between luteal cells, within blood vessels
or capsule) and 4) any other distinctive features. The first three categories were
graded individually between 0 and 3+ (where 0 indicated intact morphology, absence
of vacuoles and lack of intense cellular reaction in the tissue and 3+ indicated severe
loss of cellular structure, associated with structural luteolysis, extensive vacuolation
of large cells or an intense cellular appearance). The fourth category included more
specific features not included in the other categories such as the appearance of tissue
whorls or unusual staining patterns. This part of the study was completed before any
progesterone or PGF2K metabolite assay results were known.
5.2.4. Progesterone assay
Progesterone concentrations were used to monitor whether CL had undergone
functional luteolysis in the days leading up to slaughter. As the decrease in
progesterone concentrations occurs prior to structural regression, this is the most
useful indicator of alterations in luteal function.
Progesterone was assayed as described in Chapter 2 (Section 2.3.2.). All samples
were assayed in a single assay with an intra-assay coefficient of variation (CV) of
13.9%. The assay sensitivity was O.lng/ml and values of less than lng/ml were
considered to indicate that luteolysis had occurred.
5.2.5. 15-keto-13,14-dihydro-PGF2a (PGFM) assay
In order to give some indication of the systemic concentrations of PGF2« around the
time of slaughter, plasma samples were also assayed by non-extraction
radioimmunoassay for 15-keto-13,14-dihydro-PGF2a (PGFM) which is the stable
metabolite of PGF2H (Kindahl et al., 1976a; Grannstrom and Kindahl, 1982). The
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limit of detection was 8.9-10.6 pg/ml when assaying 0.5ml of plasma. The samples
were kindly assayed by Professor Hans Kindahl at the Swedish University of
Agricultural Sciences, Uppsala, Sweden.
5.2.6 Immunohistochemistry
Tissue was processed using the method described in detail in Chapter 2 (Section
2.5.). The same monoclonal antibodies as those described previously (Chapter 4,
Table 4.2) were used in this study.
5.2.7 Eosinophils
Eosinophils were detected using the carbol chromotrope method described in Chapter
2 (Section 2.6.). Paraffin-embedded tissue was used instead of frozen tissue. This
required the inclusion of a deparaffinisation and hydration step prior to staining with
haematoxylin.
5.2.8 Cell counts
As described in Chapter 4 (Section 4.2.6.) 6 fields of predominantly luteal cells were
counted for each section, avoiding the capsule, trabeculae and major blood vessels.
5.2.9 Statistical analysis
The results from immunohistochemistry were analysed using the Kruskal-Wallis test
for non-parametric data. The Mann-Whitney test was then used to analyse differences
between groups where present. A p value of less than 0.05 was considered to be




5.3.1. Stage ofoestrous cycle and ovarian structures
In this experiment variation in time span from oestrus (day 0) to slaughter resulted in
CL collected between days 13 and 20 of the oestrous cycle. For ease of comparison
these animals were initially divided into 3 groups; days 13-14 (n=7), days 16-17
(n=6) and days 18-20 (n=12).
CL were visually assessed using the criteria described by Ireland et al. (1980), in
order to estimate the stage of cycle. All CL, except 2 discussed below, were
identified as stage EI CL. Luteal tissue was orange in colour throughout with surface
capillaries visible on the external surface. There was some variation in size, (between
1.5 and 3.5cm diameter), which is a larger range than that described by Ireland.
The ovarian structures recorded at time of slaughter are presented in Table 5.1. As
expected there was some variation in the structures present at different stages and the
findings were consistent with the known stage of the oestrous cycle in all but 2
animals. Cow 988 had a fluid-filled cystic structure of 4cm diameter on one ovary
and cow 961 had a CL with a red apex and soft texture, findings consistent with a CL
from stage E (days 5-10) of the oestrous cycle. This was not unexpected as this cow
had not been recorded to be in oestrus at any time during oestrous synchronisation.
Both of these animals were excluded from the study.
The most obvious structure on the ovaries from animals around day 13-14 of the
oestrous cycle was a CL of around 2.5-3.5cm diameter. There was some variation in
the number and size of follicular structures present on the ovaries at this stage of the
cycle. Follicular waves have been shown to begin on days 2, 9 and 16 in heifers with
three follicular waves, and days 2 and 11 in heifers with two waves of follicular
development (Sirois and Fortune, 1988). Between days 16 and 20 there was a 2-3cm
CL and at least 1 follicle of 1-1.5cm diameter in 13 out of 18 animals.
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In late-luteal stage animals at day 19-20 (especially cow 957, which was later found
to have low progesterone for 2 days before slaughter) large follicles (>10mm) or
collapsed follicles/ very early luteal structures were not recorded although these
might have been expected to be present.
Table 5.1. Cow number, day of cycle (oestrus=day 0) and ovarian structures on
ovaries collected from synchronised heifers.
COW No Age of CL Ovary 1 Ovary 2
11030 dl 3 3cm CL / 2x1,5cm follicles NSS1
11108 dl3 2.5cm CL / 1.5cm follicle NSS
7333 dl3 3.5cm CL NSS
11671 dl4 3cm CL 1cm follicle
10766 dl4 2.5cm CL / 2cm follicle NSS
1238 dl4 3cm CL / 1.5cm follicle MSF2 / degen CL
10861 dl4 3cm CL NSS
972 dl6-17 2.2cm CL 1.5cm follicle/MSF
958 dl7 3cm CL/ 1.5cm follicle MSF
956 dl7 1.5cm CL / 2cm CL 1cm follicle/ MSF
964 dl7 1.5cm CL /1cm follicle 2.5cm CL / 1cm follicle
970 dl7 2.5cm CL NSS
980 dl7 2cm CL 1cm follicle / MSF
987 dl 8 NSS 2.5cm CL / 1.5cm follicle
962 dl 8 MSF 2cm CL / 2x1 cm follicles
974 d 18 1.5cm follicle/MSF 2cm CL
959 dl9 2.5cm CL / 1cm follicle MSF
971 dl9 2cm CL MSF
983 dl9 2.5cm CL MSF
978 dl9 1.5cm CL / 3cm follicle 2x1.5cm follicle
979 dl9 2.5cm CL / 1,75cm follicle MSF
982 dl9 2cm CL MSF
955 dl9 MSF 2cm CL / 1cm follicle
957 d20 MSF 1.5cm CL
984 d20 1cm follicle / MSF 2cm CL
1 NSS= no specific structures
2 MSF= multiple small follicles (<0.5cm)
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5.3.2. Examination ofH & E stained sections.
General tissue morphology was studied to assess whether H&E staining of sections
might allow more accurate staging of luteal tissue than visual assessment alone,
particularly around luteolysis. If so, this technique might be a useful addition to
staging CL by external appearance alone.
General examination of tissue morphology showed clear differences between the day
13-14 CL and CL from days 16-20. Day 13-14 tissue appeared very homogenous
with luteal cells, in particular large luteal cells, the most immediately obvious
structures. The stain was taken up evenly and luteal cells appeared intact (Fig. 5.1a).
Luteal tissue collected between days 16-20 appeared more cellular, luteal cells were
more intensely stained and large luteal cells were not the obviously predominant cell
type. There were many clear, small, darkly-staining cells (probably leukocytes)
between the luteal cells. Their appearance was sometimes quite dramatic (Fig. 5.1b).
The blood vessels also appeared more prominent, sometimes because of clumps of
cells either within or close by the lumen. (Fig. 5.1c) The intensity of staining was
more uneven, especially on the large luteal cells which took up the stain very
strongly. Any capsule or trabeculae extending into the tissue appeared highly cellular,
again with clumps of darkly-staining cells. Obviously there was some variation, as
sections were not cut from exactly the same region of CL, but in general the whole
picture at this stage was quite different from day 13-14 CL.
We also attempted to predict whether functional luteolysis had taken place in any of
the later stage CL (from day 16 of the oestrous cycle onwards) using morphology
alone (Table 5.2). There was only one animal (cow 957) with a CL morphology that
was distinctly different from the other animals in this group. This animal was
predicted already to have undergone functional luteolysis. The assay results later
confirmed this, along with functional luteolysis in another 4 cows (979, 955, 982 and
984) that we had not predicted.
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FIGURE 5.1a. Dayl3-14 luteal tissue (H&E, x 218)
FIGURE 5.1b. Day 19 luteal tissue containing large numbers of lymphocytes
(H&E, x 70).
FIGURE 5.1c. Day 18-19 luteal tissue. Lymphocytes in blood vessel (H&E, x 218)
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5.3.3. Progesterone profiles
Progesterone concentrations are shown in Table 5.3. All animals slaughtered between
days 13-14, 16-17 and 7 cows slaughtered between days 18-20 had progesterone
concentrations consistent with a functional CL prior to and at the time of slaughter
(progesterone >lng/ml). Five animals slaughtered between days 18 and 20 had
undergone functional luteolysis as indicated by low progesterone concentrations at
the time of slaughter, although there was some variation in the exact time that this
decrease took place.
5.3.4. PGFM assay
PGFM concentrations are shown in Table 5.3. The results show considerable
variation between samples from the same animal on different days and between
animals. This is related to many of the cows being around the time of luteolysis
which could occur at any point after day 17 of the oestrous cycle although there is
some variation between animals.
PGFM concentrations greater than lOOpg/ml were measured in 13 out of the 18
animals which were between days 16 and 20 of the oestrous cycle on the day of
slaughter. Only one of these animals (cow 955) had a concentration of greater than
lOOpg/ml in a previous sample and this animal had undergone luteolysis at the time
of slaughter, as demonstrated by the low progesterone concentration. Concentrations
greater than 150pg/ml were measured in 3 animals at slaughter, 2 animals had high
progesterone concentrations (974, 959) and 1 animal had a low progesterone
concentrations (982). Such high levels are only likely to be found during the peaks of
PGFaa release at luteolysis. However, as would be expected at so late a stage in the
lifespan of the CL, it also appears that many of the other animals were also coming
under the influence of increasing concentrations of PGF^a at this time.
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Table 5.3. Progesterone (P4, ng/ml) and PGFM (PG, pg/ml) profiles
slaughter. Results are presented as progesterone results in normal type for all
and PGFM results from animals from day 16 onwards bracketed in bold type.
around
animals






11030 dl3 n/s1 n/s 5.5
11108 dl 3 n/s n/s 2.3
7333 dl 3 n/s n/s 3.2
11671 dl4 n/s n/s 2.2
10766 dl4 n/s n/s 3.1
1238 dl4 n/s n/s 1.4
10861 dl4 n/s n/s 2.3
972 dl6-17 2.8 (68.4) 2.0 (50.4) 3.5 (114.9)
958 dl7 4.1 (72.0) 4.6 (57.4) 4.3 (80.8)
956 dl7 5.3 (58.5) 4.1 (43.9) 6.1 (111.3)
964 dl7 7.0 (44.7) 4.7 (44.3) 6.9 (69.9)
970 dl7 3.3 (55.3) 5.1 (43.6) 3.6 (91.5)
980 d 17 4.13 (77.6) 3.0 (57.1) 4.1 (115.2)
987 dl 8 n/s 3.3 (46.1) 2.9 (138.3)
962 d 18 n/s 3.3 (58.2) 4.7 (73.0)
974 dl 8 n/s 3.7 (45.4) 3.3 (242.9)
959 dl9 3.1 (58.5) 1.2 (59.9) 2.7 (197.5)
971 dl9 5.5 (49.6) 2.3 (78.0) 2.6 (117.7)
983 dl9 5.1 (57.8) 2.3 (57.4) 3.6 (114.5)
978 dl9 n/s 1.81 (71.3) 1.9(109.6)
979 dl9 n/s 0.6* (53.9) 0.3* (144.7)
982 dl 9 2.5 (47.9) 0.7* (51.8) 0.7* (231.9)
955 dl 9 2.3 (123.8) 0.9* (66.3) 0.9* (112.1)
957 d20 0.6* (50.7) 0.4* (63.1) 0.2* (78.7)
984 d20 n/s 1.5 (63.5) 0.7* (116.7)




Using the above information, particularly progesterone concentrations, the animals
were divided into four groups for comparison of immunohistochemistry results;
Group A -Days 13-14 (n=7),
Group B -Days 16-17 (n=6),
Group CI -Days 18-20, high progesterone at slaughter (n=7),
Group C2- Days 18-20, low progesterone at slaughter (n=5).
Immune cell populations and MHC II expression in CL were compared (Table 5.4).
Table 5.4. Immune cell populations (mean ± s.e.m.) around luteolysis. Each figure
represents mean results from a minimum of 5 animals.
CELL TYPE Group A Group B Group CI Group C2
(dl3-14) (dl6-17) (dl8-20/highP4) (dl8-20/low P4)
CD5+ 25.66 49.75** 43.17* 50.50**
T-lymphocytes ± 1.9 ±2.3 ±3.7 ± 1.2
CD8+ 16.06 31.78* 34.95* 40.67*
T-lymphocytes ±3.1 ±6.7 ±6.6 ± 11.2
CD4+ 5.82 3.36 5.07 4.63
T-lymphocytes ±0.8 ±0.3 ±0.9 ± 1.5
Macrophages 9.74 7.81 5.09 10.7
±2.7 ± 1.1 ± 1.0 ±3.9
MHC 11+ (DQ) 10.33 10.06 8.57 10.03
± 1.7 ± 1.4 ±0.5 ± 1.7
MHC 11+ (DR) 7.48 12.11 9.09 10.63
±0.7 ±3.1 ± 1.4 ± 1.4
Eosinophils 0.38 0.94 0.64 5.03
±0.2 ±0.2 ±0.2 ±2.9
B-cells 0 0.28 0.02 0
±0.1 ±0.05
*
p <0.05 compared to day 13-14
** p<0.01 compared to day 13-14
There were significantly higher numbers of CD5+ T-lymphocytes in Groups B
(p<0.01), CI (p<0.05) and C2 (p<0.01) i.e. all CL collected from day 16 of the
oestrous cycle onwards, compared to group A. There were also significantly higher
123
numbers of CD8+ T-lymphocytes in groups B (p<0.05), CI (p<0.05) and C2
(p<0.05) compared to group A. There were no significant differences in CD5+and
CD8+ lymphocyte numbers between CI and C2. CD4+ cell numbers were not
significantly different between any of the groups, and B-cells were recorded only
very occasionally in any of the sections counted (Table 5.4).
There were no significant differences in numbers of macrophages, eosinophils nor in
MHC II expression (DQ or DR) between groups (Table 5.4).
5.4. Discussion
In this study cell morphology and immune cell populations were investigated in the
bovine corpus luteum around the time of luteolysis. It was not possible to assess
whether luteolysis has taken place by visual appearance of the CL or cell morphology
alone, but progesterone concentrations were a useful additional technique when
staging CL. The most significant finding when studying immune cell populations was
a significant increase in the numbers of CD5+ and CD8+ T-lymphocytes in luteal
tissue collected from all cows after day 16 of the oestrous cycle compared to CL
collected between days 13-14. Cell numbers were not significantly different in
animals that had undergone functional luteolysis and those that had not.
In the previous chapter we concluded that visual assessment of CL to differentiate
between stages HI (days 11-17) and IV (days 18-20) of the oestrous cycle was not
sufficiently accurate. This study, in which all CL used were visually categorised as
stage m, confirms that it is not possible to predict whether luteolysis has taken place
by gross appearance alone and that structural luteolysis may have been underway for
some time before the gross appearance of the CL changes.
We found that morphological changes assessed by examination of tissue sections
stained with H&E were a useful addition to visual staging only when differentiating
early stage in (days 13-14) luteal tissue from CL collected between days 16-20. It
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was not possible by examining cell morphology to differentiate animals which had
undergone luteolysis from those that had not when studying CL collected between
days 16 and 20 of the oestrous cycle. Only one animal (cow 957) had a sufficiently
distinct luteal morphological appearance to indicate that this cow had already
undergone luteolysis at the time of slaughter. It is interesting to note that cow 957
had undergone functional luteolysis at least 48 hours before slaughter, as P4 levels
were less than lng/ml in all 3 plasma samples. This time lapse between functional
luteolysis and collection of the CL explains the obvious structural regresssion
apparent on examination of cell morphology.
PGFM concentrations alone were also of limited use in establishing whether
luteolysis had taken place. At luteolysis PGF2a is released in a pulsatile fashion with
peaks of increasing frequency and magnitude, prior to the decline in progesterone
concentrations (Silvia et al., 1991; Kindahl et al., 1976b). Therefore it is difficult to
interpret results from single samples at this stage. However, concentrations of PGFM
prior to luteolysis (around days 14-16) have been recorded by various workers as
being in the region of 60-70pg/ml (Kindahl et al., 1981),100pg/ml (Vighio and
Liptrap, 1986) and 70pg/ml (Basu and Kindahl, 1987). In these studies, the
concentrations of PGFM are relatively constant prior to luteolysis with only small
peaks and these figures can therefore be used as a guide whereby it can be assumed
that concentrations above lOOpg/ml are likely to be associated with luteolysis. It is
not possible however to draw conclusions from figures less than lOOpg/ml because
these could be associated with either pre-luteolytic concentrations or could be
concentrations in the troughs of luteolytic pulses.
The less pulsatile nature of progesterone release meant that progesterone assay of a
sample collected at slaughter appeared to be the single most useful method for
differentiating between animals that had or had not undergone luteolysis.
Categorisation of the stage of CL by visual assessment is a widely-used technique in
studies using tissue from animals with unknown reproductive histories. Obvious
changes in the gross appearance of the CL make staging stage I, II and late stage IV
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CL relatively easy. This is not the case at stage HI or early stage IV, when collection
of a blood sample at the time of slaughter followed by progesterone assay would
significantly improve the accuracy of visual assessment.
The most interesting finding in this study was the increase in T-lymphocytes (CD5+
and CD8+) from day 16 of the oestrous cycle which occurred in animals prior to
functional luteolysis. The presence of T-lymphocytes has been described in various
species at different stages of the cycle including the rabbit (Bagavandoss et al.,
1990), rat (Brannstrom et al., 1994a), pig (Standaert et al., 1991) and human
(Brannstrom et al., 1994c; Bukovsky et al., 1995a; Wang et al., 1992c). There are
distinct differences between species but this may be due partly to differences in the
methods and range of monoclonal antibodies used in each study. None of these
studies describe T-lymphocyte populations in detail around the time of luteolysis.
As discussed in Chapter 4, the presence of lymphocytes prior to luteolysis has been
described previously (Lobel and Levey, 1968). It is certainly likely that these cells
play a key role in events occurring after luteolysis but their presence several days
prior to this event might also suggest a more specific role for these cells within the
functional CL at this stage. T-lymphocytes and their cytokine products have been
shown to have a variety of effects on hormone production by luteal cells in culture
which might suggest a role for these cells within luteal tissue before PGF2a release
from the uterus (see Pate and Townson, 1994 for a review). Lymphocytes have been
shown to increase progesterone production by human granulosa luteal cells in vitro
(Emi et al., 1991) whereas Adashi et al., (1990) found that TNF-a inhibited hCG-
supported progesterone production in luteinised granulosa cells from the rat.
The role of these cells and other immune cell types has been much discussed in
recent years but few clear conclusions have been drawn (Pate, 1994; Brannstrom and
Norman, 1993), mainly because T-lymphocytes have a range of potential effects on
surrounding tissues through the production of a variety of cytokines. Such is the
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potency of these cell products that very few cells would be required to have a
dramatic local effect within the CL.
CD4+ T-lymphocytes, eosinophils, macrophages and MHC II expression were not
significantly different between groups. These findings for CD4+ lymphocytes and
eosinophils were similar to the previous study in which we also found no change in
CD4+ cells and showed that eosinophils were significantly higher only between days
1-5 of the oestrous cycle compared to all other stages (Chapter 4). However, the lack
of differences in macrophage populations and MHC II expression between groups
was unexpected when compared with our previous results. Using visually staged
tissue, as described in Chapter 2, we have shown that MHC II (DQ and DR)
expression was significantly higher in stage IV CL (days 18-20) when compared to
stage in CL (days 13-18). Populations of macrophages were highest at Stage IV,
although this was not significantly greater than Stage III. As we were working with
the same range of age of tissue, we might have expected similar results in the present
study. This assumes however that visual staging of luteal tissue is accurate and it is
likely that the apparent differences between the two studies are due to a wider
variation in the age of tissue used in the first study.
In particular, it is likely that the Stage IV CL (days 19-20) selected by visual
assessment of ovarian structures in the first study were older than those described as
Stage IV (days 19-20) in the present study. CL in our previous study were staged on a
variety of characteristics, including the presence of a follicle (greater then 10mm) on
either ovary at slaughter. In reality, the follicles present on ovaries described
previously as stage IV were often larger than 10mm and were more likely to be
preovulatory follicles. However, it takes several days for the ovulatory follicle to
develop after luteolysis. We commented earlier on the apparent lack of large follicles
in ovaries collected from animals around day 19-20 of the oestrous cycle in the
present study. However, this may indicate collection of CL prior to maturation of the
final follicular wave.
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In conclusion, there is an increase in T-lymphocytes (CD5+, CD8+) within bovine
luteal tissue from day 16 of the oestrous cycle onwards. Although these cells are
actively involved in destruction of luteal tissue after luteolysis these results also
suggest a potential role for them in the CL prior to luteolysis. It is likely that these
cells will exert any effect at this stage through release of their cytokine products.
However, the variety of these substances and their range of potential effects on luteal
cells at low concentrations make accurate analysis of events occurring at the cellular
level very difficult. The mechanism by which the lymphocytes are attracted into
luteal tissue at this stage of the cycle is also not known.
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Chapter 6
Immune cell populations in the bovine corpus luteum
following luteolysis artificially induced using
exogenous PGF2a
6.1. Introduction
Prostaglandin F2ce (PGF2a), which is released from the uterus and transported to the
ovary via a venoarterial countercurrent system, has been shown to be the luteolytic
substance in the cow (Knickerbocker et al., 1988; Silvia et al., 1991). However the
exact order of events that take place within the CL itself during luteolysis is not clear
(Auletta and Flint, 1988). There is some evidence that a positive feedback
mechanism is involved between prostaglandin release from the uterus and oxytocin
release from the CL (Silvia et al., 1991), although local production of various types
of prostaglandin by luteal cells could also be involved (Milvae, 1986). In recent years
there has also been increased interest in the potential role of immune cell populations
within the CL at this time (Pate, 1995).
In order to investigate these events further, it is necessary to collect luteal tissue at
specific time periods around luteolysis. However this is no easy task because of the
difficulty in anticipating luteolysis in vivo and the rapid progression of events which
take place at the level of the CL once luteolysis is initiated. For this reason induced
luteolysis has been used as a model for studying events within the CL around natural
luteolysis. Natural and artificially-derived prostaglandins can be used in the cow to
induce luteolysis during the normal oestrous cycle from around day 5 onwards (Hafs
et al., 1974; Henricks et al., 1974).
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There is evidence that induced luteolysis is an appropriate model to be used for
studies looking at luteolysis in the cow and sheep. Stacey et al. (1976) showed that
the morphological changes associated with induced luteolysis in the sheep were
similar to those occurring during natural luteolysis and in the cow. Spicer et al.
(1981) found that similar hormonal changes occurred during induced and natural
luteolysis. Changes in blood flow are also similar between the two processes in sheep
(Niswender et al., 1976). There would appear to be no difference between the
hormonal response induced by using PGF2a or a synthetic product to induce
luteolysis (Baishya et al., 1994).
Although the hormonal changes in the cow during induced and natural luteolysis are
similar, it is not known whether the morphological changes within the CL are also
comparable. This is an important question if induced luteolysis is to be used
successfully as a model to study cellular events around luteolysis and, in particular,
changes in immune cell populations within the CL at this time. The purpose of this
study therefore was to collect luteal tissue at several time periods after artificially
inducing luteolysis and examine tissue morphology, immune cell populations and
MHC II expression within the CL to assess whether induced luteolysis resulted in
similar changes to cell populations to those previously described following natural
luteolysis (Chapter 5). In addition, the results of analysis ofMHC II expression using
flow cytometry were compared with those of immunohistochemistry to assess
whether this technique would be useful in future studies.
6.2. Materials and methods
6.2.1. Oestrous synchronisation and induction of luteolysis
Sixteen mature Friesian or Ayrshire cows were obtained from two dairy herds. Each
cow was examined per rectum to assess the state of the reproductive tract. The
oestrous cyles of these animals were then synchronised using progesterone-releasing
intravaginal devices (PRID, Sanofi Animal Health,Watford, U.K.) for 12 days.
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Cloprostenol (50|ag), a synthetic PGF2a analogue (Estrumate, Pitman-Moore Ltd,
Crewe, U.K.) was given by intramuscular injection on day 10 of the PRE) treatment.
Following PRE) removal the animals were observed for signs of oestrus 3 times
daily. On the day that each animal showed standing oestrous behaviour coccygeal
blood samples (7ml) were collected into lithium heparin (143U/tube). After
centrifugation (30 min, 1000 g) plasma was collected and stored at -20°C for
progesterone analysis. Throughout the time of synchronisation and prior to collection
of the CL the cows were housed in a straw court and fed a maintenance ration of
silage and concentrate with free access to water.
On day 10 (standing oestrus = day 0) the ovary bearing the CL was identified by
transrectal ultrasound examination. Animals were assigned to one of 4 groups and
luteolysis was induced in 3 of the groups using an intramuscular injection of 25mg
dinoprost, a synthetic form of natural PGF2a (Lutalyse, Upjohn Ltd, Crawley, U.K.)
6, 12 or 24 hours prior to removal of the CL. Coccygeal blood samples were
collected for progesterone analysis immediately before injection of PGF2a. The
fourth group were control animals and did not receive any PGF2a.
6.2.2. Collection of the CL
Prior to surgery the cows were starved for 24 hours although water intake was not
restricted. At the time of surgery each animal was sedated using 0.05-0.lmg/kg
intravenous xylazine (Rompun, Bayer pic, Suffolk, U.K.). The left flank was clipped
and local anaesthesia achieved by infiltration of the body wall with 2% lignocaine
(Lignavet, C-Vet, Leyland, Lanes., U.K.). The skin was prepared for surgery and a
10cm vertical incision was made through the body wall. The uterus and ovary bearing
the CL was identified and the CL was removed from the ovary by enucleation. This
technique was used rather than ovariectomy, as originally intended, because of the
ease with which enucleation was performed, particularly in the PGF2a-treated
animals. This was probably due to alterations in blood supply and shrinkage of tissue
which takes place very rapidly after induction of luteolysis. The main risk with this
procedure is bleeding from the ovary after removal of the CL. This was of more
131
concern with control animals. In order to detect any bleeding, a dry swab was applied
to the ovary to check for excessive haemorrhage immediately after removal of the CL
and prior to inserting final sutures in the abdominal wall. The peritoneum and
abdominal muscles were closed in two layers using interrupted sutures of 5 metric
coated vicryl (Ethicon Ltd) and the skin was sutured using 4 metric mersilk (Ethicon
Ltd). Duplocillin LA (20-25ml, i.m. Mycofarm UK Ltd, Cambridge) was given to
each animal as prophylactic antibiotic cover at this time. Blood samples (7ml) for
progesterone analysis were collected from the jugular vein at the time of surgery.
After surgery the cattle were housed separately in loose boxes and observed for 24
hours before returning to the straw court. Rectal temperatures were recorded daily for
a period of 3 days after surgery.
6.2.3. Treatment of luteal tissue
All CL collected were immediately placed on a sterile petri dish sitting in crushed
ice. The CL were weighed and measured before cutting into 4-5 sections using a
sterile scalpel blade. One section for immunohistochemistry was snap-frozen onto a
cork disc using a slurry of dry ice and isopentane. Two sections were snap-frozen in
aluminium foil for molecular studies and the remaining sections were placed either in
10% paraformaldehyde for preparation of paraffin blocks or Hanks Buffered Salt
(without divalent cations) prior to dissociation of tissue for analysis by FACS.
6.2.4. Haematoxylin and eosin staining ofsections
Sections (8pm) were cut from paraffin-embedded tissues and stained with
haematoxylin and eosin (H&E) as described in Chapter 2 (Section 2.8.). These
sections of CL were examined by high power microscopy (x40) to assess the general
appearance of the cells present in tissue from PGF2a-treated animals in comparison to
control animals. The presence of shrunken cells, fibrous whorls of tissue and
vacuolated cells was noted and each section from the PGF2a-treated cows were
assessed for loss of structure and graded between 1+ and 5+, where 1+ indicates
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minimal change in luteal structure and 5+ indicates complete loss of structure in
comparison to CL from control animals (day 10).
6.2.5. Immunohistochemistry
Sections (6|im) of frozen tissue were stained by immunohistochemistry as described
in Chapter 2 (Section 2.5.). The luteal tissue sections were stained using the same
panel of monoclonal antibodies as described in Chapter 4 (Table 4.2.). Positively
stained cells were counted in 6 fields as described in Chapter 4 (Section 4.2.6.). The
capsule and areas predominated by blood vessels were avoided.
6.2.6. Carbol chromotrope stain for eosinophils.
Individual sections (8pm) from paraffin-embedded tissues were stained as described
in Chapter 2 (Section 2.7).
6.2.7. Progesterone assay
All samples were analysed using the progesterone assay described in Chapter 2
(Section 2.3.2.). O.lng/per ml was the limit of detection and concentrations of less
than lng/ml were taken to indicate that luteolysis had taken place. The intra-assay
coefficient of variation (CV) was 13.9%.
6.2.8. Flow cytometry ofdispersed luteal cells
The flow cytometer can be used to count positively stained cells from a population of
dispersed cells, expressing them as a percentage of the total cell number. Dispersed
cells are first stained with a specific monoclonal antibody and the secondary antibody
is conjugated with a fluorescent marker. This technique has been used previously in
CL studies, most often to study MHC II expression (Fairchild Benyo et al., 1991;
Kenny et al., 1991). Dispersed portions of luteal tissue were stained for MHC n
expression using monoclonal antibodies that had also been used for
immunohistochemistry (VPM36 and TH14B). MHC II expression in luteal cell
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populations obtained by both collagenase and mechanical dissociation were
compared with each other and with results from immunohistochemistry.
6.2.8.1. Dispersion of luteal tissue
Luteal tissue was dispersed as described in detail in Chapter 3 (Section 3.2.2.) and
summarised as follows:
The portions of CL were weighed and chopped finely using a scalpel blade prior to
mechanical dissociation by repeated inversion of the chopped tissue suspended in
6mls HBSSVg. The solution was then filtered and the filtrate collected to recover
cells dispersed by mechanical dissociation (MD) and the washed tissue was
resuspended in a solution containing collagenase (Collagenase XI, Sigma, 3ml/g
tissue) and incubated for 50 minutes at 37°C in a shaking water bath. The solution
was filtered and the filtrate collected represented cells dispersed by collagenase
dissociation (CD). The dispersed populations of luteal cells (MD and CD) were then
washed twice in HBSS".
6.2.8.2. Preparation of blood cells for flow cytometry
White blood cells, collected as described below, were used as a positive control
throughout:
A blood sample (10ml) was collected into lithium heparin (200 U) and the red blood
cells were lysed as follows; 90ml NH4CI (0.16M) were added to 10ml of Tris
(0.17M, pH 7) and the solution (pH 7.2) was heated to 37°C. Heparin (0.5%) was
added and 35 ml of the lysis solution was then mixed with 10ml of whole blood. The
solution was centrifuged at 250 g for 5 minutes, lysed cells poured off and the
remaining cells resuspended in lysis solution and centrifuged. This process was
repeated once more and the cells were finally suspended in FACS buffer (0.1 % azide,
1% BSA in PBS) containing 0.5% heparin.
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6.2.8.3. Incubation with monoclonal antibody
The dispersed cells were washed in FACS buffer, counted and resuspended in FACS
buffer to give a concentration of approximately 2 x 106 cells/ml. Monoclonal
antibodies TH14B and VPM 36 (25ptl) at concentrations of 3/2000 and 3/10
respectively (diluted in PBS containing 0.1% azide) were added to 50|ll dispersed
cells, mixed gently and incubated at 4°C for 1 hour.
6.2.8.4. Fluorescence staining of cells
The cells were washed twice in FACS buffer and were then re-incubated with 25jll
fluorescein isothiocyanate-labelled second antibody (FITC, 1/250 in FACS buffer) at
4°C for 30 min. After incubation the cells were washed twice in buffer and
resuspended in 200|ll FACS buffer + 200pl 1% paraformaldehyde.
6.2.8.5. Flow cytometry
Positively-stained cells were counted using the FACSCAN (Becton Dickinson UK).
For each sample a total of lxlO4 cells were analysed. Specific gates were not set at
this time to select specific cell populations. Gate settings included all cells. The data
collected were then divided into four regions at the time of data analysis (Figure 6.1)
which was performed using Consort 30 (Becton Dickinson, UK).
6.2.9. Statistical analysis
Results from immunohistochemistry and FACS were analysed using the Kruskal-
Wallis test for non-parametric data and the Mann-Whitney test was then used to
analyse differences between samples where present. A p value of less than 0.05 was
taken to be statistically significant. All statistical analyses were performed using
Minitab software (Pennsylvania State University).
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Figure 6.1. Flow cytometry: Dot-plot appearance of luteal cell populations showing
regions (gates 1-4) that were used during analysis of results.
6.3. Results
6.3.1. Tissue assessment
There were differences in size and weight of CL collected (Table 6.1). As there is
always a great deal of variation in CL size between cows, especially older animals, it
is not possible to draw major conclusions from these results except to note that most
animals treated with PGF2a 12 and 24 hours before tissue collection had CL that were
smaller and lighter than those of the control animals. There was also an alteration in
the texture of luteal tissue which became much more fibrous and difficult to cut in
CL obtained 24 hours after treatment.
6.3.2. Progesterone assay
Progesterone concentrations had decreased in all PGF2a-treated animals by the time
of surgery in comparison to pre-treatment samples (Table 6.1). However, all cows
treated with PGF2a 6 hours before surgery had progesterone concentrations consistent
with a CL that was still functional at surgery (P4> lng/ml). Three cows treated 12
hours before surgery and 2 cows treated 24 hours before surgery also had
progesterone concentrations higher than those associated with functional luteolysis at
the time of surgery, although the concentrations were lower than those seen 6 hours
after treatment.
6.3.3. Morphological examination ofH&E stained tissue
All CL from prostaglandin-treated animals showed some alteration in luteal structure
but the degree of alteration varied from animal to animal and was not consistent
within each group (Table 6.2). Although there was significant loss of structure in all
CL after 24 hours, obvious changes were detectable in all cows even after 6 hours.
The most frequently observed change was the presence of fibrous whorls and strands
of cellular tissue in between luteal cells (Fig. 6.2b-6.2d) which often dominated the
fields in comparison to tissue from control animals which was predominantly made
up of luteal cells (Fig. 6.2a).
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FIGURE 6.2a. Luteal tissue collected on day 10 of the oestrous cycle
(H&E x218).
FIGURE 6.2b. Day 10 luteal tissue 6 hours after PGF2a injection
(H&E x218).
FIGURE 6.2c. Day 10 luteal tissue 12 hours after PGF2a injection
(H&E x218).
FIGURE 6.2d. Day 10 luteal tissue 24 hours after PGF2a injection
(H&E x218).













45 Control B.lg 4cm - 2.89
T71 Control 13.0g 3.5cm - 1.01
X63 Control 9.8g 4cm - 1.18
X2 Control 6.1g 2cm - 2.28
36 6 hours 6.0g 2.3cm 4.6 2.79
646 6 hours 3.3g 1.9cm 2.8 1.0
T18 6 hours lO.Og 4cm 5.7 3.1
M39 6 hours 11.Og 5cm 7.5 3.48
652 12 hours 4.2g 2.5cm 3.1 2.46
496 12 hours 3.8g 2cm 1.1 1.05
511 12 hours 2.6g 2.2cm 1.1 0.77
186 12 hours 4.4g 2.5cm 2.2 1.38
235 24 hours 3.7g 2.4cm 3.4 0.81
S6 24 hours 4.3g 2cm 4.4 1.11
S48 24 hours 4.8g 2cm 2.8 1.17
X381 24 hours 7.0g 2.5cm 4.1 0.62
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Table 6.2. Results from morphological examination of luteal tissue.





45 Control - distinct luteal cells predominate. Even
staining of tissue.
T71 Control - as 45
X63 Control - as 45
X2 Control - as 45
36 6 hours 1+ small blood vessels obvious, whorls of
fibrous tissue. Weak staining
646 6 hours 1+ luteal cells obvious, strong even stain,
no whorls
T18 6 hours 3+ luteal cells appeared shrunken, some
normal and some whorls of cells
M39 6 hours 2+ luteal cells appear shrunken
652 12 hours 2+ whorls of vacuolated fibrous tissue
between luteal cells
496 12 hours 3+ uneven staining of LLC1, intercellular
tissue appears vacuolated. Fibrous
cellular whorls present
511 12 hours 4+ intensely cellular, loss of individual cell
outline. Whorls in some areas.
186 12 hours 1+ Appeared intact, lots of intact LLC
235 24 hours 4+ Loss of luteal cell outline, obvious
fibrous intercellular tissue present.
S6 24 hours 4+ Fibrous areas dominate areas of luteal
cells. Luteal cells shrunken
S48 24 hours 2+ Loss of luteal cell outline. Fibrous tissue
between cells limited.






There were no significant differences between the numbers of T-lymphocytes (CD5+,
CD8+ or CD4+) or macrophages counted in luteal tissue from control or treated
animals (Table 6.3). However, MHC II/DR and MHC II/DQ expression was
significantly higher (p<0.05) at all time periods after injection of PGF2a in
comparison to controls (Figure 6.3).
TABLE 6.3. Immune cells in the CL after PGF2a treatment (Each figure represents
the mean result +/- s.e.m. from CL collected from 4 animals per group,
counting 6 fields per CL).
Control 6 hours 12 hours 24 hours
CD5+ 27.92 ±3.2 30.67 ±8.6 21.67 ±3.9 51.38 ± 17.3
CD8+ 12.11 ±4.2 11.08 ±3.3 8.17 ± 2.2 11.96 ± 1.9
CD4+ 7.38 ±0.9 5.16 ± 0.5 1.71 ±0.6 13.67 ±6.5
B-cells 0.04 ± 0.05 0 0.04 ± 0.05 0.04 ± 0.05
Macrophages 9.21 ±2.6 24.25 ± 4.9 11.5 ± 2.2 24.21 ±7.9
Eosinophils 0.38 ±0.1 3.75 ± 1.4 1 ±0.3 5.63 ±3.5
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FIGURE 6.3. MHC n/DR (TH14B) and MHC IPDQ (VPM36) expression in luteal





0 6 12 24
Time (hours) after PGF2a injection
*MHC II expression was significantly higher (p<0.05) at all time periods
after injection of PGF2cc compared to control animals.
'Each figure represents the mean result +/-s.e.m. for CL collected from 4
animals per group, counting 6 fields per CL.
6.3.5. Flow cytometry
Cells expressing MHC II (DQ+DR) were counted in the four regions of the dot-plot
and there were no significant differences between control and treated cows at any of
the time periods after PGF2a injection using cells that were mechanically dissociated
or dispersed using collagenase. The results from flow cytometry of luteal cell
populations produced by both mechanical dissociation and collagenase dispersion
then stained with TH14B (MHC II/DR) are shown in Figures 6.4a and 6.4b.
140
FIGURE 6.4a. MHC II/DR (TH14B) expression in luteal tissue collected 0, 6, 12 or
24 hours after treatment with PGF2a, dispersed by mechanical
dissociation and analysed in 4 regions of the cell population (gates 1-
4) by flow cytometry. Each bar represents mean ± s.e.m. for 4
animals.
Gate 1 Gate 2 Gate 3 Gate 4
FIGURE 6.4b. MHC II/DR (TH14B) expression in luteal tissue collected 0, 6, 12 or
24 hours after treatment with PGF2C(, dispersed with collagenase and
analysed in 4 regions of the cell population (gates 1-4) by flow
cytometry. Each bar represents mean ± s.e.m. for 4 animals.
Gate 1 Gate 2 Gate 3 Gate 4
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6.4. Discussion
In order to investigate whether induced luteolysis resulted in cell populations and
morphology similar to those seen after natural luteolysis (Chapter 5) CL were
examined at 3 time periods after injection with a standard dose of PGF2a. MHC 13
expression within the CL was significantly higher at all time periods after luteolysis
artificially induced on day 10 of the oestrous cycle compared to day 10 CL where
luteolysis had not been artificially induced. The numbers of lymphocytes and
macrophages did not differ significantly between groups although both six and
twenty four hours after treatment the numbers of macrophages in luteal tissue were
considerably higher than those of the control group. CL from all time periods after
PGF2a treatment differed morphologically from the control CL with significant loss
of luteal structure in some animals after only 6 hours, although progesterone
concentrations in the majority of animals were still representative of a functional CL
at the time of surgery.
Induced luteolysis has been described by some workers to be useful as a model for
studying events that occur during natural luteolysis particularly as the hormonal
changes which take place during both processes have been found to be similar in
heifers (Spicer et al., 1981). However, the present study did not find similar cellular
events to those seen around the time of natural luteolysis (Chapter 5). There was no
significant alteration in the number of T-lymphocytes at any time period after
induced luteolysis, a process that appears to accompany natural luteolysis in the cow
(Lobel and Levey, 1968; Chapter 5). MHC II expression however was significantly
increased at all time periods after induced luteolysis, a change that was not observed
in 5 animals between 1-2 days after natural luteolysis (Chapter 5) but was observed
in abattoir-derived Stage IV luteal tissue, which (as discussed in Chapter 4) is likely
to represent CL several days after luteolysis. Although not statistically significant, the
increased numbers of macrophages seen 6 or 24 hours after treatment were also
observed in stage IV luteal tissue but not immediately after natural luteolysis.
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The morphological changes in appearance of luteal tissue after induced luteolysis
also differed from those seen after natural luteolysis. Alterations to tissue
morphology took place rapidly and, unlike the order of events during natural
luteolysis, occurred prior to a significant decrease in the progesterone concentrations
of each animal. Natural luteolysis could only be detected by changes in cellular
morphology alone in one animal although a total of 5 animals had undergone
luteolysis during the course of the study (Chapter 5, Section 5.3.2.). However, in the
present study, signs of structural regression were apparent in animals at all time
periods after injection of PGF2a. These findings differ from those of Tian et al.
(1994) who did not observe morphological changes in CL until 24 hours after PGF2(X-
induced luteolysis. However the different results may be due to the use of heifers in
this study as well as inducing luteolysis at an earlier stage of the cycle (days 6-7).
It would appear that luteolysis induced with a standard dose of PGF2a in the cow
results in a much more rapid alteration to luteal structure than that seen in the first
two days of natural luteolysis. This is in contrast to findings in the sheep where the
morphological changes which take place during induced luteolysis are described as
being similar to natural luteolysis (Gemmell et al., 1976; Stacy et al.,\916). However
these studies were based on luteolysis induced by infusion of PGF2a directly into the
uterine vein at a considerably lower dose rate than that used to induce luteolysis by
intramuscular injection. This technique of inducing luteolysis, although technically
more difficult, is bound to result in PGFM profiles that are far more representative of
the pulses of PGF2a release that occur during natural luteolysis (Kindahl et al.,
1976a) than a single high dose of PGF2a.
The use of luteolysis induced by a single bolus of exogenous PGF2a as a model for
events occurring at natural luteolysis is debatable for other reasons. The
concentrations of plasma PGF2a achieved by treatment with 25mg of exogenous
PGF2(X are considerably higher than the concentrations of PGF2a in peripheral plasma
during natural luteolysis in the cow (Chapter 5, Section 5.3.4.). It is also impossible,
without cannulation of the ovarian vessels, to know exactly what concentration of
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PGF2a is actually reaching the ovary after intramuscular injection. In addition, where
luteolysis is induced before approximately day 15 of the oestrous cycle the luteal cell
populations in CL will differ from those found around the time of natural luteolysis.
There is variation in luteal cell types, particularly the ratio of large:small luteal cells,
during the oestrous cycle (Hansel et al., 1987). The relative numbers of large and
small luteal cells are significant because the two cell types respond differently to
PGF20C (Koos and Hansel, 1981; Hansel et al., 1991).
In contrast to immunohistochemistry, analysis of luteal cells by fluorimetry did not
detect any differences in MHC II expression between any of the groups. There are
various possible reasons for this. It may be that the dispersion and preparation of
cells resulted in cell damage and loss of MHC II cell surface markers. The production
of well dispersed populations of intact luteal cells appropriate for analysis by
fluorimetry in itself is not easy (O'Shea et al., 1990). Mechanical dissociation
produces intact cell types but they are often not completely dissociated and there is
some evidence that the process of collagenase dispersion results in damage to cell
surface receptors (Chapter 3). However, as LH-receptor levels in mechanically and
enzymatically dissociated cells were similar in this study, the lack of variation
between animals does not appear to be related specifically to the use of collagenase.
Paraformaldehyde fixation of stained cells, required because samples could not be
immediately analysed, is another possible source of cell damage. Other workers have
successfully used unfixed luteal cells for analysis (Fairchild Benyo et al., 1991).
There was a large variability in the results from individual animals within groups and
this was compounded by the small group size. It is possible that larger numbers of
animals may have shown significant differences by fluorimetry. Finally, in this study,
cells were not sorted into specific cell populations prior to data analysis. In contrast
Fairchild Benyo et al. (1991) did observe increased MHC II expression on sorted
luteal cells 12 hours after injection of PGF2a- It is also possible to sort dispersed
luteal cells into separate populations of large and small cells of greater than 90%
purity prior to analysis by fluorimetry (Alila et al., 1988). This might allow detection
144
of MHC II on specific cell types such as large or small cells, instead of including all
cell types present.
However, even using effective cell dispersion and computerised cell separation
techniques prior to cell counting fluorimetry is still not always an accurate technique
for counting cells in luteal tissue. As discussed in Chapter 3, there are problems
working with dispersed CL caused by cell clumping because counts are based on size
and complexity. For example, any large clumps of small luteal cells will be counted
as large cells. For these reasons it would appear that there is little to be gained in the
use of FACS in comparison to immunohistochemistry which involves less processing
of tissue and better identification of specifically stained cells.
At the time of surgery, all cows at 6 hours after injection of PGF2ot, 3 cows at 12
hours and 2 cows at 24 hours still had progesterone concentrations consistent with a
functional CL (P4> lng/ml). These relatively high concentrations of progesterone
were unexpected, particularly 24 hours after injection. However the results are
similar to those of Berardinelli and Adair (1989) who found that it took around 32
hours before concentrations of progesterone decreased significantly (<lng/ml) in
heifers injected with PGF2a (25mg, Lutalyse) at mid-cycle (days 10-14) in
comparison to twenty four hours in animals injected either in the early (days 5-9) or
late (days 15-19) luteal phase. Similarly Schallenberger et al. (1984) found that
progesterone concentrations did not reach basal concentrations until 24-36 hours after
induced luteolysis. This apparent variation in speed of response to exogenous PGF2re
at different stages of the CL lifespan may be related to the differing cell populations,
particularly large:small cell ratios, in the CL at these times as more PGF2(X receptors
are found on large cells than small cells (Fitz et al., 1982; Niswender et al., 1985).
In conclusion, the results of this study indicate that the cellular events which occur
after induced luteolysis are considerably more dramatic and rapid than those seen
during natural luteolysis. For this reason it has to be concluded that the artificial
induction of luteolysis by a single high dose injection of PGF2a does not result in
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morphological changes that are representative of natural luteolysis. Studies using
animals during a normal cycle or employing pulsatile infusion techniques during the
late luteal phase, preferably directly into the uterine vein, are likely to be of far more
use in analysing events that occur in vivo.
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Chapter 7
The effect ofprostaglandin inhibition on immune cell
populations in the bovine corpus luteum around the time
of luteolysis.
7.1. INTRODUCTION
The numbers of T-lymphocytes (CD8+, CD5+), macrophages, eosinophils and MHC II
expression vary within the cow CL throughout the oestrous cycle (Chapter 4 and Chapter
5). The most interesting finding is a significant increase in CD5+ and CD8+ T-
lymphocytes within luteal tissue from day 16 of the oestrous cycle onwards which
occurred prior to functional luteolysis (see chapter 5).
The role, if any, of this apparent influx of T lymphocytes within the CL in the days
leading up to luteolysis is not known and it is also unclear what factor(s), systemic or
intraovarian, are involved in stimulating the movement of T-lymphocytes into the CL
around day 16 of the oestrous cycle. Uterine prostaglandin F2a (PGF2a), released in large
pulses around day 18, has been established as the luteolytic substance in the cow (Inskeep
and Murdoch, 1980; Auletta and Flint, 1988). Several workers, measuring the stable
metabolite of PGF2ot, 13, 14-dihydro-15-keto-prostaglandin F2a (PGFM), have also
observed that there is an increase in concentrations of PGFM between days 14 and 17 of
the oestrous cycle, prior to luteolytic concentrations being recorded. Shemesh and Hansel
(1975) noted increased concentrations of PGF2oc within the endometrium and uterine vein
from around day 15 and episodic increases in systemic PGFM from day 14 were recorded
by Parkinson and Lamming (1990) and day 17 (Basu and Kindahl, 1987). It is possible
that this pre-luteolytic increase in the concentration of PGF2a may be involved as a signal
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to T-lymphocytes or may activate cells already present within the CL to recruit other
leukocyte populations.
One way in which this hypothesis can be tested is by inhibiting PGF2a production in the
days leading up to luteolysis. Various substances have been used to inhibit PGF2a
including intrauterine indomethacin, a cyclo-oxygenase inhibitor (Lewis and Warren
1977; Milvae and Hansel, 1985) and intrauterine nordihydroguaiaretic acid, a cyclo-
oxygenase and lipoxygenase inhibitor (Hamilton et al., 1990). More recently flunixin
meglumine, a potent non-steroidal anti-inflammatory drug which is licensed for use in
cattle, has been used. Flunixin is a cyclo-oxygenase inhibitor acting within the
arachidonic acid cascade (Fig. 7.1). It is widely used in veterinary medicine as an anti¬
inflammatory / antipyrexic drug; however it also inhibits PGF2a produced by the
reproductive tract and, at four times the therapeutic dose rate, has been shown to delay
luteolysis (Aiumlamai et al., 1990; Odensvik and Gustafsson, 1994; Odensvik, 1995).










In this study, in order to investigate whether PGF2a is involved in stimulating an influx of
T-lymphocytes into the cow CL prior to functional luteolysis, we used high dose flunixin
meglumine to suppress PGF2a production by 12 cows in the days leading up to luteolysis,
replacing PGF2a artificially in six of the flunixin-treated animals. Immune cell types and
MHC II expression present within luteal tissue were quantified using
immunohistochemistry and the cell populations observed in the two treatment groups and
a control group were compared.
7.2. Materials and methods
7.2.1 Experimental Animals
7.2.1.1. Experiment 1; Prostaglandin trial
The purpose of this preliminary experiment was to calculate the dose of exogenous PGF2a
that would give systemic PGFM concentrations similar to those seen in the days leading
up to luteolysis, without inducing luteolysis itself. This dose would then be used to
artificially replace prostaglandin in one group of flunixin-treated cows in the main
experiment.
Experimental protocol
The oestrous cycles of 6 mature Holstein-Friesian dairy cows from the Roslin Institute
herd were synchronised using progesterone-impregnated intravaginal devices (PRID,
Sanofi Animal Health, Watford, U.K.) for 12 days. 50|ig of cloprostonol, a synthetic
PGF2a analogue (Estrumate, Pitman-Moore Ltd, Crewe, UK) was given by intramuscular
injection 2 days before PRID removal. The cows were observed for signs of oestrus three
times daily for the next three days.
On day 9-10 of the following oestrous cycle intravenous cannulae were inserted into the
jugular vein of each animal under local anaesthetic. The cows were then allocated to one
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of 3 groups and 3 different dose rates (0.0 lmg, 0.1mg or lmg ) of a naturally-occurring
PGF2a ( Lutalyse, Upjohn Ltd, Crawley, UK.) were given in a 5ml volume of sterile
saline through the jugular cannula over a period of 1 minute. Blood samples (7ml) were
collected into heparinised glass tubes (Vacutainer, Becton Dickinson 143U heparin /tube)
at 5 minute intervals for 15 minutes prior to PGF2a injection and then every 2 minutes for
6 minutes; 5 minute intervals for 30 minutes, 10 minute intervals for 30 minutes,15
minute intervals for 30 minutes and then 30 minute intervals for 1.5 hours. Catheters
were flushed with sterile saline after treatment and between samples. Daily blood samples
were collected by coccygeal venepuncture for the 3 days following treatment in order to
assess whether any of the dose rates had been sufficient to induce luteolysis. Blood
samples were centrifuged at 1000 g for 30 min at 4°C and the plasma was then collected
and stored at -20°C prior to being assayed for PGFM and progesterone concentrations.
7.2.1.2. Experiment 2; Flunixin inhibition of prostaglandin production
Oestrous synchronisation
Mature Holstein Friesian cows were selected from the Roslin Institute dairy herd at Blyth
Bank Farm and the reproductive tract of each animal was examined per rectum for any
detectable abnormalities prior to the start of the experiment. Oestrus was synchronised as
described in Experiment 1 although, in addition to frequent observation for signs of
oestrous behaviour, blood samples were collected 2 days after PRID removal for
progesterone assay to confirm oestrus at this time. On day 6 after oestrus the ovaries were
examined by ultrasound to locate the corpus luteum. During the time of oestrous
synchronisation the cows were kept indoors in an open straw-bedded court with natural
light and maintained on a diet of hay and a small quantity of concentrate with free access
to water at all times.
Flunixin treatment
A cannula was inserted into the left jugular vein of each cow on day 15 of the oestrous
cycle under local anaesthetic. Each cannula was made from sterile silastic tubing because
of its flexibility and resistance to kinking which makes it suitable for long-term
150
cannulation. The cannulae were stitched to the skin at the entrance to the jugular vein
then attached to the halter by tape and to the hair along the neck of the animal to the
shoulder using umbilical clips. This allowed blood samples to be collected and treatments
to be administered with minimal disturbance to the animal. All animals were haltered in
separate stalls on wood shavings during treatment with individual access to water and
hay. After cannulation the cows were put in their stalls and left for 12-18 hours to settle
before commencing treatment.
The cows were assigned to one of three groups of six animals;
Group 1; Flunixin
These cows were treated 4 times daily with 2.2mg/kg flunixin meglumine (Finadyne,
generously supplied by Schering Plough, UK) from day 16-18, following a protocol
previously described by Odensvik, (1995). Following infusion of flunixin the cannulae
were flushed with 10ml saline which contained heparin (50U/ml).
Group 2; Flunixin and PGF2a
This group were treated with flunixin as in group 1 but for the final 12 hours of treatment,
immediately prior to surgery, PGF2a (Lutalyse, UpJohn, Crawley, UK) was infused using
a pump system at a rate of 170|ig/hour in a volume of 5ml sterile saline/hour. During
PGF2a infusion, flunixin was also administered through the jugular cannula but blood
samples were collected from the coccygeal vein.
Group 3; Control
The animals in this group were given 20ml of sterile saline 4 times daily.
7.2.1.3. Blood sampling
Throughout treatments for all groups blood samples (10ml) were collected 8 times daily
into heparin, all samples were centrifuged at 1000 g for 30 min and the plasma was then
collected and stored at -20°C.
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All cows had access to hay and water ad libitum throughout the treatment period,
although initially it had been intended to restrict hay and water in the 24 hours before
ovariectomy to reduce problems at surgery caused by excessive gut contents. The change
of plan was caused by the side-effects of high dose flunixin treatment. Prolonged, or in
this case, high dose flunixin meglumine, in common with other non-steroidal anti¬
inflammatory drugs (NSAIDS) can cause irritation and erosions in the wall of the gut.
This is thought to be due to inhibition of prostaglandin E2-mediated bicarbonate and
mucus secretion with reduced control of, and protection against, gastric acid secretion
(Boothe, 1995). It became apparent early in treatment (within 18-24 hours) that this was
going to be a problem as all flunixin-treated cows developed diarrhoea which sometimes
contained blood. However, the animals did not actually appear ill, were normal on
clinical examination and continued to eat. It was decided at this stage to keep all the
animals on hay as an empty intestinal tract would be much more prone to damage. After
the first 36 hours of treatment most animals seemed to 'adapt' to the flunixin and the
diarrhoea was less severe.
7.2.1.4. Ovariectomy
On day 18 of the oestrous cycle after three days of treatment the ovaries were removed by
ovariectomy. At the time of surgery each animal was sedated using 0.05mg/kg
intramuscular xylazine (Rompun, Bayer pic, Suffolk, UK). The left flank was then
clipped, infiltrated with 100ml 2% lignocaine (Lignavet, C-Vet, Leyland, Lanes, UK) and
prepared for surgery. An incision was made in the left flank into the abdominal cavity, the
uterus located and both ovaries were removed using umbilical clamps to achieve
haemostasis of the ovarian stump. The peritoneum and abdominal muscles were closed in
two layers using interrupted sutures of 5 metric coated vicryl (Ethicon Ltd) and the skin
was sutured using 4 metric mersilk (Ethicon Ltd). Long-acting penicillin (Duplocillin LA,
20-25ml, Mycofarm UK,Ltd, Cambridge) was given to each animal as prophylactic
antibiotic cover at this time.
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7.2.1.5. Tissue collection
The ovary bearing the corpus luteum was immediately placed in a sterile petri dish on ice.
The CL was dissected free of the surrounding ovarian tissue and then cut into four
portions using a scalpel. One section was placed in 4% paraformaldehyde for paraffin
blocking and the other sections were snap frozen in dry ice/isopentane for
immunohistochemistry and molecular studies. The remaining ovarian tissue and second
ovary were used for follicular studies.
7.2.2. Sample analysis
7.2.2.1. Progesterone assay
Plasma progesterone concentrations were measured as described in Chapter 2 (Section
2.3.2.). All samples were measured in a single assay with an intra-assay coefficient of
variation (CV) of 16.1%.
7.2.2.2. PGFM assay
Experiment 1 These plasma samples were analysed for PGFM using a protocol developed
by Dr R. Kelly, MRC Centre for Reproductive Biology, Edinburgh. The protocol is
described in Chapter 2 (Section 2.3.3.).
Experiment 2
All samples from experiment 2 were analysed by Professor Hans Kindahl at the Swedish
University of Agricultural Sciences, Uppsala, Sweden. PGFM was analysed in
unextracted plasma by radioimmunoassay (Kindahl et al., 1976b; Grannstrom and
Kindahl, 1982 ). The antiserum cross-reacted 16% against 15-ketodihydro-PGF2a , 4%
against 13,14-dihydro- PGF2K, 0.4% against PGF2a and 1.7% against 15-ketodihydro-
PGE2, a major metabolite of PGE2. For other prostaglandins tested the cross-reaction was
less than 0.1%. The detection limit of the assay was between 25-30pmol/l. The inter-assay
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coefficient of variation was 14% and the intra-assay coefficient of variation ranged
between 6.6% and 11% at different points on the standard curve.
7.2.2.3. Immunohistochemistry
Sections of luteal tissue were stained as described in Chapter 2 (Section 2.5.) using the
same panel of monoclonal antibodies as previously (Chapter 4, Table 4.2).
7.2.2.4. Quantification of stained cells
The number of positively stained cells in each of 6 fields per section were counted as
described in Chapter 4 (Section 4.2.6.).
7.2.3. Statistical analysis
The results were analysed using the Kruskal-Wallis test for non-parametric data.
Differences between groups were then analysed by the Mann-Whitney test. A p value of
less than 0.05 was taken to be significant. All statistical analysis was performed using




Luteolysis was not induced in any of the animals as demonstrated by plasma progesterone
concentrations of greater than lng/ml in the 3 days following treatment.
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7.3.1.2. PGFM
An immediate increase in peripheral concentrations of PGFM was seen using all 3 dose
rates of prostaglandin (Fig. 7.2). The amount of time taken to return to pre-trial levels of
PGFM varied from around 20 minutes at the lowest dose rate to over 90 minutes at a dose
of lmg.
FIGURE 7.2. PGFM concentrations after treatment with 3 doses (0.0lmg, O.lmg, lmg)
of PGFaa, 2 animals per treatment.












7.3.2 Selection of'PGF2a dose rate for main experiment;
Previous studies have shown a range of concentrations of PGFM in the cow around
luteolysis. Parkinson and Lamming (1990) reported concentrations of between 60-
lOOpg/ml (170-282pmol/l) prior to luteolysis with luteolytic peaks of around 400pg/ml
(1128pmol/l). Vighio and Liptrap (1986) reported peaks ranging from 300pg/ml
(846pmol/l) in the days leading up to luteolysis and luteolytic peaks of 500-600pg/ml
(1400-1700pmol/l) which are similar results to those of Kindahl et al. (1976a) and Basu
and Kindahl, (1987) Any variation in results from these studies is likely to be due to
differences in frequency of sampling, methods and sensitivity of assay as well as variation
between animals. In addition to the results of the studies mentioned and our own results,
we also had to take into account the fact that baseline production of PGF2a would be
suppressed in flunixin-treated animals. We elected to use a dose rate of 170pg
PGF2a/hour given by constant infusion through the jugular cannula.
7.3.3. Experiment 2
7.3.3.1. Progesterone
2 animals from the control group (542, 185) underwent luteolysis during the course of the
trial as shown by an increase in PGF2a metabolite and an associated decrease in
progesterone concentrations (Figure 7.3a / 7.3b). Progesterone concentrations in the
remaining control cows and all flunixin-treated animals indicated the presence of a
functional CL throughout the trial (P4>lng/ml). There were no significant differences in
progesterone concentrations between any of the groups (excluding the 2 cows in which
luteolysis occurred).
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FIGURE 7.3a. Cow 542 (Control Group). Plasma PGFM and progesterone






















FIGURE 7.3b. Cow 185 (Control group). Plasma PGFM and progesterone
























Mean concentrations of PGFM are shown in Figures 7.4a-7.4c. It can be seen that
synthesis of PGF2a was inhibited in all flunixin-treated animals resulting in PGFM
concentrations that were approximately 50% of those of the control cows. This result is
similar to previous studies (Aiulamai et al., 1990, Odensvik, 1995). The pulses of PGFM,
associated with luteolysis, which were clearly observed in 2 control cows (542, 185) were
also absent in flunixin-treated animals (Fig 7.4b). During infusion of PGF2« in group 3
(Fig. 7.4c) concentrations of PGFM in jugular plasma were elevated throughout the 12
hour treatment to levels of around 300-600pg/ml, although in one animal (cow 574, Fig.
7.4c) concentrations as high as 1600 pg/ml were recorded..
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FIGURE 7.4c. Plasma PGFM concentrations for flunixin treated animals where PGF2a
was replaced for 12 hours prior to ovariectomy.
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Four lymphocyte subsets were investigated in this study: B-lymphocytes and CD5+,
CD8+ and CD4+ T-lymphocytes. B-lymphocytes were not found to be present in any of
the tissue sections studied except one, which is similar to our previous studies.
There were no significant differences between numbers of CD5+, CD8+ or CD4+ T-
lymphocytes counted in luteal tissue from any of the groups (Table 7.1). However, CD5+
and CD8+ T-lymphocytes were consistently lower in both groups of treated animals
compared to the control group. CD4+ T-lymphocytes were present in similar numbers in
each group.
7.3.4.2. Macrophages /MHC II expression
Numbers of macrophages (Table 7.1) were significantly lower in both flunixin and
flunixin/ PGF2a-treated cows (p<0.05). There were no significant differences in MHC II
expression between any of the groups (Table 7.1).
7.3.4.3. Eosinophils
Populations of eosinophils did not differ significantly between groups with a mean of 0- 2
cells counted per field. However one of the control animals had between 15-25
eosinophils/field.
160
Table 7.1. Populations of immune cells within CL




44.3 ± 11 26.44 ±3.9 35.17 ±6.3
CD8+ T-
suppressor/cytotoxic
16.53 ±2.2 12.53 ± 1.7 10.97 ±3.7
CD4+
T-helper/inducer
3.35 ± 1.2 3.72 ±0.7 4.78 ± 1.6
Macrophages 11.03 ±2.7 4.47 ± 0.9* 4.70 ± 0.9*
MHC II (DQ) 16.86 ±2.1 12.19 ±2.5 13.47 ±2.1
MHC II (DR) 12.86 ±2.1 11.64 ± 1.3 10.5 ± 1.8
Eosinophils 3.72 ±2.9 0.19 ±0.05 0.47 ± 0.3
B-cells 0 0 0
*Mean value significantly lower then control group (p<0.05).
7.4. Discussion
Inhibition of PGF2« production using intensive flunixin treatment between days 16 and 18
of the oestrous cycle resulted in a significant decrease in the numbers of macrophages
present in luteal tissue compared to untreated control animals. This effect was limited to
macrophages and the number of T-lymphocytes and MHC II expression in the CL was not
significantly different between any of the groups. B-cells were insignificant in CL from
all cows and eosinophils were only present in large numbers in one cow. Both of these
cell types appear to be unimportant in bovine CL at this stage of the oestrous cycle.
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The decrease in the numbers of macrophages during flunixin treatment was unexpected as
T-lymphocytes, not macrophages, were previously associated with the most dramatic
changes in numbers at this stage of the oestrous cycle (Chapter 5). However,
macrophages were observed in CL collected throughout the oestrous cycle in previous
studies. Using visually-staged luteal tissue (chapter 4) macrophages were found to be
present in significantly higher numbers at Stages I (days 1-4), HI (days 11-17) and IV
(days 18-20) of the oestrous cycle compared to Stage II (days 5-10). There were more
macrophages in Stage IV CL than Stage HI. The numbers of macrophages increase in
Stage IV CL as a result of their role in structural luteolysis (Paavola, 1979; Bagavandoss
et al., 1988) and high numbers of macrophages (in comparison to Stage H) in CL in the
days prior to luteolysis (Stage HI) are likely to be present in preparation for this role.
However it is also possible that macrophages, which are potent sources of a range of
cytokines such as tumour necrosis factor-a (TNF-a), may have other, as yet unknown,
roles locally within the CL at this time.
The results of this study demonstrate that PGF2a is a key substance in controlling
macrophage populations within the CL around the time of luteolysis. It is possible that
PGF2a may act directly as a chemoattractant for monocytes/macrophages. PGF2ot is a
central substance in any inflammatory reaction and, when present in sufficient
concentrations within the ovary and CL, may itself act as a direct stimulus for the influx
of immune cells. A variety of cyclo-oxygenase products of the arachidonic acid pathway
have been shown to have chemotaxic effects on different types of immune cells in vitro
(Lees et al., 1986). However there is a significant degree of variation between species and
there are no specific descriptions of the effects of PGF2ot on bovine leukocytes or
macrophages.
PGF2a could also act indirectly, stimulating other cell types that are then involved in
attracting macrophages into luteal tissue. If this is the case than the potential mechanisms
of action may be very complex. Activation of existing immune cell populations and
cytokine production by cells including lymphocytes and macrophages, as well as luteal
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cells, endothelial cells or fibroblasts could be involved (Adashi, 1992a; Pate, 1995).
Cytokines such as TNF-a, interleukin 1(3 (IL-1(3) and interferon-y (IFN-y) have been
shown to increase production of PGF2a by luteal cells themselves (Pate and Townson,
1994). Therefore it is possible that positive feedback on local PGF2a release may occur.
Recently there has also been interest in the role of a specific cytokine, monocyte-
chemoattractant protein-1 (MCP-1), in the CL. This substance is a specific
chemoattractant for monocytes and expression of MCP-1 in the rat occurs before the
increase in macrophages which is associated with structural regression (Townson et al.,
1996). It is produced by a variety of cell types including lymphocytes, macrophages and
endothelial cells (Leonard and Yoshimura, 1990). MCP-1 may therefore also have a role
in the cow CL and this will be discussed in more detail in Chapter 8.
Although this study describes the suppression of systemic production of PGF2a during
luteolysis, local production of PGF201 will also be reduced by intensive treatment with
flunixin. Within the CL luteal cells as well as non-luteal cells, such as endothelial cells,
produce PGF2a (Milvae and Hansel, 1983; Milvae, 1986) although the highest
concentrations are seen early in the cycle (Rodgers et al., 1988). Therefore it should not
be assumed that uterine PGF2a alone is involved in macrophage attraction to the CL. In
fact, when the results of the previous studies are considered, it would seem likely that
locally-produced PGF2a may be significant. Increased numbers of macrophages were
observed in our previous study (Chapter 4) from Stage III (days 11-17) onwards. As
systemic concentrations of PGF2a do not increase until around day 15-16 of the oestrous
cycle (Basu and Kindahl,1987; Parkinson and Lamming, 1990) it appears that the
increase in macrophages may occur before any increase in systemic concentrations of
PGF2a. Similarly, in Chapter 5, using accurately staged luteal tissue, macrophage
numbers were similar in CL collected on day 13-14 of the oestrous cycle and in CL
collected around the time of luteolysis (days 15-20). Therefore, local production of PGF2a
may be important, at least initially, in the days before increased uterine production of
PGF2a.
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The results of this study indicate that PGF2ct is not directly involved in the influx of T-
lymphocytes which occurs around day 16 of the oestrous cycle and that some other
substance(s) must be involved. However, as discussed above, it is also possible that,
although PGF2(x is not involved in attracting T-lymphocytes to the CL, it may be involved
in activation of existing populations of T-lymphocytes. Therefore the reduction in the
numbers of macrophages after flunixin treatment may be caused, either completely or in
part, by a lack of stimulation of T-lymphocytes at this stage.
In this study there was no reduction in MHC II expression which might have been
expected in the presence of reduced numbers of macrophages after flunixin treatment.
However MHC II expression within the CL is not confined to cells of the immune system
and is also found on other cells, including luteal cells, particularly in older CL and after
PGF2a induced luteolysis (Fairchild Benyo et al., 1991a; Kenny et al., 1991). It may be
therefore that, although there were fewer macrophages in CL from animals treated with
flunixin, their contribution to MHC II expression overall in the CL was of limited
significance in comparison to the contribution of other cell populations present.
Although there was a significant decrease in populations of macrophages in all flunixin-
treated groups there was no significant increase in populations of these cells in flunixin-
treated animals which were also infused with PGF2(X prior to ovariectomy. If PGF2a is
involved in immune cell recruitment within the CL then we might expect that replacing it
artificially would reverse the effect of flunixin on immune cell numbers within the CL.
However it is very difficult to reproduce in vivo concentrations of PGF2a artificially. In
our study peripheral concentrations of PGF2a metabolite during treatment were higher
than those reported at luteolysis in various in vivo studies but we do not know what
concentrations of PGF2a actually reached the CL. PGF2a has a relatively short half-life
within the body (tj/2<l min). Therefore it may be that in our attempts to avoid inducing
luteolysis we have produced concentrations of PGF2(X at the level of the ovary which were
below physiological concentrations for this stage of the oestrous cycle. It is also possible
that the PGF2a concentration was adequate but that a pulsatile release pattern would have
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been more effective or that there are other factors involved of which we are as yet
unaware.
PGF2a is not the only prostaglandin whose production is inhibited by treatment with
flunixin although it is the most important relative to luteolysis. Other prostaglandin
products of the arachidonic acid pathway known to have some effects on luteal function
are prostaglandin E-2 (PGE-2) and prostacyclin (PGI2). Both these compounds have been
shown to have luteotrophic, rather than luteolytic effects in vivo (Gimenez and Henricks,
1983; Milvae, 1986) on luteal cells. However we did not observe any significant
alteration in progesterone concentrations during flunixin treatment.
In conclusion, we have shown that inhibition of PGF2a production in the days leading up
to luteolysis causes a reduction in the number of macrophages within the CL at this time.
It is not clear whether systemic or local PGF2a production is most significant in this
process; indeed both may be involved. PGF2a is not only the luteolytic substance in the
cow but is also involved in events occurring at the cellular level within luteal tissue prior
to luteolysis. Further studies are required to investigate the mechanisms through which
PGF2a exerts its effects at this stage of the oestrous cycle.
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Chapter 8
Cytokine production in the bovine corpus luteum
8.1. Introduction
In addition to studies of immune cell types in the CL, there is an increasing amount
of literature investigating production of cytokines within luteal tissue as well as the
effects of various cytokines on luteal cells in vitro (Adashi, 1992a; Brannstrom and
Norman, 1993). This interest has been stimulated by the rapid expansion of
information available in recent years relating to the cytokine products of immune
cells and their range of effects on cells outwith the immune system.
Cytokines are soluble protein molecules which act as intercellular messengers. They
are secreted by immune cells and also by some other cell types (Roitt, 1992). A large
number of secreted proteins come under the broad term 'cytokines' including
interleukins, colony stimulating factors, tumor necrosis factors and interferons. These
substances are extremely potent, act locally at very low concentrations (10"15 M) and
have a short half-life. The known sources and effects of some common cytokines
which, for reasons discussed below, are of interest in luteal function are shown in
Table 8.1. However, there is a significant degree of interaction and overlap of effect
between cytokines; therefore their effects in vivo are unlikely to be as clear cut as
described in luteal cell studies in vitro (Townson and Pate, 1994).
Various techniques have been used to look at cytokine production in CL (Park-Sarge
and Mayo, 1993). These include bioassays and immunohistochemistry which detect
the protein, as well as molecular techniques such as the polymerase chain reaction
(PCR) and in situ hybridisation which detect messenger RNA (mRNA). Results vary
considerably, not only depending on the technique used, but also depending on the
particular species studied (see Vinatier et al., 1995, for a review). There has been
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particular interest in tumour necrosis factor-a (TNF-a) because of its potential role
during luteal regression (Terranova et al., 1991; Payne et al., 1991; Hunt, 1993). This
cytokine is produced by macrophages which are present in significant numbers in
luteal tissue after luteolysis. It is also cytotoxic to tumour cells and the cellular
processes involved in this have been compared to luteal regression (Ji et al., 1991).







Mediator of inflammatory response
Cytotoxic effect on some tumours
Interleukin-1-beta (11-1(3) Macrophages
Fibroblasts
Proliferation of activated B- and T-
cells
Induction of cytokine production by
macrophages.
Interferon gamma (IFN-y) Leucocytes Macrophage activation
Stimulates expression of MHC class I
and II on macrophages and other cells
TNF-a has been detected in cow CL by immunohistochemistry (Roby and Terranova,
1989) and radioimmunoassay of dialysate collected directly from the CL in vivo
(Shaw and Britt, 1995). In addition, a considerable number of in vitro studies have
been published relating to the effects of a variety of cytokines, either individually or
in combination, on bovine luteal cells in culture (Townson and Pate, 1994, Pate,
1995, 1996). The three main cytokines studied are TNF-a, interleukin-1 beta (11-1(3)
and interferon-gamma (EFN-y). The findings from this group of studies are
summarised in Table 8.2.
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Table 8.2. The effects of TNF-a, IL-1(3 and IFN-y, individually or in combination,
on luteal cells in culture.
Cytokine(s) Effect on mid-cycle (days 9-12) luteal cells in culture
TNF-a Inhibition of LH-stimulated progesterone production and enhanced
production of prostaglandins, including PGF2tt
11-lp Inhibition of LH-stimulated steroidogenesis
Stimulation of prostaglandin (PGF200 PGE2 and prostacyclin)
synthesis
IFN-y Initial inhibition of prostaglandin synthesis for 24 hours followed by
inhibition of LH-stimulated progesterone production and stimulation
of prostaglandin production. Some loss of cell viability.
TNF-a+Il-lp Positive synergistic effect on luteal production of prostaglandins
TNF-a+IFN-y Cytotoxic effects on luteal cells
More recently the potential role of another cytokine, monocyte chemoattractant
protein-1 (MCP-1), within the CL has been of interest, particularly in relation to the
influx of macrophages which occurs during structural luteolysis. MCP-1, which is
also known as monocyte chemotactic and activating factor (MCAF), is a member of
the intercrine p family of cytokines. The cytokines in this group are involved in
inflammation and tissue repair and there are 2 subfamilies, a and |3, based on their
amino acid sequence and chromosomal position (see Oppenheim et al., 1991 for a
review).
MCP-1 is produced by a variety of cell types including fibroblasts, endothelial cells,
lymphocytes and macrophages and is involved in the cellular immune response as
well as response to tissue damage (Leonard and Yoshimura, 1990). MCP-1 is a
specific chemoattractant for monocytes when injected into the ears of rats (Zachariae
et al., 1990) and also acts as a chemoattractant for monocytes in vitro (Yoshimura et
al., 1989). During tissue injury in vivo, platelet-derived growth factor (PDGF)
stimulates release of MCP-1 from fibroblasts inducing an influx of monocytes/
macrophages which act as a first line of defence against bacteria as well as being
involved in tissue remodelling. In addition to PDGF released by fibroblasts, some
168
other growth factors and cytokines such as TNF-a and IL-1 also act as stimulants of
MCP-1 release (Larsen et al., 1989; Strieter et al., 1989).
These properties (specific monocyte chemoattraction / tissue remodelling) first led
workers to consider a role for MCP-1 in the CL, particularly in the influx of
macrophages which is observed in late stage CL. The macrophages are involved in
the rapid destruction of luteal tissue which occurs after functional luteolysis (Paavola
et al., 1979). Both MCP-1 and MCP-2 have been described in pig luteal cells
(Hosang et al., 1994a, 1994b) and increased expression is seen in late stage CL in the
rat, a finding that supports the theory of MCP-1 involvement around luteolysis
(Townson et al., 1996).
Populations of immune cells vary throughout the oestrous cycle and, in particular,
there is a significant increase in numbers of T-lymphocytes (CD5+, CD8+) present
within the bovine CL prior to functional luteolysis (Chapters 4 and 5). These results
suggest that immune cells may have an active role in altering luteal function,
particularly around the time of natural luteolysis. One way in which immune cell
activity can be assessed is by measurement of cytokine gene expression.
The aim of this study was to measure cytokine mRNA expression (TNF-a, 11-1(3,
IFN-y and MCP-1), using the reverse transcription-polymerase chain reaction (RT-
PCR), in cow CL throughout the oestrous cycle, as well as following induced
luteolysis and inhibition of PGF2« release between days 15 and 18 of the oestrous
cycle.
8.2. Materials and methods
The molecular techniques used in this study are summarised briefly here and
described in more detail in Appendix 1.
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8.2.1. Collection of luteal tissue
CL obtained from four groups of cows were used in this study. The synchronisation
techniques, methods of CL collection and tissue treatment are described in detail
elsewhere (Chapters 4, 5, 6 and 7) and can be summarised as follows;
Group A: Natural luteolysis.
The oestrous cycles of a group of 18 normally-cycling heifers were synchronised and
the CL were then collected at slaughter between days 16 and 20 of the resulting
oestrous cycle (standing oestrus = day 0). A portion of luteal tissue was snap frozen
in dry ice / isopentane and stored at -70°C until RNA extraction was performed.
Blood samples, collected for 1-2 days prior to and at the time of slaughter, were
analysed for progesterone concentrations to allow assessment of which animals had
undergone functional luteolysis (P4<lng/ml). The results showed that five animals
had undergone luteolysis at the time of slaughter, all other animals had progesterone
concentrations consistent with a functional CL.
Group B: Days 2-14 of the oestrous cycle.
This group of 14 CL was collected from various groups of animals. Two CL were
collected at the abattoir and assessed as being stage I (days 1-4) of the oestrous cycle
using visual assessment (Ireland et al., 1980, see Chapter 2, Section 2.2.2.). Six CL
were collected from animals in which oestrous synchronisation had been
unsuccessful and the CL were again visually staged at the time of slaughter as Stage I
(days 1-4, n=3) and Stage II (days 5-10, n=3). Six CL were collected from cows
whose oestrous cycles were successfully synchronised as described in Chapter 5. The
CL from these animals were collected on day 10 (n=2) or days 13-14 (n=4).
Group C: Induced luteolysis
The oestrous cycles of 16 mature dairy cows were synchronised and the animals were
divided into four groups. Three groups were given 25mg prostaglandin F2« (PGF2a,
Lutalyse, Upjohn Ltd, Crawley, UK) either 6 (Group 1), 12 (Group 2) or 24 (Group
3) hours before surgical collection of the CL on day 10 of the oestrous cycle. Group 4
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were control animals and did not receive any PGF2ot. A portion of luteal tissue was
snap frozen in dry ice /isopentane and stored at -70°C.
Group D\ Inhibition of PGF2a release around the time of luteolysis.
The oestrous cycles of 18 mature dairy cows were synchronised and the animals were
allocated to one of three groups. In order to suppress release of endogenous PGF2oc
Group 1 were treated with flunixin meglumine (Finadyne, Schering Plough, U.K.)
intravenously via an indwelling cannula every 6 hours (2.2mg/kg) between days 15
and 18 of the oestrous cycle and the CL was surgically removed on day 18. Group 2
were also treated with flunixin but in addition these animals were infused with
exogenous PGF2a (Lutalyse, 170|_lg/hr) through the cannula for 24 hours prior to
surgery. Group 3 were control cows and were treated with saline for 3 days before
surgery. Blood samples were collected from all animals every 3 hours during
treatment for measurement of 15-keto-13,14-dihydro-PGF2a (PGFM), the stable
metabolite of PGF2a, and progesterone concentrations. Luteal tissue was snap frozen
in dry ice/isopentane and stored at -70°C.
8.2.2. Collection and storage of tissue
All luteal tissue obtained was handled in such a way as to minimise RNase
contamination; gloves were used at all times and sterile petri dishes and scalpels used
for cutting of tissue. The ovaries were initially placed on petri dishes on ice and then
CL were carefully removed by blunt dissection from the surrounding tissue. Small
portions were foil-wrapped and snap frozen in a slurry of dry ice and isopentane as
soon as possible after collection (within 10 minutes after surgical collection and
within 20-30 minutes after death when tissue was collected at an abattoir). Frozen
samples were then stored at -70°C prior to RNA extraction.
8.2.3. RNA Extraction
Good quality RNA is a prerequisite for successful use of the RT-PCR. There are a
variety of techniques available and in recent years new methods have been developed
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to allow rapid, uncomplicated RNA extraction. TRI Reagent™ (Molecular Research
Centre, Cincinnati, USA) and Qiagen RNeasy kits (Qiagen Ltd., Crawley, UK) were
used initially for extractions but the yield and quality of the RNA produced from
luteal tissue was not sufficient for RT-PCR. Finally a guanidine thiocyanate
extraction protocol (Chomczynski and Sacchi, 1987) was used which gave a
reasonable yield of good quality RNA. The extraction techniques are described in
Appendix 1 (Section 1.4.).
8.2.4. Testing the quality ofRNA
Extracted RNA was examined by spectrophotometry and electrophoresis to assess the
quality and quantity of RNA yielded prior to reverse transcription.
8.2.4.1. Spectrophotometry
Samples of extracted RNA were diluted 1:100 in diethylpyrocarbonate (DEPC)-
treated water and the absorbance measured in a spectrophotometer at wavelengths of
260nm and 280nm. The A26o:A28o ratio was then calculated which gave an indication
of the quality of the RNA. Ratios in the region of 1.6-2 were taken to indicate RNA
of good enough quality to proceed with the RT PCR. The absorbance at a wavelength
of 260nm was also used to calculate the yield of RNA using the formula;
RNA (p,g/ml) = A26ox 40 x dilution factor (100)
8.2.4.2. Formaldehyde Gel electrophoresis
A formaldehyde gel was prepared and run using lp.g RNA from each sample
(Appendix 1, Section 1.5.). The gel was examined under ultraviolet light looking for
2 well-defined bands which correspond to 28S and 18S ribosomal RNA. RNA
degradation was indicated where well-defined bands were not visible.
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8.2.5. Reverse-Transcription PCR (RT-PCR)
RT-PCR was performed on the extracted RNA as soon as possible after preparation
using standard methods which are described in detail in Appendix 1 (Section 1.6-
1.7.).
8.2.5.1. Reverse transcription - Control samples
For every RNA sample that was reverse transcribed a control sample, containing no
reverse transcriptase enzyme, was prepared and used in the PCR.
For every set of samples a control tube was prepared which was identical to the
reverse transcription reaction but contained no RNA.
8.2.5.2. Selection of primers
The primer sequences for TNF-a, DL-l (3 and IFN-y used in this study were provided
by Dr R. Collins from The Institute for Animal Health, Compton, UK. The bovine
MCP-1 gene, which has been characterised by Wempe et al. (1994), was used to
design primers for MCP-1. The primer sequences and PCR product sizes are shown
in Table 8.3.






TNF-a 1 5' -ACTCAGGTCATCTTCTCAAGCC-3'
2 5' -ATGATCCCAAAGTAGACCTGCC-3' 464
IL-13 1 5' -TGACGCACCCGTTCAGTCAAT-3'
2 5' -AGTGAAGTTCAGGCTGCAGCT-3' 564
IFN-y 1 5' -GCAAGTAGCCCAGATGTAGC-3'
2 5' -AGTGAAGTTCAGGCTGCAGCT-3' 316
MCP-1 1 5' -AACAGCTTCCCGCTGAAAC-3'
2 5' -TCTGCACATAACTCCTTGCC-3' 270
ATPase 1 5' -ACGAACACCACTCCTGGATGAGC-3'
2 5' -CACGGACGTCTCCAGGCTGTGTA-3' 193
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8.2.5.3. Optimisation of PCR
The volume of RTase reaction used in the PCR was varied for each cytokine studied
to give a distinct PCR product. The number of cycles and annealing temperature used
in the thermal cycler was also varied between 25 and 35 cycles and 55°-65°C for each
cytokine to find optimal conditions for PCR.
8.2.5.4. PCR Control samples
Internal control
As ATPase is present in all living cells, a preliminary PCR was performed using
primers for ATPase on a limited number of samples from each set of RTase reactions
to ensure that reverse transcription had been successful and that comparable amounts
of RNA had been transcribed from different samples. ATPase primers (Table 8.3)
were designed from the bovine ATPase gene (Brandt et al., 1988) by Dr C. Woodall,
Department of Veterinary Pathology, University of Edinburgh.
Negative controls
For each sample two separate reactions were prepared. One contained the product of
the RTase reaction (RTase +) and the other contained the RTase reaction which had
no enzyme (RTase -). In addition, for each set of reactions prepared, a negative
control was included which had been reverse transcribed but contained no RNA.
Positive controls
Samples of plasmid for TNF-a, 11-1(3 and EFN-y were generously supplied by Dr R.
Collins from The Institute for Animal Health, Compton, U.K (Table 8.4). The
plasmids were used as positive controls for the RT-PCR. The PCR mix for plasmid is
described in Appendix 1 (Section 1.7.3.). To avoid contamination of other PCR
samples the plasmid was added last to the reaction in a separate location after all
other reaction mixtures had been prepared.
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Table 8.4. cDNA clones
cDNA GCG Accession no. Length and bases
TNF-a ovine is X55152 465bp (387-852)
EL-1P M35589 564bp (380-994)
IFN-y M29867 430bp (165-595)
8.2.5.5. Visualisation of PCR product
The PCR products were visualised on a 3% agarose gel prepared using a standard
method (Appendix 1, Section 1.8.), stained with ethidium bromide, destained in
water and visualised and photographed under UV light.
Where visible differences in intensity of bands between animals were observed the
negative images were analysed by image analysis using NIH-Image 1.6 (NTH,
Bethesda, MD). Repeated sample ANOVA on log-transformed data was performed
and individual comparisons between bands were made using an unpaired t-test. All
statistical analysis was performed using Minitab Software (Pennsylvania State
University, USA). A significant difference in PCR product intensity was taken to be
present where p<0.05.
8.2.6. Confirmation ofPCR product- enzyme digests
In addition to the use of individual cytokine plasmids as positive controls, the
identification of individual PCR products using primers for TNF-a, 11-1(3 and IFN-y
was confirmed by digestion with specific restriction enzymes (Table 8.5) as
described in Appendix 1 (Section 1.9.)
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Table 8.5. Restriction enzymes and digested product sizes for TNF-a, II-1 (3
and IFN-y
Cytokine Restriction enzyme Digested product sizes (bp)
TNF-a Bgll 355,109
11-1(3 PvuII 317, 247
IFN-y EcoRV 164, 152
8.2.7. Amplification and sequencing ofMCP-1
In order to confirm the identity of the PCR product for MCP-1 the product was
amplified and sequenced using standard techniques which are described in detail in
Appendix 1 (Section 1.10.).
8.3. RESULTS
8.3.1. RNA extraction
The A260/A280 ratios produced by RNA extracted using the three different techniques
varied between 1.5 and 1.9. Extractions using TRI reagent and Qiagen RNeasy kits
yielded RNA with an A260/A280 ratio between 1.5 and 1.6. Chloroform extraction
improved the A26o/A28o ratios but did not alter the appearance of the RNA on a gel.
The extraction of RNA using guanidine thiocyanate phenol (Chomczynski and
Sacchi, 1987) yielded good quality RNA (Fig. 8.1). The quantity of RNA extracted
using this technique ranged between 150-200flg from lOOmg of luteal tissue.
8.3.2. RNA loading
Amplified bands for ATPase were of similar intensity between samples which
confirmed that the amounts of RNA added to the initial RTase reactions were
comparable (Figure 8.2)
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Figure 8.1. RNA extracted from luteal tissue (10 samples) and fractionated by
formaldehyde gel electrophoresis to show 2 distinct bands which correspond to 28S
and 18S ribosomal RNA.




Figure 8.2. Examples of the products from RT-PCR using primers for ATPase to
demonstrate comparable RNA loading between samples.
Lanes 1-8 - PCR products, Lane 9 - molecular weight marker
b.p. 123456789 b.p.
-300
8.3.3. Optimisation ofPCR conditions
PGR reactions for the individual cytokines were optimised. The amount of RTase
reaction added to the PCR, annealing temperature and number of cycles varied (Table
8.6). For PCR the thermocycler was programmed as follows; 5 min at 95°C; 30 sec at
95°C, 30 sec at 60-65°C, 30 sec at 72°C for 30-35 cycles and finally 5 min at 72°C.
Table 8.6. Optimal PCR conditions for individual cytokines.





TNF-a 10 60 30
11-1(3 8 60 30
IFN-y 10 60 35
MCP-1 6 60 30
ATPase 6 60 30
8.3.4. Validation ofRT-PCR
8.3.4.1. Restriction enzyme analysis
Digestion of PCR products for TNF-a, II- 1(3 or IFN-y with specific restriction
enzymes gave products of the expected sizes confirming that the RT-PCR products
did result from amplification of the mRNA for the different cytokines within luteal
tissue (Fig. 8.3).
8.3.4.2. Amplification and Sequencing of MCP-1
The MCP-1 PCR product was successfully amplified and sequenced. The DNA
sequence was 100% homologous with the MCP-1 gene.
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Figure 8.3. IFN-y, TNF-a and IL-ip - products of enzyme digests.
a) IFN-y














Lane 1 - IFN-y, cut (digest product sizes; 152, 164 b.p.)
Lane 2 - IFN-y, uncut (316 b.p.)
Lane 3 - molecular weight marker
b) TNF-a and II-ip
Lane 1 - TNF-a, cut (digest product sizes; 109, 355 b.p.)
Lane 2 - TNF-a, cut
Lane 3 - TNF-a, uncut (464 b.p.)
Lane 4 - blank
Lane 5 - II-1 p, cut (digest product sizes; 247, 317 b.p.)
Lane 6 - Il-ip, cut
Lane 7 - II-1P, uncut (564 b.p.)
Lane 8 - molecular weight marker
8.3.5. PCR for cytokines TNF-a, II-If, IFN-yandMCP-1
8.3.5.1. Group A - Natural luteolysis
Amplified bands corresponding with the expected PCR product size for TNF-a, 11-1(3,
IFN-y and MCP-1 were visible in all animals. Although the band intensity varied
between animals, overall there were no visible differences in band intensity for TNF-
a, 11-1(3 or IFN-y between animals before or after luteolysis. However, the amplified
bands for MCP-1 from luteal tissue after functional luteolysis were more intense than
those seen before functional luteolysis (Fig. 8.4). The intensity of the bands were
measured by image analysis of two sets of PCR. The intensity of the bands produced
by RT-PCR of mRNA from luteal tissue after functional luteolysis was significantly
higher (p<0.01) in both sets of reactions, than that seen in luteal tissue before
luteolysis.
8.3.5.2. Group B - Days 2-14 of the oestrous cycle
Amplified bands corresponding with TNF-a were present in CL from all animals but
the intensity of staining was faint. Bands corresponding to the expected product sizes
for II-1(3 and IFN-y were also present at all stages. The intensity of staining was
variable but was not obviously different between early and mid-cycle CL. MCP-1 was
present in all CL collected between days 2-14 of the oestrous cycle.
8.3.5.3. Group C - Induced luteolysis
Positive PCR products for TNF-a were faintly present in CL from all cows. Positive
PCR products for 11-1(3, IFN-y and MCP-1 were present in luteal samples from all
animals. The band intensity varied between individual animals but there were no
distinct differences between groups (for example, IFN-y, Fig. 8.5).
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Figure 8.4. Luteal tissue around the time of natural luteolysis: RT-PCR products
using primers for MCP-1.
b.p. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 b.p.
Lanes 1-10 - Pre-luteolysis, RT-PCR of luteal tissue collected between days 16 and
20 of the oestrous cycle where the CL was still functional at the time of
slaughter (plasma progesterone concentration > lng/ml).
Lanes 11-15 - Post-luteolysis, RT-PCR of luteal tissue collected between days 16 and
20 of the oestrous cycle where the CL was not functional at the time of
slaughter (plasma progesterone concentrations < lng/ml).
Lane 16 - molecular weight marker.
Figure 8.5. Luteal tissue 0, 6, 12 or 24 hours after luteolysis artificially induced
using PGF2a on day 10 of the oestrous cycle: RT-PCR products using
primers for IFN-y.
Lanes 1-4 - control cows (no PGF2a)
Lanes 5-8 - 6 hours after PGF2a
Lanes 9-12 - 12 hours after PGF2a
Lanes 13-16-24 hours after PGF2a
Lane 17 - molecular weight marker
Lane 18 - IFN-y plasmid control
Figure 8.6. Luteal tissue collected after inhibition of PGF2(X release between days 16
and 18 of the oestrous cycle: RT-PCR products using primers for TNF-a.
b.p. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 b.p.
Lanes 1-6 - control cows
Lanes 7-12 - Flunixin only
Lanes 13-17 - Flunixin+PGF2a
Lane 18 - molecular weight marker
Lane 19 - TNF-a plasmid control
8.3.5.4. Group D - Inhibition of PGF2a release between days 15 and 18 of the oestrous
cycle.
PCR product corresponding to TNF-cx was found in CL samples from all animals
studied. The bands varied in intensity between animals but not between groups (Fig.
8.6). Cow 595, from the group of cows treated with flunixin only, showed the
brightest band. II-1 [3 was also present in luteal tissue from all cows, the most intensive
bands were seen in luteal tissue from cows 185 (Control group) and cow 595. There
were positive PCR products for IFN-y in all animals studied. The most intense
staining was again observed from cow 595. The PCR products for MCP-1 varied in
intensity between animals but this occurred randomly and was not associated with any
specific treatment group. The most intense band for MCP-1 was associated with cow
185, a control cow that underwent luteolysis during the trial.
8.4. Discussion
All four cytokines investigated, TNF-a, II-1P, EFN-y and MCP-1, were detectable by
RT-PCR using luteal tissue from animals throughout the oestrous cycle, after induced
luteolysis and during suppression of PGF2a production between days 15 and 18 of the
oestrous cycle. The most significant finding was the increased amount of MCP-1 in
luteal samples from cows in group A which had undergone functional luteolysis
compared to those in the same group that still had functional CL.
Apart from this distinct variation in MCP-1 mRNA in CL from Group A there was
also some variation between individual animals within groups. The RT-PCR in its
basic form is not designed for accurate quantification and comparison of PCR
products from different samples. However, as the same amount of RNA was used
throughout preparation of PCR mixtures for each individual cytokine (as confirmed by
similar intensity of bands for ATPase in samples), visible differences in the intensity
of bands may represent significant differences in cytokine content between samples
from different animals. It may be that variations between groups do not exist but it is
also possible that any changes are outwith the sensitivity of a PCR and that
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another more quantitative technique, such as an RNase protection assay, should be
used to study this in detail.
When investigating TNF-a, 11-1(3 and IFN-y the most consistently intense bands were
from a cow (595) in the group treated with flunixin to inhibit production of PGF2«-
This animal had the most intense band for all three cytokines studied in a total of 18
animals. Previous results obtained using immunohistochemistry and hormone assays
(Chapter 7) provide no obvious explanation for this difference. The numbers of
immune cells or MHC 13 expression were not significantly different from the rest of
the group and the concentrations of progesterone and PGFM were within the range of
the other cows being treated with flunixin.
Cytokine production, in particular the presence of TNF-a, has been studied in CL
from various species. One of the earliest studies using bio-assays produced
inconclusive results about TNF-a production in the rabbit CL. Although TNF-a
bioactivity was present in culture media from rabbit luteal cells treated with
lipopolysaccharide, none was detected in unstimulated culture media (Bagavandoss
et al., 1988). However, immunohistochemistry has been used successfully to detect
the presence of TNF-a within CL from the rat and cow (Roby and Terranova, 1989),
human (Roby et al., 1990) and mouse (Chen et al., 1993). 11-1(3 has also been located
in the mouse CL (Simon et al., 1994). The majority of these studies have not
compared cytokine production at different stages of CL lifespan, although increased
staining for TNF-a and IL-1[3 has been described in regressing CL, in comparison to
younger CL, collected from the mouse (Chen et al., 1993; Simon et al., 1994). There
is also a detailed study in the pig which demonstrates that, in contrast to our findings
in the cow, TNF-a is detectable in pig CL at various stages of pregnancy and during
the oestrous cycle but cannot be detected in CL after luteolysis (Hehnke-Vagnoni et
al., 1995).
Immunohistochemistry has been used most frequently to detect cytokines in the CL.
However a recent novel study in the cow collected samples directly from luteal tissue
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during luteolysis using a microdialysis unit which had been pre-placed in the CL.
Radioimmunoassay was used to measure TNF-a in the dialysate and an increase in
concentration, which followed the decline in serum progesterone, was observed
following both induced and natural luteolysis (Shaw and Britt, 1995). A similar
finding has been recorded following induced luteolysis in the sheep where TNF-a
bioactivity gradually increased in luteal tissue collected at 5 time periods between 0
and 16 hours after luteolysis induced by a single injection of PGF2« (Ji et al., 1991).
It appears therefore that, using a sensitive enough system, quantitative changes in the
concentrations of cytokines can be successfully detected in tissue collected at
different stages of the CL lifespan. However in addition to this, the production site of
these cytokines is also important. Although TNF-a, II-1(3 and EFN-y were detected in
cow CL from all groups in the present study, the specific cell sources are not known.
Cytokines are not only produced by cells of the immune system but may also be
produced by cell types such as fibroblasts, endothelial cells or even luteal cells
themselves. Various techniques are available which may be used to identify the site
of cytokine production and future studies should include in situ hyridisation to locate
the cell sites of cytokine production within the CL.
In CL the cell types which are associated with cytokine production vary considerably
between species. In the human, TNF-a has been detected in both small and large
luteal cells using immunohistochemistry (Roby et al., 1990), but in the cow and the
rat TNF-a expression was found in thecal cords within luteal tissue and was
associated with cells which also stained positively as macrophages and not luteal
cells (Roby and Terranova, 1989). Similarly, in the mouse, immunoreactive TNF-a
was found in macrophage-like cells and not luteal cells although luteal cells did
express mRNA for TNF-a (Chen et al., 1993). In contrast, 11-1(3 is expressed in large
amounts by mouse luteal cells and in comparatively small amounts by macrophages
(Simon et al., 1994). Finally, in the pig CL the endothelial cell is the source of TNF-
a. Macrophages were not associated with TNF-a staining in the pig CL even when
present in increased numbers after luteolysis (Hehnke-Vagnoni et al., 1995). These
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findings are consistent with the presence of TNF-a receptors on small cells (small
luteal cells and endothelial cells) in the pig (Richards and Almond, 1994)
Most of the above studies are based on immunohistochemistry. This technique will
only detect protein that has actually been formed and is present at that particular
moment of time. It does not assess other cells which might be potential sources of the
cytokine which may be important in assessing the significance of cytokines within
the CL. For example, Ji et al. (1991) found increasing TNF-a bioactivity (a function
of the protein ) in the sheep CL following induced luteolysis. However, somewhat
surprisingly, TNF-a mRNA was not detectable by Northern blots or in situ
hybridisation in any sample of luteal tissue and the authors suggested that this was
because the TNF-a had been pre-formed in an external source, most probably
immune cells.
The expression of MCP-1 in CL at all stages studied is not unexpected when the
cellular components of luteal tissue are considered. MCP-1 is produced by a wide
variety of cells including endothelial cells, fibroblasts, lymphocytes and macrophages
(Leonard and Yoshimura, 1990). All of these cell types are present, sometimes in
significant numbers, in luteal tissue although their proportions relative to large and
small luteal cells vary at different stages of the oestrous cycle (O'Shea et al., 1989;
Lei et al., 1991). It is possible that the presence of MCP-1 is mainly passive
throughout most of the CL lifespan until after functional luteolysis. However, MCP-1
is known to have a role in tissue remodelling, in common with many of the intercrine
family (Leonard and Yoshimura, 1990). Therefore, in addition to its potential role as
a chemoattractant for monocytes/ macrophages in late-stage CL, MCP-1 might also
be involved in the growth and remodelling of luteal tissue throughout its lifespan.
This study did not find any difference in MCP-1 expression, detectable by PCR,
between very early CL and those collected between days 5-14. However there was
only a limited amount of visually staged tissue available from between days 1-4 of
the oestrous cycle and it would be interesting to study more CL collected at a known
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time soon after ovulation, particularly as Townson et al. (1996) have described
increased expression of MCP-1 in the early post-ovulatory rat CL using
immunohistochemistry. Increased concentrations of MCP-1 in rat CL after ovulation
could be associated with the rapid vascular development (angiogenesis) that takes
place at this time (Zheng et al., 1993) which is not dissimilar to events occurring
during healing of damaged tissue (Redmer and Reynolds, 1996).
The most significant finding was the increase in MCP-1 mRNA expression within
luteal tissue from animals that had undergone functional luteolysis in the 48 hours
preceding slaughter. The increase in MCP-1 at this stage is consistent with a role for
this substance after functional luteolysis but before structural luteolysis, probably in
activating existing populations of macrophages as well as attracting other
macrophages into luteal tissue.
Declining progesterone concentrations and/or increasing concentrations of PGF2a
could be the stimulus for enhanced MCP-1 expression in the cow after luteolysis. In
the rat enhanced MCP-1 expression in the CL of late pregnancy is associated with
declining progesterone concentrations (Townson et al., 1996). It is also possible that
immune cell populations present within luteal tissue could have a role in affecting
MCP-1 production. T-lymphocytes are themselves a potent source of MCP-1
(Kaczmarek et al., 1985; Yoshimura et al., 1989) but also produce cytokines such as
TNF-a and EL-1 which are known to promote expression of MCP-1 (Larsen et al.,
1989; Strieter et al., 1989). There are significant numbers of T-lymphocytes within
the cow CL from day 16 of the oestrous cycle onwards (Chapter 5). It is possible
therefore that cytokine production by resident populations of T-lymphocytes, and also
macrophages, may have a role in up-regulating MCP-1 mRNA expression causing an
influx of macrophages into the CL.
There was no detectable variation in luteal MCP-1 expression between any of the
groups treated with flunixin between days 15 and 18 of the oestrous cycle, although
the CL from one control cow (185) did appear to contain higher concentrations of
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MCP-1 mRNA compared to any of the other animals. This cow had undergone
functional luteolysis during the trial, approximately 24 hours before CL collection,
and so this was a similar result to that seen in the group around natural luteolysis.
From these results it appears that MCP-1 production is not significantly affected by
inhibition of PGF2a production around luteolysis. However, as the increase in MCP-1
production in Group A was not observed until after functional luteolysis, this
experiment would be more significant if repeated in the days around and immediately
after luteolysis than in the days before.
Similarly, induced luteolysis did not result in any detectable increase in MCP-1
expression within luteal tissue. This was surprising as it might be expected that the
rapid structural regression taking place after induced luteolysis would involve
significant numbers of macrophages. However, this finding did fit in with results
from tissue morphology and immunohistochemistry from these cows (Chapter 6) as
the cellular events occurring after induced luteolysis were considerably different from
those seen after natural luteolysis and no increase in the number of macrophages was
observed at any time period after injection.
It is not clear from the results of the present study whether MCP-1 is actually
produced by luteal cells themselves. Further studies involving in situ hybridisation or
immunohistochemistry, where expression of MCP-1 can be localised to individual
cell types, are required to clarify this point. Hosang et al. (1994a) described
expression of MCP-1 by luteal cells from the pig but this study used dispersed luteal
tissue which would contain large numbers of endothelial cells and fibroblasts which
could themselves act as the source of MCP-1.
In conclusion, we have shown that there is message for TNF-a, 11-1(3, IFN-y and
MCP-1 in cow CL collected from animals at different stages of the oestrous cycle as
well as after induced luteolysis and during suppression of PGF2a around the time of
luteolysis. There is enhanced expression of MCP-1 after functional luteolysis,
possibly influenced by hormonal changes or cytokine release from resident
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populations of immune cells. This finding, in conjunction with immunohistochemical
findings suggests a role for MCP-1 in attracting monocytes/macrophages to the CL
for structural regression.
The large variance in results, both within and between species, suggests that it is not
possible to draw conclusions using one technique alone. Further studies should
involve techniques that detect both the secreted form of the protein
(immunohistochemistry, bioassay) as well as the messenger RNA within the CL at
different stages of the oestrous cycle. The transient nature of cytokine release as well





The hormonal changes and ovarian events which occur during the oestrous cycle of
the cow have been known for many years. However, our understanding of events
which take place at the cellular level within the ovary itself is limited. It appears that
there are many factors yet to be clearly identified, that affect the bovine reproductive
cycle. In particular there is very little information about local factors within the CL
which may influence luteal function in vivo.
In recent years the fields of reproduction, particularly endocrinology, and
immunology have become less clearly differentiated and there appears to be a
significant overlap in their functions from the level of the hypothalamus to the ovary
(Seamark et al., 1992; Tabibzadeh, 1994). Cells of the immune system have been
identified as one of the factors which could affect ovarian function at all stages of the
oestrous cycle in the cow as well as other species (Brannstrom and Norman 1993;
Pate, 1995). Immune cells have been described in luteal and follicular structures
throughout the oestrous cycle and they were first recorded in the cow CL by Lobel
and Levey (1968). The presence of these cells was originally thought to be passive,
resulting from the high blood flow to the ovary. Their only known function was in
destruction of the CL after luteolysis (Paavola, 1979). However, the rapid expansion
in our understanding of immune cells and their potential to affect cells outwith the
immune system led researchers to consider other roles for these cells within the CL.
If immune cells do have a significant role in luteal tissue then it is likely that their
populations will vary during the lifespan of the CL. The aim of this study was to
investigate the immune cells present in the cow CL at different stages of the oestrous
cycle, particularly around luteolysis. Preliminary studies established the most
appropriate technique to use. The changes in immune cell populations and MHC II
expression throughout the oestrous cycle and during natural luteolysis were
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investigated first. Immune cell types and numbers present after induced luteolysis
were then compared with those seen during natural luteolysis to assess whether
induced luteolysis could be a useful experimental model for studies around luteolysis
in the cow. The effect of inhibiting PGF2a release around the time of luteolysis on
immune cells and MHC II expression was studied and finally, the presence ofmRNA
for four cytokines in luteal tissue was investigated using the reverse transcriptase
polymerase chain reaction (RT-PCR).
For the purposes of the discussion I will first summarise the results from the different
chapters. I will then discuss the significance of the findings in relation to current
thinking on the immune system in CL function, discussing future studies where
relevant.
The original intention was to study immune cell populations and MHC II expression
using both immunohistochemistry and flow cytometry. To optimise the cell
populations used for flow cytometry, collagenase dissociation, using a range of
collagenase enzymes and mechanical dispersion of luteal tissue were compared
(Chapter 3). There was considerable variation in the cell dispersions produced using
the different techniques. Most significantly, the numbers of large cells varied
markedly between dispersions. This was not unexpected as selective loss of large
cells has been connected to collagenase dissociation of luteal tissue (Rodgers et al.,
1984; O'Shea et al., 1989). However, in addition to these finding there was also
variation in the LH binding between cell populations produced by different
collagenase enzymes and mechanical dissociation. This was a novel use of the
ubiquitous LH receptor as an indicator of luteal cell membrane damage. It was
concluded that not only were luteal cells visibly damaged during tissue dissociation
but cell membranes were also affected to varying degrees, depending on the type of
collagenase used.
At this stage in the study a collagenase enzyme was selected which 1) produced luteal
cell populations which were most closely representative of the cell populations in the
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intact CL, 2) resulted in minimal reduction in LH-receptor numbers and 3) gave a
well dispersed population of luteal cells. This collagenase was then employed when
preparing cell dispersions for flow cytometry.
Immunohistochemistry was first used to identify immune cells and MHC II
expression in CL collected at an abattoir from animals of unknown reproductive
history (Chapter 4). The CL were visually staged using a widely used technique
(Ireland et al., 1980). The numbers of T-lymphocytes, macrophages, eosinophils and
cells expressing MHC II varied at different stages of the oestrous cycle. Immune cell
populations and MHC II expression were then studied in more detail around the time
of luteolysis. CL were collected from animals between days 16-20 of the oestrous
cycle. There was a significant increase in the numbers of T-lymphocytes (CD5+,
CD8+) from day 16 of the oestrous cycle onwards which occurred before the fall in
progesterone concentration associated with functional luteolysis (Chapter 5). This
finding is of great significance. It implies a specific role for T-lymphocytes prior to
luteolysis and is further evidence that the immune system may be important in
controlling ovarian function in the cow.
This study (Chapter 5) also revealed a potential danger in the use of visually staged
luteal tissue for CL studies, particularly around luteolysis. Comparing the results
obtained using luteal tissue of known age to visually staged tissue, it became
apparent that visually staged tissue described as Stage IV (post-luteolysis days 18-20)
was often further advanced in terms of structural regression than that seen
immediately after natural luteolysis. It was not possible to categorise pre- and post-
luteolytic CL in the 48 hour period around luteolysis by gross or morphological
appearance. It was concluded that visually staged tissue is not appropriate for detailed
studies around luteolysis (although a single blood sample for progesterone analysis,
taken at time of CL collection, would allow more accurate identification of the stage
of cycle relative to luteolysis).
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Visually staged tissue has been widely used in studies investigating CL function and
the properties of luteal cells. The appearance of CL from Stage I (days 1-4), Stage II
(days 5-10) and Stage IV (days 18-20, i.e. 24-48 hours after functional luteolysis) is
distinct enough to allow accurate staging. However, it is not possible to differentiate
late Stage HI CL immediately before and immediately after luteolysis. There is a
danger therefore that some studies employing Stage HI CL will inadvertently have
included CL that have undergone functional luteolysis but are not obviously different
in structure. This is likely to affect results, as luteal cell function and responsiveness
to different luteotrophic and luteolytic hormones will be altered after luteolysis.
Collection of luteal tissue around the time of natural luteolysis requires large groups
of cows and repeated blood sampling to ensure sufficient animals at appropriate
stages of luteolysis when CL are collected. Induced luteolysis could be a useful
technique for studying cell changes around luteolysis as it can be much more easily
controlled. In Chapter 6 the cellular events associated with induced luteolysis were
investigated. The immune cell populations present at 6, 12 and 24 hours after induced
luteolysis bore little resemblance to those seen in the 24 hours after natural luteolysis.
MHC II expression was increased in all samples but there were few macrophages or
lymphocytes. Morphologically, the tissue was dramatically altered. There was rapid
loss of luteal cell structure at all time periods after treatment. The changes in
structure were more comparable with a CL several days after natural luteolysis. These
results indicated that induced luteolysis is of limited use for studies relating to
cellular events during natural luteolysis.
However, the above statement applies only to this particular method of inducing
luteolysis. A single bolus injection of high dose of PGF2a is the most widely used
technique for inducing luteolysis in the cow. The increase in PGF2K concentrations
and resulting changes in concentrations of other hormones are far more dramatic than
those seen during natural luteolysis (Basu and Kindahl, 1987; Schallenberger et al.,
1984; Parkinson and Lamming, 1990). It is possible therefore that gradual infusion of
PGF2« in physiological concentrations would be a better approach. This method has
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been used in the sheep. Stacy et al. (1976) reported that the morphological changes
seen in CL after infusing PGF201 directly through a uterine vein were similar to those
during natural luteolysis. The uterine vein would be the route of choice for PGF2a
infusion but this technique is considerably more complicated than using the jugular
route. Whatever route of administration is used, in addition to using a pulsatile,
infusion of PGF2a, it would also be appropriate to induce luteolysis as close to the
timing of natural luteolysis as possible. As the CL ages the proportions of luteal cells
alter and the number of receptors for PGF2a as well as other hormones changes
(Chegini et al., 1991; Sakamoto et al., 1995). This is likely to affect the
responsiveness of the CL in vivo.
Any alteration in the numbers of immune cells or MHC II expression could be caused
by a range of local or systemic factors. The increase in the numbers of T-lymphocytes
(CD8+, CD5+) in the days before luteolysis occurs whilst progesterone
concentrations are still high but in the presence of a rising concentration of PGF2a,
released from the uterus (Parkinson and Lamming, 1990). In Chapter 7 the possible
relationship between the increase in T-lymphocytes and pre-luteolytic concentrations
of PGF2a was investigated. Flunixin meglumine, a cyclo-oxygenase inhibitor, was
used to suppress PGF2a release in 12 cows between days 15 and 18 of the oestrous
cycle. PGF2a was replaced artificially in 6 out of 12 cows for 12 hours prior to
collection of the CL. Numbers of macrophages, but not T-lymphocytes, were
significantly lower in all flunixin -treated animals compared to untreated controls.
Immune cell populations and MHC II expression did not vary between cows treated
with flunixin and cows treated with flunixin and PGF2a. However, this may have
been due to an underestimation of the amount of exogenous PGF2a required to give
physiological concentrations within the CL. The results of the flunixin trial indicate a
specific role for PGF2a in controlling populations of macrophages within luteal
tissue.
In Chapter 8 the results from RT-PCR of luteal tissue are presented. Three cytokines,
whose effects on luteal cells in vitro have been studied in some detail (Pate, 1995,
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1996), were investigated. mRNAs for tumour necrosis factor-a (TNF-a) interleukin-
1(3 (11-1(3) and interferon-y (IFN-y) were found in luteal tissue from all stages of the
oestrous cycle, after induced luteolysis and when PGF2a production was inhibited by
flunixin. Although cytokine production, particularly TNF-a has been studied to some
degree in the cow, this is the first description of mRNA for these cytokines in CL
from such a range of animals.
Monocyte chemoattractant protein-1 (MCP-1) was found in all groups of luteal
tissue. However, unlike the three other cytokines, there was an obvious increase in
mRNA for MCP-1 in CL from animals which had undergone natural luteolysis
compared to those that were pre-luteolytic. This finding was similar to a recent study
in the rat (Townson et al., 1996) and suggests a role for MCP-1 in the attraction of
macrophages to the CL in preparation for luteal regression. The cell sources ofMCP-
1 are many but include T-lymphocytes as well as other cells present in the CL. This is
the first report ofMCP-1 mRNA expression in the cow CL.
During the course of these studies flow cytometric analysis of luteal cell populations,
stained with a range of fluorescent-linked monoclonal antibodies, was unsuccessful.
This was primarily because of the difficulties in identifying separate cell types within
the whole population. An attempt was made to use flow cytometry to assess MHC II
expression on luteal cells after induced luteolysis (Chapter 6). This technique had
been used successfully by other workers looking at MHC II expression. However,
there were major problems in identification of separate cell types and flow cytometry
failed to detect changes in MHC II expression that were detected using
immunohistochemistry.
Flow cytometry had appeared potentially to be a very useful and accurate technique
for identification of immune cells and MHC II expression in dispersed luteal tissue. It
has not been widely used in studies of luteal tissue however. Kenny et al. (1991)
recognised the damage to sheep luteal cells that occurs during collagenase
dissociation and attempted to overcome this by allowing dispersed cells a recovery
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period in culture for 18-24 hours prior to flow cytometry. However, whether the
levels of MHC I or MHC II expression found after dissociation and culture in this
study is comparable with that in vivo is open to question. Fairchild Benyo et al.
(1991) studied MHC II expression at different stages of the oestrous cycle and after
induced luteolysis, observing variations in MHC II expression at different stages. The
potential influence of collagenase dissociation on MHC II expression itself are not
discussed but it seems likely that both collagenase dispersion and preparation of
dispersed cells for flow cytometry may alter MHC expression.
Immune cells- further evidence ofa role in luteolysis andfuture studies
Our results, particularly the variation in T-lymphocytes and MHC II expression at
different stages of the oestrous cycle, indicate that the immune system does have a
significant role within the CL, particularly around the time of luteolysis. The exact
mechanisms through which immune cells influence the CL, and the factors
controlling the changes in immune cell populations and MHC II expression, are not
clearly established. However from these results and other relevant studies it is
possible to formulate some potential modes of action and suggest appropriate further
investigations.
Any attempt to clarify the specific roles of different cell types and cytokines will be
difficult. It is likely that immune cells/cytokines are involved in a number of events
occurring simultaneously. Recently various workers have attempted to summarise
these processes (Vinatier et al., 1995; Terranova and Montgomery Rice 1997).
However, results from different species vary considerably and it cannot be assumed
that the effect of one cell type or cytokine within the CL in one species will be
similar in another. Therefore it is necessary to consider the cow CL alone. The
majority of studies relating to the immune system and the CL involve investigating
the effect of immune cells and cytokines on luteal cells in vitro (Pate, 1995, 1996).
These studies are described either in the Literature review (Chapter 1) or in the
relevant chapters (Chapters 4-8).
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Within the cow CL, immune cells can be expected to function by the same processes
that occur throughout the body. Cell-mediated immunity rather then humoral
immunity appears to be significant in the cow CL. It is likely that the main role of the
immune system is to prepare for, and co-ordinate, destruction of luteal tissue after
luteolysis. Therefore the primary function of increased numbers of CD5+/CD8+ T-
lymphocytes may be attraction of macrophages and activation of existing
macrophage populations within the CL. However in immunological terms this would
be an unusual role for CD8+ T-lymphocytes. Traditionally CD4+ helper/ inducer T-
lymphocytes are more central to initiation of a cell-mediated immune response.
CD4+ T-lymphocytes release cytokines which will activate both CD8+ T-
lymphocytes and macrophages. CD8+ T-lymphocytes are associated with the
cytotoxic response to antigen presented in combination with MHC I molecules and
produce fewer cytokines than CD4+ T-lymphocytes.
However, in this study, no alteration in numbers of CD4+ lymphocytes was observed
at any stage of the oestrous cycle. Further studies are required to investigate whether
the function of, and relationships between immune cells, are similar in luteal tissue to
those in the rest of the body. A starting point would be to investigate whether, as
occurs during a cell-mediated immune response, there is evidence that CD8+
activation is taking place within the CL. This is associated with expression of the
interleukin-2 receptor in response to IL-2 released by CD4+ T-lymphocytes. The IL-2
receptor may be identified by immunohistochemistry.
The increases in CD8+ T-lymphocyte numbers but not CD4+ T-lymphocytes within
the CL, as discussed above, could be due to unusual immune cell interactions and
functions in this tissue compared to other body tissues. Alternatively, CD4+ T-
lymphocytes may still play a central role. Cytokines acting locally are extremely
potent and it is possible that existing populations of CD4+ T-lymphocytes, when
activated, release sufficient cytokines to initiate the required immune response.
However, the field of immunology is rapidly advancing and it is also possible that
our understanding of all the processes and cellular reactions involved between
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populations of T-lymphocytes are oversimplified. Recent studies have suggested that
there are subpopulations of CD8+ T-lymphocytes which are potent sources of a
variety of cytokines, including IFN-y which is involved in activation of macrophages.
In addition there is evidence that certain subpopulations of CD8+ T cells may react
with antigen presented in combination with MHC II, not MHC I (Kemeney et al.,
1994).
Activation of T-lymphocytes (as well as macrophages and possibly luteal cells) will
result in increased production of cytokines. In the present study mRNA for a variety
of cytokines has been described within the CL. This proves only that there is the
potential for these cytokines to be produced within the CL. It is important that future
studies include identification of the active protein form of the cytokines. The use of
in situ hybridisation or immunohistochemistry would also allow identification of the
specific cell sources of different cytokines. At present, cytokine production (TNF-a
has been identified in the most detail) is frequently associated with macrophages (see
Terranova, 1997 for a review article) although other cell types, including luteal cells,
may also be sources.
The role of MHC expression will also be more clearly understood when precise
interactions between immune cells and MHC expression is established. Initially
MHC II expression was associated with immune cells only but now it is accepted that
non-immune cells may also express MHC II. There is a detailed study describing
MHC II expression in the cow CL throughout the oestrous cycle and during
pregnancy. This study involved FACS analysis of collagenase-dissociated CL
(Fairchild Benyo et al., 1991). MHC II expression varied between cells of different
sizes but, to summarise briefly, increased MHC II expression was seen with
increasing age of CL and after induced luteolysis. MHC II expression was
significantly lower in CL on day 18 of early pregnancy compared to day 18 cyclic
CL. These findings in CL from non-pregnant cows are similar to our own but, as
discussed above, caution is required in assessing MHC II expression in cells that
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have been collagenase-dispersed. There is also the problem of identifying specific
cell types by flow cytometry.
In our own study MHC H-expressing cells were difficult to identify specifically
because of the diffuse nature of immunohistochemical staining. However
macrophage-like cells and endothelial cells in blood vessels were the most obvious
cell types to express MHC II in CL from Stages I-II (days 1-10) of the oestrous cycle.
MHC II expression was increased in Stage HI compared to Stage II CL but was most
obvious in Stage IV CL and after induced luteolysis. In these CL large numbers of
cells were expressing MHC II (including luteal cells) although staining was most
intense around blood vessels. MHC II expression has been described on luteal cells in
culture (Fairchild and Pate, 1989).
Alteration in MHC I or MHC II expression provides an important mechanism
through which immune cell responses can be controlled within the CL. Increased
expression of MHC I and II on immune and non-immune cells is associated with a
range of cytokines (Ohmann et al., 1988). Specifically, IFN-y has been shown to
increase MHC I (+25%) and MHC II (+370%) expression on luteal cells in vitro
(Fairchild and Pate, 1989). Recent evidence also suggests that large luteal cells
themselves may be able to activate T-cells in combination with MHC II expression
(Greene et al., 1996). Therefore a variety of immune processes may be involved with
altered MHC II expression. The apparent increase in expression of MHC II by
endothelial cells might also indicate that blood vessels are an important early target
for destruction by immune cells during luteolysis. A reduction in blood flow within
the CL is one of the first events to occur during luteolysis.
In addition to the role of immune cells in communicating with each other and
initiating an immune response, these cells (and in particular their cytokine products)
may be able to affect luteal cells directly. The results of a large number of in vitro
studies (reviewed by Pate, 1995) suggest that cytokines influence bovine luteal
function through alteration of progesterone release and PGF2(t production. TNF-a, II-
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1 (3 and IFN-y and different combinations of these cytokines have a variety of effects
on luteal cells in culture: however the majority of responses are luteolytic i.e.
progesterone production is suppressed and PGF2« production stimulated. Although
uterine PGF2a is the luteolytic substance in the cow, it is not clear exactly how
luteolysis takes place within the CL itself. Increased numbers of CD8+ T-
lymphocytes, possible activation of CD4+ T-lymphocytes and activation of
macrophages during an immune response will result in increased production of a
range of cytokines, including TNF-a, II-1 (3 and IFN-y. This suggests another possible
mechanism of action for immune cells acting through their cytokine products to
promote luteolysis at the cellular level within the bovine CL. This effect could be
direct on specific luteal cells or could function through positive feedback
mechanisms involving luteal substances including PGF2a, oxytocin and cytokines
released not only from immune cells but also possibly from other cells within the CL.
The possibility that cytokines may be produced by, or exert their effects on, cells
outwith the immune system provides evidence of other potential actions for these
substances within the CL. In the pig CL, TNF-a has been localised to endothelial
cells (Hehnke-Vagnoni et al., 1995) and it is suggested that the endothelial cell
would be a prime target for the action of TNF-a as damage to endothelial cells and
resultant collapse of vascular components of the CL would significantly reduce the
luteal blood supply. It is not clear however whether a reduction in blood supply is a
mechanism for, or a consequence of, luteolysis (Nett et al., 1976; Niswender et al.,
1976). Further evidence of a specific role for TNF-a in the pig CL is the presence of
specific TNF-a receptors on the small cell population which includes small luteal
cells and endothelial cells (Richards and Almond, 1994). A recently published study
in the sheep has localised TNF-a to thecal endothelial cells in preovulatory follicles
(Murdoch et al., 1997). It seems likely that endothelial cells may also be a prime
target for TNF-a action in the cow CL and further studies should examine
endothelial cells in the cow CL for evidence of cytokine production and/or the
presence of receptors.
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Confirming the presence of cytokine receptors not only on endothelial cells but also
on other cells in luteal tissue would be significant evidence of 'non-immune' roles
for these substances in the CL. Adashi (1995) stated that substances assessed to be
important in intraovarian regulation must fulfil certain criteria. These are evidence of:
1) local production, 2) local reception and 3) local action. In addition it is suggested
that evidence of a vital role is also established through for example, neutralisation
studies using specific antibodies. There is evidence of local production of cytokines
within the cow CL. However, the other criteria of local reception and local action are
as yet unfulfilled.
There have been no investigations into the presence of specific cytokine receptors
within the cow CL although they have been described in other species (see Terranova
and Montgomery Rice, 1997 for a recent review article). Specific cell sites of action
for cytokines are also unclear in the cow CL. A recent in vitro study using human
granulosa-luteal cells found that TNF-a and IL-2 stimulated proliferation of
lymphocytes and monocytes in culture with luteal cells but had no effect on luteal
cells themselves. The authors urged caution in attributing effects of cytokines on
luteal cells specifically (Wang et al., 1995). The localisation of specific receptors on
cells of the CL is therefore an important step in defining their role. Cytokine
receptors are located on many types of cell and have similar structural features
(Kuby, 1994). There are specific receptors for individual cytokines although some
cytokines, for example TNF-a, have more than one receptor (Tabibzadeh, 1994;
Davies and Wlodawer, 1995).
Immune cells and their cytokine products have the potential to induce apoptosis
within the CL. It is not yet known how significant apoptosis is in the process of luteal
regression but apoptotic cells have been observed in luteal tissue during structural
regression (Juengel et al., 1993; Rueda et al., 1995). Macrophages, eosinophils and
neutrophils have also been shown to generate reactive oxygen species (ROS) which
are involved in apoptosis. Activation of various immune cells by cytokines, including
TNF-a, can stimulate ROS release (Riley and Behrman, 1991) and TNF-a has been
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shown to induce apoptosis directly in combination with specific receptors (Wertz and
Hanley, 1996). It is possible therefore that immune cells and cytokines may exert
some of their effects within the CL through the induction of apoptosis (Pate, 1995;
Tilly, 1996). In addition, recent studies have revealed that ROS may also play
significant roles in affecting luteal function, in particular having a luteotrophic effect
(Kato et al., 1997). Therefore, immune cells and /or cytokines could also be involved
in luteotrophic support of the CL at different stages of the oestrous cycle through
generation of ROS. Future investigations should consider the significance of
apoptosis within the CL around the time of luteolysis relative to immune cell
numbers or cytokine production. It would be of some interest to investigate the
numbers of apoptotic cells in CL where immune cells and cytokine production have
been suppressed.
The factors that control the presence of immune cell populations within luteal tissue
are unclear. Changes in the concentrations of peripheral and/or local hormones such
as progesterone, oxytocin, oestradiol and PGF2« could be involved. Various
hormones have effects on immune cells at different levels from the hypothalamus to
the ovary (Tabibzadeh, 1994). For example, oestrogen inhibits CD8+ T-lymphocyte
activity, and during pregnancy high progesterone concentrations suppress cell-
mediated immunity (Grossman, 1985). Some hormones may act directly or indirectly
as chemoattractant substances such as hCG in the human which attracts neutrophils,
monocytes and lymphocytes in vitro (Reinisch et al., 1994) and PGF2« which
stimulates production of a chemoattractant for eosinophils in the sheep CL
(Murdoch, 1987). It is also possible that the signals originate from existing
populations of immune cells through production of cytokines.
In the course of the present study the role of PGF2a on immune cell populations in
the cow CL at the time of luteolysis was investigated. The increase in the number of
T-lymphocytes (CD5+/CD8+) cells observed earlier in this study was not affected by
inhibition of PGF2a in the days leading up to luteolysis but the numbers of
macrophages present were significantly reduced. It appears that PGF2a is not the
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stimulus for an influx of T-lymphocytes but does influence macrophage numbers in
the CL. However there are many other factors that must be investigated before it is
possible to construct a specific order of events.
There is evidence also that a changing hormonal environment alters expression of
various cytokines by peripheral immune cells as well as within the reproductive tract.
High concentrations of progesterone and oestrogen reduce TNF-a in blood
monocytes and 11-1(3 is three-fold higher in blood monocytes during the luteal phase
compared to the follicular phase in women (Loy et al., 1992; Polan et al., 1994).
TNF-a is under hormonal regulation throughout the reproductive tract in women (see
Hunt, 1993 for a review article). There are no studies describing alterations in
immune cell populations or cytokine production in the cow CL, in relation to changes
in the hormonal environment, apart from an increase in TNF-a production in the CL
after luteolysis in the cow (Shaw and Britt, 1995). However, it is likely that a
changing hormonal environment, either locally or peripherally, is important in
altering immune cells and cytokine production within the cow CL.
If immune cells play a significant role in luteolysis then their presence and/or activity
must be suppressed for successful maintenance of pregnancy. The populations of T-
lymphocytes in the cow CL during pregnancy have not been described in detail,
although reduced numbers of macrophages and lymphocytes in pregnant cow CL
compared to CL from a non-pregnant cycle were observed in an early study (Lobel
and Levey, 1968). Interferon-T released by the trophoblast has been shown to have a
range of anti-luteolytic effects, including inhibition of release of luteolytic pulses of
PGF2a from the uterus (Bazer and Johnson, 1991; Bazer et al., 1991; Thatcher et al.,
1995). However, basal concentrations of PGF2ot are not lower in the pregnant cycle
and low level pulses of PGF2a have been recorded between days 14 and 16 after
oestrus in pregnant animals (Kindahl et al., 1976; Parkinson and Lamming, 1990). In
addition, PGF2a receptors in the CL are not reduced in early pregnancy (Sakamoto et
al., 1995). Therefore, other mechanisms, taking effect after PGF2a binding, may also
be involved in inhibition of luteolysis (Wiltbank et al., 1992b).
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Culture media from day 18 embryos were immunosuppressive as were uterine
flushings from day 18 pregnant and non-pregnant cows (French and Northey, 1983;
Fisher et al., 1985). The anastamoses between the uterine vein and artery have been
shown to transport uterine PGF2a to the ovary. It is conceivable that
immunosuppressive factors (possibly interferon-T) could also be transported to the
ovary by this route. Fisher et al. (1985) failed to find any evidence of
immmunosuppressive substances in the uterine vein blood. However the authors
indicated that the assay may not have been sufficiently sensitive to detect low
concentrations. Lymphocyte proliferation is however inhibited by interferon-T (Low
et al., 1991; Skopets et al., 1992). There is also a decline in the number of intra¬
epithelial lymphocytes in the bovine endometrium at the site of attachment of the
conceptus (Hansen, 1995).
Future studies should involve investigations into immune cell populations within CL
from pregnant cows around day 16-18 of pregnancy. In addition more detailed studies
into the immunosuppressive effects of blood from the uterine vein / ovarian artery
(specifically interferon-T) at this stage of the oestrous cycle would be of interest.
Another more invasive approach to investigate the altered T-lymphocyte population
would be to depress the numbers of T-lymphocytes present within the ovary and CL.
There are already various studies that confirm that artificially altering the immune
status affects reproduction in general. For example, ovulation was inhibited in rats
treated with anti-thymocyte serum (Bukovsky et al., 1977) and, in the cow, reducing
the total numbers of circulating lymphocytes altered CL function (Alila and Hansel,
1984). However, in order to investigate immune cells in the CL more specifically a
more subtle approach will be necessary whereby only the ovary is affected. This
could prove somewhat difficult, although the successful use of a microdialysis
system placed within the cow CL in vivo might encourage the development of a
technique to allow the supply of immunosuppressive substances directly to the CL
(Shaw and Britt, 1995).
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From the above observations it can be seen that there are many possible routes of
further investigation, all of which would add to our understanding of how the
immune system functions within the CL, particularly around luteolysis. T-
lymphocytes, macrophages and TNF-a, 11-1(3 and EFN-y are the primary cell sources
and cytokines of interest. However the presence of MCP-1 in cow CL was a
significant finding in this study, particularly as MCP-1 expression was increased
prior to structural luteolysis.
MCP-1 has never been described in bovine luteal tissue previously and its presence
could explain the role of increased numbers of CD5+/CD8+ T-lymphocytes in cow
CL before functional luteolysis. Further investigations in our laboratory have already
indicated that T-lymphocytes are the source of MCP-1 in the cow CL prior to
structural luteolysis (unpublished observations). The regions of tissue where MCP-1
is strongly expressed on in situ hybridisation are associated with populations of
CD5+ T-lymphocytes stained by immunohistochemistry of parallel sections.
Therefore T-lymphocytes may be central to the attraction and activation of
macrophages into the CL during structural luteolysis. Future studies relating to MCP-
1 will investigate its expression in animals where PGF201 production was inhibited by
flunixin as this resulted in a decrease in the numbers of luteal macrophages. PGF201
could be the substance that signals the release of MCP-1 from T-lymphocyte
populations (and possibly other cell types) within the CL.
Conclusion
To conclude; based on the results of this study, and our present understanding of
basic immunological and reproductive processes, the following order of events
within the CL around luteolysis are proposed;
Between days 5 and 10-14 of a non-pregnant cycle, populations of immune cells and
MHC II expression stay reasonably constant. Around day 16 of the oestrous cycle,
increased numbers of CD8+ T-lymphocytes enter luteal tissue, possibly under the
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influence of a changing hormonal environment, although specific chemoattractant
substances could be involved. The populations of T-lymphocytes then act, either
directly or indirectly through their cytokine products, in the processes which occur
during luteolysis, i.e. decreased steroidogenesis and/or luteal production of PGF2a.
Luteolytic concentrations of PGF2a at this time stimulate release ofMCP-1 from cells
of the CL, including T-lymphocytes, causing activation of existing populations of
macrophages and also acting as a chemoattractant to other macrophages, bringing
them into the CL at the time of structural luteolysis. During luteolysis MHC II
expression is also upregulated (possibly by PGF2a or cytokines) and the destruction
of luteal tissue takes place rapidly as a result of a co-ordinated immune response
against the cells of the CL. In addition, destruction of the CL may be accelerated by
an increase in the rate of apoptosis induced by cytokines produced by immune cells
or even luteal cells. The rapid loss of CL function and progesterone production
during luteolysis may be a direct effect of cytokines, in particular TNF-a, on
endothelial cells, causing a collapse of the blood supply within the CL.
These findings demonstrate that the cells of the immune system are significant in
affecting CL function around luteolysis in the cow, although the exact nature of their
role has yet to be clearly defined. They also highlight specific areas of future research
relating to the immune system and reproductive function in the cow. Further studies
should concentrate initially on investigating immune cell populations and cytokine
production within the CL from the early-pregnant cow. In addition, specific cytokine
cell sources and cytokine receptors within the CL must also be located in order to





Sources of specific chemicals and molecular kits are described in the relevant
protocol. All other chemicals were purchased from Sigma Chemical Co., Poole,
Dorset, UK, Pharmacia Biotech, St Albans, Herts, UK or Gibco BRL, Life
Technologies Ltd., Paisley, Scotland, UK.
1.2. Buffers / culture media
1.2.1. TAE buffer (SOx)
242g Tris base
57.1ml glacial acetic acid
100ml EDTA (0.5M, pH 8.0).
1.2.2. MOPS (lOx)
3-(N-morpholino) propanesulfonic acid [MOPS, 0.2M]
















Adjust pH to 7.0 with 5N NaOH and sterilise.
1.3. Diethylpyrocarbonate (DEPC)-treatment
All solutions and utensils used when working with RNA were DEPC-treated to
minimise RNase contamination as follows;
Solutions
Treated with 0.1% DEPC overnight and then sterilised.
Glassware/utensils
Treated with 1% DEPC for 2 hours at 37°C, rinsed with sterile water and then
autoclaved prior to use.
1.4. Extraction of RNA
1.4.1. Method 1
TRI Reagent™ (Molecular Research Centre, Cincinnati, USA), a ready-to-use
reagent containing phenol and guanidine thiocyanate, was used to extract RNA
following the method described by the manufacturers which is summarised below.
Sterile glassware and plugged sterile pipette tips were used throughout;
1. 50-100mg of frozen luteal tissue was added to 1 ml of TRI reagent in a sterile glass
homogeniser on ice and homogenised rapidly.
2. The homogenised samples were then decanted into 1.5ml screw top Eppendorf
tubes and stored on ice for 5 min.
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3. Chloroform (0.2ml) was added and the tubes were shaken vigorously for 15 sec
then stored for 2-15 min prior to centrifugation at 12000 g for 15 min at 4°C.
4. The upper aqueous phase was transferred to a 1.5ml Eppendorf, 0.5ml of
isopropanol was added and the tubes were then stored at room temperature for 5-
10 min. This was followed by centrifugation at 12000 g for 10 min at 4°C after
which an RNA precipitate was visible on the side of the tube.
5. The supernatant was then removed and the RNA pellet washed twice in 75%
ethanol before air drying for 5-10 min at room temperature.
6. The RNA was stored at -20°C after dissolving the pellet in 40p.l sterile distilled
water.
1.4.2. Method 2
RNA was extracted using Qiagen RNeasy kits (Qiagen Ltd., Crawley, UK) following
the recommended protocol. Sterile plugged pipette tips or positive placement pipettes
were used throughout.
1. 30-40mg of luteal tissue was homogenised in 600pl lysis buffer RLT (containing
guanidinium isothiocyanate and (3-mercaptoethanol)
2. 600fil of 70% ethanol was added, mixed by pipetting and loaded onto an RNeasy
spin column which was then centrifuged at 8000 g for 15 sec at room temperature.
3. The flow through was discarded and the column was then washed with 700pl wash
buffer RW1 (containing guanidinium isothiocyanate).
4. The column was washed twice more with 500pi of wash buffer RPE (concentrate
diluted with 4 volumes of 100% ethanol) with a final centrifugation at maximum
speed for 2 min to dry the spin column membrane.
5. 30|al of DEPC-treated water was added and the column was centrifuged at 8000 g
for 60 sec to elute the RNA. This step was repeated in order to collect as much
RNA as possible.
The quality of RNA produced from luteal tissue using this technique was poor. In
order to assess whether this could have been due to significant RNA degradation
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after extraction, the method was modified by extracting the RNA initially produced
with phenohchloroform as follows;
1.4.2.1. Additional chloroform extraction
1. An equal volume of phenohchloroform was added to the RNA sample produced
using the Qiagen RNeasy kit and mixed to form an emulsion.
2. The sample was centrifuged at 8000 g for 15 sec at room temperature and the
upper aqueous phase removed to a fresh tube.
3. An equal volume of chloroform was added and steps 1-2 repeated.
4. 0.1 volumes of sodium acetate (3M, pH 5) and 2.5 volumes of ethanol (100%)
were added and the tubes were stored at -20°C for 30 min and then centrifuged at
8000 g for 20 min at 4°C.
5. The cell pellet was washed twice in ethanol (70%), briefly air dried and then
resuspended in the original volume of DEPC-treated water.
1.4.3. Method 3
RNA extraction was performed using a basic guanidine thiocyanate technique
described by Chomczynski and Sacchi (1987).
1. 100|il of (3-mercaptoethanol was added to 14ml of denaturing solution (4M
guanidine thiocyanate in 42mM sodium citrate).
2. 200-400mg of luteal tissue was minced on ice and added to 5ml of denaturing
solution in a 50ml polypropylene tube also on ice. The tissue was homogenised
using a polytron homogeniser.
3. 50)l11 of N-Lauryl sarcosine (20%), 0.5ml of sodium acetate (2M), 5ml of
chloroform and 1ml of chloroform/isoamyl alcohol (24:1) were added to the
homogenate. The tubes were then shaken vigorously for 10 sec and stored on ice
for 15 min.
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4. The samples were then centrifuged at 10000 g for 20 min at 4°C and the aqueous
phase then transferred to a fresh tube and mixed with an equal volume of
isopropanol. The tubes were stored overnight at -20°C to precipitate the RNA.
5. After precipitation the tubes were centrifuged at 10000 g for 20 min at 4°C. The
supernatant was discarded and the pellet then dissolved in 1ml of denaturing
solution (containing 0.2mM of (3-mercaptoethanol and 0.83% of N-lauryl
sarcosine).
6. 1ml of isopropanol was added and the samples were stored at -20°C for 1 hour and
then centrifuged at 10000 g for 20 min at 4°C.
7. The RNA pellet was washed in ethanol (75%), air-dried and then resuspended in
100p.l of DEPC-treated water. A 1/100 dilution was prepared for
spectrophotometry and, after calculating the amount of RNA, each sample was
diluted in dfUO to give a concentration of approximately lp,g RNA/|il. For long
term storage, 3 volumes of ethanol (100%) were added to each tube and the
samples stored at -70°C.
1.5. Formaldehyde Gel electrophoresis
An agarose gel was prepared;
lg agarose (Appligene Oncor., Co. Durham, UK)
10ml MOPS buffer (10X)
75ml DEPC-treated water
The solution was heated in a microwave until the agarose dissolved and then cooled
to 50°C and 40% volume of formaldehyde (17ml) added immediately before pouring.
The gel was then allowed to set at room temperature for 1 hour before submersion in
running buffer (lxMOPS).






The RNA mixtures were heated in the thermal cycler at 65°C for 10 min, 2.5pl of 6x
gel loading buffer (50% glycerol, O.lmg/ml bromophenol blue) added and then 25pl
was loaded onto the gel. The samples were run at 150mA for around 45 min, stained
with ethidium bromide for 20 min and then destained for 30-40 min in dFLO.
1.6. Reverse transcription of RNA
The RTase reaction was prepared as follows
1. RTase reaction; 1 (Xg of RNA sample inlOpl DEPC-treated water
0.5pl of d(NTP)6 (125pmol, Pharmacia Biotech, UK)
0.5pi of RNasin (Promega UK Ltd., Southampton, UK)
The RNA was denatured by heating to 70°C for 10 min in a thermocycler. The
reactions were then stored at 4°C prior to addition of the enzyme mix.
2. Reverse transcriptase (RTase) mix (enough for 20 reactions)
84pl of MgCl2 (25mM)
42pl of RTase buffer (lOx, Gibco BRL)
[250mM Tris-HCL (pH 8.3), 375mM Kcl, 15mM MgCL2]
42pl of dNTP mix (lOmM, Pharmacia Biotech.)
12pl of RTase [Superscript™ II, Gibco BRL, (25U/pl)]
20pl of DEPC-treated H2O
9ul of RTase mix was added to each sample and the tubes were then placed in the
thermocycler which was programmed to run for 20°C/10 min, 42°C/ 60 min, 95°C/
5 min and then hold at 4°C.
3. All samples were diluted to lOOpl by adding;
4pl of MgCl2 (25mM),
8pl of RTase buffer (lOx)
68pl of dH20
4. The samples were stored at -70°C prior to PCR.
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1.7. PCR
1.7.1. Method 1 - Hot Start PCR
1. A PCR mix was prepared as follows for each sample;
6pil- lOpil of RTase reaction
12|il of dH20
1|B of PCR buffer (lOx, Gibco BRL)
[200mM Tris-HCl (pH 8.4), 500mM KC1]
2. The tubes were placed in a thermocycler at 90°C for 60 sec.
3. A Taq / primer mix was prepared; 5pl of Taq DNA polymerase, (5U/pl)
[Gibco BRL]
lOpil of primer mix (100-200pmol)
10|il of dH20
1 jllI of Taq /primer mix was added to each tube using separate plugged tips. The
Taq DNA polymerase was kept on ice at all times to avoid reduction of enzyme
activity.
4. The tubes were then centrifuged briefly and placed in the thermocycler and run at;
93°C/5 min, then 30-35 amplification cycles of 93°C/30 sec, 60-65°C/30 sec,
72°C/30 sec and finally 72°C/5 min. The annealing temperature and number of
cycles used varied between different primers.
1.7.2. Method 2 - Using TaqStartAntibody
TaqStart™ antibody (Clontech Laboratories, California, USA), is a neutralising
monoclonal antibody which blocks the activity of the Taq DNA polymerase enzyme
during the setting up of a PCR reaction, reducing the production of non-specific
amplification products. Antibody is inactivated when the temperature is raised above
70°C. Cost prohibited its use throughout, and Taq Start was only used where non¬
specific products were a problem.
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1. A basic PCR mix was prepared for each sample as described above.
2. Taq polymerase/primer mix; 5pl of Taq DNA polymerase
5pi of TaqStart antibody (1.1 pg/pl)
lOfil of primer mix (100-200pmol)
5(xl of dH20
lpl of Taq polymerase/primer mix was added to each PCR mix using separate
plugged tips for each tube.
3. The thermocycler was then activated to cycle mode as above.
1.7.3. PCR ofcytokine plasmid
A PCR reaction mix was prepared;
14.4|il of dH20
lp.1 of cytokine plasmid (approx. 1.3pg)
0.6|xl of MgCl2 (25mM)
2pl of PCR buffer (1 Ox)
l)Ltl ofdNTP mix (4mM)
ljil of Taq polymerase / primer mix (see section 1.7.2.)
The tubes were then included in the thermocycler as described above.
1.8. Preparation of an agarose gel
1. A 3% gel was prepared containing; 1.5g of NuSieve® GTG® Agarose
(FMC BioProducts, Rockland, USA)
0.75g of Appligene agarose
75ml of lxTAE buffer
The solution was mixed well, heated in a microwave until the agarose had
dissolved and then cooled to 50°C.
2. The solution was then poured into a gel tray and allowed to set for 1 hour at 4°C.
The combs were then carefully removed and the gel submerged in approximately
800ml of running buffer (lxTAE).
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3. 1(0,1 of 6x blue/orange loading buffer (Promega Ltd., Southampton, UK) was added
to 5(0,1 of each PCR product and mixed gently before being loaded carefully onto
the gel using separate pipette tips for each sample.
4. Molecular weight marker (300ng/5|il, Promega Ltd., Southampton, UK) was
diluted 50:50 in dPUO. For each lane required, 5|0l was then added to l|ol of
loading buffer, mixed gently and then loaded onto the gel.
5. The gel was then run at 150mA for around 50 min and then submerged in a
solution of ethidium bromide (0.5(ig/ml) for 30 min.
6. The gel was destained for 30 min in dPUO, examined under ultraviolet light and
photographed.
1.9. Confirmation of PCR products - enzyme digests
TNF-a, 11-1(3 and IFN-y PCR products were digested with specific restriction
enzymes as follows;
Restriction enzyme digests were performed in a final volume of 30|Ltl containing;
15(0,1 of PCR product,
30 U of Bgl I, Pvu II (Boehringer Mannheim UK) or EcoRV (New England
Biolabs)
lx reaction buffer (as provided with the individual enzymes)
The reactions were incubated at 37°C for 90 min and were fractionated on an agarose
gel.
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1.10. Sequencing of MCP-1
The PCR product for MCP-1 was amplified and sequenced as follows;
1.10.1. RT-PCR
Bovine luteal RNA was reverse transcribed as described above (Appendix 1, Section
1.6) followed by PCR using MCP-1 primers (Appendix 1, Section 1.7).
1.10.2. PCR Purification
PCR purification was carried out using the QIA quick PCR kit (Qiagen Ltd.,
Crawley, UK) according to the manufacturer's instructions;
1. 15|il of PCR product was added to 75(il of PB buffer, mixed and added to a spin
column for centrifugation at maximum speed in a bench-top centrifuge for 60 sec.
2. The flow through was discarded and the column washed with 750[il of PE buffer.
3. The column was then centrifuged at maximum speed for 2 periods of 60 sec to
allow drying of the membrane.
3. The PCR product/DNA was eluted using 50|il of dH20.
1.10.3. Ligation
Ligation was performed using Promega T4 DNA ligase (Promega Ltd., Southampton,
UK).
1. Ligation mix; lfll of T4 DNA ligase buffer
1 jllI of pGEM-T vector
0.5, 1.5 or 4.5(ll1 of purified PCR product
6.5, 5.5 or 2.5ml of dH20
l|il of T4 DNA ligase
2. The reactions were incubated at 15°C for 3 hours.
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1.10.4. Transformation
1. Promega high efficiency JM109 cells were removed from storage at -70°C and
placed on ice for 5 min until just thawed.
2. The cells were mixed gently and 50)0.1 aliquots placed in 1.5ml tubes on ice.
3. 2(tl from each of the ligation reactions, which contained different volumes of
DNA, was added to each tube, mixed gently and placed on ice for 15 min.
4. The cells were heat-shocked in a water bath at 42°C for 45 sec and then returned to
ice.
5. 900(0,1 of room temperature L-broth was added to each tube and the samples were
then shaken for 1 hour at 37°C.
6. 100)ol of transformation mix from each tube was plated onto agar plates (400ml
agar, 30mg ampicillin, 1 6jll1 5-bromo-4-chloro-3-indolyl-P-galactopyranoside [X-
Gal] and 4|0.1 isopropyl-P-thiogalactopyranoside [IPTG]) and kept at 37°C
overnight.
7. Colonies were examined and numbers of white (containing insert) and blue (no
insert) colonies counted. Five separate white colonies and 1 blue colony were
added to 6 Universals containing 10ml of L-broth / ampicillin (100(ig/ml) and
incubated overnight with shaking at 37°C.
1.10.5. DNA purification and isolation.
1.10.5.1. Minipreps
Wizard minipreps DNA purification systems (Promega UK Ltd., Southampton, UK)
were used according to the manufacturer's instructions;
1. 3ml of cells from each of the overnight incubations were pelleted by centrifugation
at maximum speed in a bench-top centrifuge for 1 min and then resuspended in
200pl of cell resuspension solution.
2. 200(il of cell lysis solution was added and the tube inverted repeatedly until the
cell suspension became clear.
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3. 200|il of neutralisation solution was added and mixed by inversion.
4. The tubes were then centrifuged at maximum speed for 5 min and the supernatant
removed to a fresh tube.
5. 1ml of DNA purification resin was added to each tube and mixed by inversion.
6. The resin/DNA mix was pipetted into a syringe barrel attached to a Wizard
minicolumn (Promega Ltd.) and a vacuum applied to pull the mix into the
minicolumn.
7. 2ml of column wash solution was added to the syringe barrel and the vacuum
reapplied to draw the wash solution through the column and then for a further 2
min to dry the resin.
8. The minicolumn was then transferred to a microcentrifuge tube and spun at
maximum speed for 20 sec to remove any remaining column wash.
9. 50ptl of dFLO (65°C) was then applied to the column and after 1 min the column
was spun at maximum speed for 20 sec and the plasmid DNA collected in a new
1.5ml tube.
10. For each tube the A260/A280 ratio was measured after dilution of the plasmid
1/100 with dH20.
1.10.5.2. Miniprep digests
The miniprep products were digested using specific restriction enzymes to confirm
that ligation had been successful.
1. Reactions were prepared;
15|il from each miniprep,
5|il of lOx buffer 3 (New England Biolabs)
10nl of dH20
2.5fll of NCOl (New England Biolabs)
2.5|il of NOT1 (New England Biolabs)
2. The samples were then incubated at 37°C for 1 hour.
214
3. Each sample was prepared for a PCR
IjllI of sample
0.6pl of MgCl2 (25mM)
lp.1 of dNTP mix (4mM)
14.4p.l of dH20
2pl of PCR buffer (1 Ox)
1(0.1 of Taq polymerase /primer mix
Taq mix;
2|0.1 of Taq DNA polymerase
2)0.1 of Taqstart antibody
0.8|J.l of primer l/0.8|il of primer 2
4.4)0,1 of dH20
4. The PCR product was amplified for 30 cycles at 60°C and then visualised on a 3%
agarose gel.
1.10.5.3. Maxiprep
Maxipreps were performed using Wizard™ Plus Maxipreps DNA purification
system (Promega UK Ltd., Southampton, UK) following the manufacturer's
instructions.
1. 10ml from a miniprep sample was added to 500ml of L-broth (containing
lOOpg/ml ampicillin) and incubated at 37°C overnight with shaking.
2. 5ml of culture media was retained for a frozen glycerol culture (Section 1.10.6.)
and the remaining medium was centrifuged for 10 min (25°C, 5000 g).
3. The resulting cell pellet was suspended in 15ml of cell lysis solution, mixed gently
and left at room temperature for 20 min.
4. 15ml of neutralisation solution was added and then centrifuged for 15 min (25°C,
14000 g).
5. The solution was then filtered through four layers of cheesecloth, 0.5 volumes of
isopropanol added and mixed gently before centrifugation for 15 min (25°C,
14000 g).
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6. The supernatant was carefully poured off and the centrifuge bottle allowed to drain
for 5 min.
7. The cell pellet was resuspended in 2ml of TE buffer, 10ml of DNA resin was
added and mixed.
8. The solution was poured into a maxicolumn (Promega Ltd.) and a vacuum applied.
13ml of column wash were used to wash out the centrifuge bottle and added to the
maxicolumn.
9. The column was then washed through with 12ml of column wash and then 5ml of
80% ethanol and a vacuum applied for 1 min.
10. 1.5ml of TE buffer (65°C) was added to the column which was then centrifuged
for 5 min (15°C,1300 g) to allow collection of the plasmid.
11. The A260/A280 ratio was calculated and the plasmid was stored at 4°C.
1.10.6. Frozen glycerol culture
A small amount of culture medium was frozen for long term storage as follows;
1. 1.5ml of culture media from overnight incubation at 37°C were centrifuged for 15
min at maximum speed in a bench-top centrifuge (4°C).
2. The supernatant was poured off and the cells resuspended in 1ml of TM buffer
[50mM Tris-Cl (pH 7.5), lOmM MgSCL] and mixed well.
3. 1ml of sterile glycerol was added and mixed.
4. 0.5ml aliquots were snap-frozen in liquid nitrogen and then stored at -70°C.
1.10.7. Sequencing of the PCR product
The DNA was sequenced using the Sequenase™ Version 2.0 DNA sequencing kit
(Amersham Life Science, USA).
1.10.7.1. Denaturing double-stranded DNA
1. 10pl of plasmid was mixed with 10|il of distilled water, 2pl of NaOH (2M) and
2pl of ethanol (100%) and incubated for 30 min at 37°C.
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2. 2\il of sodium acetate (NaAc, 3M, pH5.5) and 60|Ltl of ethanol (100%) were added
and mixed gently. The mixture was incubated for 30 min at -20°C.
3. The tube was centrifuged for 15 min at maximum speed in a bench-top centrifuge.
4. The pellet was washed in ethanol (75%) and then air dried before being
resuspended in 7pl of dH20.
1.10.7.2. Annealing
Annealing was performed using the DNA sequencing kit (Amersham Life Science)
according to the manufacturer's instructions.
1. Annealing mixture; 5|ll ofDNA
2pl of dH20
2fil of reaction buffer
(200mM Tris-HCl, [pH 7.5], lOOmM MgCl2, 250mM NaCl)
1 pi of primer
2. The DNA was annealed by heating for 2 min at 65°C then slowly cooled to 35°C
over 15-30 min. The tube was centrifuged briefly and stored on ice.
3. Labelling reaction; 10pl of annealed DNA mixture
lpl of DTT (0.1M)
2pl of diluted labelling mix
0.5|al of [35S]dATP
2\i\ of diluted Sequenase polymerase
The labelling reaction was mixed and incubated at room temperature for 2-5 min.
4. 3.5|al of labelling reaction was added to 4 termination tubes, each containing 2.5|il
termination mixture (G, A, T, and C) and pre-warmed to 37°C. The reactions were
mixed and incubated at 37°C for 5 min.
5. The reactions were stopped by adding 4pl of stop solution (95% formamide,
20mM EDTA, 0.05% bromophenol blue and 0.05% xylene cyanol FF).




A sequencing gel was prepared using SequaGel™ Sequencing System (National
Diagnostics, Hull, UK) following the manufacturer's instructions as follows;
To prepare a 6% monomer Sequagel
1. Basic gel solution 24ml of SequaGel concentrate
66ml of SequaGel diluent
10ml of SequaGel buffer
2. Add 0.8ml of 10% (w/v) ammonium persulphate and mix.
3. Polymerise by adding 40pl N,N, N',N'tetramethyl-ethylenediamine (TEMED) and
mix.
4. Pour gel into cassette.
5. Running buffers are 0.5x TBE (top) and 0.5x TBE/0.1M Na2HP04 (bottom).
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